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Cycloaddition of allylic azides and alkynes. The 1,3-dipolar Huisgen azide-alkyne 
cycloaddition is a significant area of interest in modern chemistry. The use of allylic azides as 
dynamic reaction partners represent a novel variant of this chemistry as they undergo facile 1,3-
allylic azide rearrangement, which is also known as the Winstein rearrangement. We combined 
such an allylic azide rearrangement with an intramolecular Huisgen cycloaddition to afford 
substituted triazoles in a diastereoselective fashion. Although modest diastereoselectivity was 
observed in most cases, the majority of diastereomeric pairs were separable. Also, depending on 
the conditions, a difference in the reactivity of various allylic azides was noticed. Under thermal 
conditions, vinyl-substituted triazoloxazines were formed, in contrast to copper(I)-catalyzed 
conditions which afforded dimerized macrocyclic products. 
Hexafluoro-2-propanol promoted Friedel–Crafts acylation reactions. The Friedel–Crafts 
acylation is one of the most important reactions in both academia and industry for the synthesis of 
aromatic ketones. The reaction is typically promoted by stoichiometric or greater amounts of acids, 
such as AlCl3, FeCl3, or H2SO4, which activate the carbonyl for attack by an aromatic group. A 
drawback of this extremely versatile acylation reaction is the generation of large amounts of 
corrosive aqueous waste following post-synthesis workup. We have shown that hexafluoro-2-
propanol (HFIP) promotes both intramolecular and intermolecular FC acylation without additional 
catalysts or reagents. This solvent-promoted acylation is practically simple and accommodates a 
broad substrates scope. Our preliminary kinetic studies reflects involvement of 3 molecules of 
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Combined allylic azide rearrangement and azide–alkyne cycloaddition reaction 
1.1 Introduction 
Allylic azide rearrangement  
        In 1960, Winstein and co-workers first reported that allylic azides undergo rearrangement and 
exist as an equilibrating mixture of regioisomers, specifically they showed that α- and β-
methylallylic azides undergo facile rearrangement to give equilibrating mixture of two 
regioisomers (Figure 1).1  
 
Figure 1. Winstein rearrangement. 
Two possible mechanisms for this rearrangement include: 1) a concerted [3,3]-sigmatropic 
rearrangement (path A, preserves stereochemical integrity of the molecule), 2) an ion-pair 






Figure 2. Proposed mechanism of allylic–azide rearrangement. 
        VanderWerf and Heasley first supported the concerted [3,3]-sigmatropic rearrangement 
pathway (path A).3 This was further confirmed by Padwa et al.2, where during their studies of 
rhodium catalyzed O-H insertion of carbenoid they observed stereospecific [3,3]-sigmatropic 
rearrangement of allylic azide in a suprafacial manner. Since the allylic azide rearrangements are 
facile and generates a mixture of isomers, it has been considered a liability in many cases.4-8 
However, allylic azide rearrangements could be advantageous if one could selectively capture a 
specific regioisomer arising from rearrangement.9 In fact, Fokin and coworkers studied the 
reactivity of allylic azides isomers in Cu(I)-catalyzed azide–alkyne cycloaddition and mCPBA 





Scheme 1. Allylic azides in Cu(I)-catalyzed azide–alkyne cycloaddition and mCPBA epoxidation 
reactions9 
 
Klepper et al. observed in their synthesis of queuosine that at low temperature they could 
freeze the rearrangement and capture one isomer by performing a Staudinger reduction at 0 ˚C 
(Scheme 2a).10 It has been also reported that one regioisomer of the allylic rearrangement can be 





Scheme 2. Examples toward selective stabilization of one regioisomer of allylic azides10,11 
 
        Craig and coworkers reported Johnson-Claisen and Ireland-Claisen rearrangements of 
equilibrating mixture of allylic azides (Scheme 3).13 They found that irrespective of initial ratio of 
allylic azides regioisomers, only one regioisomer undergo Claisen rearrangement effectively.  









        Triazoles are found in many biologically active compounds which possess HIV-1 reverse 
transcriptase inhibitory activities,14 antiparasitic,15 antiplatelet,16 antimicrobial,17-21 anticancer,22,23 
antimalarial,24 and anti-inflammatory activities.25 One of the most commonly utilized reaction to 
synthesize triazoles from azides and alkynes is by an azide–alkyne cycloaddition reaction. 
        Huisgen initially studied azide–alkyne cycloaddition reactions.26,27 However, the major 
limitations of Huisgen cycloaddition reaction were high temperature (60-120 °C), long reaction 
times and the fact that the reaction produced a mixture of regioisomers (1,4- and 1,5-disubstituted 
1,2,3-triazoles, Figure 3).28,29 These limitations were overcome by independent research of 
Sharpless and Meldal, who reported a copper-catalyzed (Cu(I)) version of the azide–alkyne 
cycloaddition reaction that selectively produced 1,4-disubstituted 1,2,3-triazoles under mild 
conditions.30,31 This is very useful reaction utilized in biomolecular ligation32 and in vivo 
tagging33,34 as well as in polymerization chemistry.35,36 Subsequently, Fokin and co-workers 
developed an azide–alkyne cycloaddition catalyzed by a ruthenium(II) ([Cp*RuCl] complexes) 
that selectively produced 1,5-regioisomers of 1,2,3-triazoles.37,38 





Figure 3. Azide–alkyne cycloaddition.28 
Combined allylic-azide rearrangement and azide–alkyne cycloaddition 
        Sharpless and co-workers studied the reactivity of allylic azides in Cu(I)-catalyzed azide–
alkyne cycloaddition reactions (Figure 4).9 They noticed greater selectivity in primary and 
secondary allylic azides versus tertiary allylic azides where no product obtained from tertiary 
allylic azides under Cu(I)-catalyzed cycloaddition conditions (Figure 4a-b). However, under these 
conditions primary versus secondary allylic azides gave the mixture of triazole products similar to 
that of the starting allylic azides ratio (Figure 4c). Subsequently, Batra and co-workers studied the 
formation of annulated triazoles from differently substituted allylic azides utilizing thermal 






Figure 4. Examples of combined allylic azide rearrangements and azide–alkyne cycloaddition. 
Recently, Aubé and co-workers utilized the allylic azide rearrangement in combination with 
the Schmidt reaction to generate diastereomerically enriched lactam products towards the 






Figure 5. Allylic azide rearrangement and intramolecular Schmidt reaction. 
        Based on the previous work of the Aubé laboratory, we thought to combine the allylic azide 
rearrangement with an intramolecular Huisgen cycloaddition reaction focusing on the effects of 
substrate structure on the product stereochemistry .41 
        An equilibrating mixture of allylic azides (terminal azides cis-t/trans-t and internal azides 
i1/i2), with already existing stereogenic center, could in theory lead to the formation of three 
triazole products under thermal cycloaddition condition (Scheme 4). The internal azides i1 and i2 
would lead to the formation of diastereomers x and y, respectively.  If the equilibrium of allylic 
azides is rapid compared to cyclization then the ratio of products x and y would reflect the relative 
energies of transition states leading to each (one contains an equatorial vinyl group and the other 
contains an axial vinyl group, assuming that the R group in the tether prefers an equatorial 
orientation). Furthermore, the z product would be obtained from terminal azide cis-t if the product 
can accommodate a cis double bond in the fused ring system. However, low yield of product z 
would be expected as the cis olefin exists in low amounts in equilibrium mixture of allylic azides 





double bond in the fused ring, would not be expected to form due to ring strain. In addition, 
intermolecular (dimerization) products could arise from any of these isomers. 
Scheme 4. Proposed combined allylic azide rearrangement and azide–alkyne cycloaddition 
 
1.2 Results and discussion 
        A series of alkynyl azides linked by three-atom oxygen-containing tethers were prepared as 
shown in Scheme 5. The first step involved alkylation of a propargylic alcohol with 1,4-





NaN3. As shown in Scheme 5, each compound was obtained as a mixture of equilibrating allylic 
azides.   
Scheme 5. General route to allylic azides 
 
        The mixture of equilibrating azides was then purified by chromatography to give the trans-t 
isomer. Based on 1H NMR, most of the isolated azides regained equilibrium in about a week at 
room temperature. For example compound 7 undergoes rearrangement to give a mixture of 
isomers. Crude 1H NMR of compound 7 (prepared by azide displacement of the corresponding 
bromide) reflects all isomers initially observed. Compound 7 was purified by column 
chromatography to isolate trans-7 which was monitored by 1H NMR at room temperature in CDCl3 
for a week. At that point the equilibrium ratio was obtained as no further spectral changes were 












                                                                                  
 
 
Figure 6. 1H NMR spectras of compound 7 at different time points. Peaks at 5.8 ppm assigned to 





Different substituents in azidoalkyne compounds were studied under thermal conditions. The 
unsubstituted azide 1 upon heating in reflux CHCl3 for 4 h gave 11 in a 72% yield (Table 1, entry 
1). The product resulted from cycloaddition of only the internal isomers of allylic azides which 
was about 17% in the equilibrated mixture of 1. This result suggested that the rearrangement occurs 
at a faster rate than azide–alkyne cycloaddition to allow triazole formation from the starting 
mixture of azides. Azides 2–10 were also subjected to similar conditions to obtain corresponding 
cycloaddition products. In most cases, separable products were obtained with relatively good 
yields. However, poor diastereoselectivity were observed in all cases (highest being 2:1, Table 1, 
entry 7). At room temperature compound 2 was reacted to give 12 in about 20 days with similar 
diastereoselectivity. 










entry azide (R1, R2, R3, R4) ter/int ratiob triazole (yield, %) dr (a/b)c 
1 1 (H, H, H, H) 83:17 11 (72)  
2 2 (Me, H, H, H) 67:33 12 (85) 1.7:1 
3 3 (Ph, H, H, H) 84:16 13 (83) 1.4:1 
4 4 (Ph, Me, H, H) 64:36 14 (76) 1.3:1e 
5 5 (Me, H, Et, H) 69:31 15 (93) 1.9:1 
6 6 (Et, H, Me, H) 86:14 16 (88) 1.5:1 
7 7 (Me, H, Ph, H) 81:19 17 (84) 2:1 
8 8 (iPr, H, Ph, H) 74:26 18 (84) 1.5:1d 
9 9 (H, H, H, Me) 88:12 19 (79) 1:1 
10 10 (H, H, H, Ph) 74:26 20 (82) 1:1e 
aConditions: toluene, reflux, 1–2 h (except for entry 1: CHCl3, reflux, 4 h). 
bEquilibrium ratio as 
determined by NMR analysis of purified allylic azides; compounds attained equilibrium over 1 
week at room temperature. cRatio determined by NMR analysis of crude reaction mixtures. dThe 
relative stereochemistry of triazoles 18a and 18b was confirmed by X-ray crystallography. 
eInseparable mixture. 
The poor diastereoselectivity could be explained using Figure 7. Transition state B which has 
the vinyl group axial could be unfavored because it includes a potential 1,3-diaxial interaction. 
However, in the observed case the 1,3-diaxial interaction is between vinyl group and an oxygen 
lone pair which results in small energy difference between the two transition states A and B. In 






Figure 7. Transition states, with vinyl group equatorial or axial, leading to product isomers a and 
b, respectively. 
As mono-substituted carbon tether between the azide and alkyne moieties resulted in poor 
product diastereoselectivity, we thought to explore multi-substituted carbon tethers. Thus, number 
of azidoalkynes were prepared having all-carbon tethers where the new stereocenter would arise 
in a 1,2- or 1,3-orientation to an existing center (Table 2). In all cases equatorial transition states 
were favored but the diastereoselectivity were still modest.    

















































aConditions: toluene, reflux, 2–8 h. bRatio determined by NMR analysis of crude reaction 
mixtures. cThe relative stereochemistry of triazoles 27a, 28a, and 29a was determined by X-ray 
crystallography. dInseparable mixtures.  
       The results suggest a minor penalty for an axial versus equatorial vinyl group (A-value 
between 1.49 and 1.68,42,43 Figure 8a) or a flattened reactive conformation (Table 2, entry 2). 
Furthermore, we studied the effect of the addition of a ring system in our substrates on the 
stereoselectivity (Table 2, entries 3-5). In each case, diastereoselectivity was improved compared 
to previous examples discussed but still remained modest with the highest ratio being 6.2:1 for the 
formation of 28 (Table 2, entry 4). This result can be explained by a transition state involving 1,3-
diaxial interactions between the axial vinyl group and the cyclohexane ring system (Figure 8c). In 
formation of compound 27, the minor isomer was disfavored with similar 1,3-diaxial interaction 






Figure 8. Steric interactions encountered en route to disfavored isomers, specifically compounds 
(a) 25b, (b) 27b, and (c) 28b. 
        As noted earlier, 1H-NMR studies showed that the allylic azide rearrangement occurring at 
room temperature obtained equilibrium in about a week. It was also noted that if a compound 
possessed terminal alkyne substitution (e.g. compound 7) no azide–alkyne cycloaddition was 
observed. In contrast, if the compound had no terminal substitution, azide–alkyne cycloaddition 
was observed at the slower rate (i.e., about 40% of product formation observed in 6.5 days for 
compound 1 at that point allylic azide equilibrium was also observed44). If we consider the rates 
to relatively similar at higher temperature then terminally substituted alkyne compounds follow 
the Curtin-Hammett conditions while compounds with no terminal alkyne substitution follow a 
mixed kinetic profile, where the barrier for product formation seems close in energy with barrier 
in allylic azide rearrangement.45 
        Upon treatment with CuSO4·5H2O compound 2 interestingly gave dimerized azide–alkyne 
cycloaddition product 31 (Scheme 6, determined by mass spectroscopy). The trans double bond 
was depicted based on the vicinal coupling constant J = 15.5 Hz in case of compound 31. While 
these vicinal protons were coincide in 1H NMR of compound 32. Thus, for compound 32, trans 





resonances was observed in both the 1H and 13C NMR spectra. Relative stereochemistry could not 
be assigned with certainty to either product as well as one could not rule out the presence of mixture 
of stereoisomers. The regioisomer (i.e., 1,4-disubstituted triazole) obtained in both of these cases 
were in accordance with Cu-catalyzed azide–alkyne cycloaddition reaction outcome.46,47 Due to 
strain of the ring system as well as low amount of the cis-t might have prevented the potential 
formation of compound 30. The intermediate shown in Scheme 6 is quite possible where the azide–
alkyne cycloaddition happens first between two molecules followed by allylic azide rearrangement 
and macrocyclization.  






        The allylic azide 33 gave oxazepine 34 under thermal conditions while under the copper(I) 
catalyzed condition the same azide resulted in macrocyclic triazole 35 (Scheme 7).  
Scheme 7. Reactivity under different conditions. 
 
1.3 Conclusions 
        In conclusion, interesting heterocycles were synthesized by an intramolecular Huisgen 
cycloaddition of an interconverting allylic azide isomers under thermal conditions. The products 
contain an alkene moiety which can be used as handle for further modification. However, 
stereoselectivity were modest, products were separable in most cases by column chromatography. 










1.4 Experimental Section 
General information. Reactions were performed under an inert atmosphere (argon or 
nitrogen) in oven-dried glassware. All chemicals were used as received from commercial source 
without further purification. TLC was performed using commercial glass-backed silica plates (250 
microns) with an organic binder. Visualization was accomplished using UV light or aqueous 
KMnO4 by heating. Purification was achieved by flash chromatography on a CombiFlash Rf 
(automated flash chromatography) system. IR spectra were acquired as thin films or solids. All 
NMR spectra (1H, 13C, DEPT, COSY, NOESY, HMBC, and HSQC) were acquired on either a 400 
MHz or a 500 MHz instrument. Chemical shifts are reported in parts per million (ppm) and are 
referenced to the center line of the solvent ( 7.26 and 2.50 ppm with respect to CDCl3 and DMSO-
d6 for 
1H NMR and  77.16 and 39.52 ppm with respect to CDCl3 and DMSO-d6 for 
13C NMR, 
respectively). Coupling constants are given in Hertz (Hz). HRMS data were collected with an 
electrospray ion source (ESI). Allyl bromide intermediates were failed to give HRMS. Melting 
points were determined on an automated melting point apparatus and are uncorrected.  
 
(E)-4-Azidobut-2-en-1-ol (trans-1a), 2-azidobut-3-en-1-ol (i-1a). To a solution of 2-
vinyloxirane (370 mg, 5.28 mmol) and ammonium chloride (1.41 g, 26.4 mmol) in a mixed solvent 





mixture was refluxed for 24 h. After cooling to room temperature, water and dichloromethane were 
added. After separation, the aqueous layer was extracted with dichloromethane three times. The 
combined organic layers were washed with brine, dried over anhydrous sodium sulfate and 
concentrated. The residue was purified by silica gel column chromatography (10-20% 
EtOAc/hexanes) to afford trans-1a and i-1a (280 mg, 47%, 96:4) as a colorless oil. Azides trans-
1a and i-1a: Rf = 0.30 (50% EtOAc/hexanes). Azide trans-1a: 
1H NMR (400 MHz, CDCl3) δ 5.88-
5.96 (m, 1H), 5.73-5.80 (m, 1H), 4.19 (d, J = 6.4 Hz, 2H), 3.79 (d, J = 6.4 Hz, 2H), 2.28 (br, 1H); 
13C NMR (100 MHz, CDCl3) δ 134.4, 124.1, 62.5, 52.2. Azides i-1a (diagnostic peaks only): 
1H 
NMR (400 MHz, CDCl3) δ 5.85-5.93 (m, 1H), 5.73-5.80 (m, 1H), 5.36-5.43(m, 2H),   2.54 (br, 
1H), 3.53-3.57 (m, 1H), 3.63-3.67 (m, 1H), 4.03-4.07 (m, 1H), 5.36-5.43(m, 2H), 5.41 (dt, J = 17.2 
Hz, 1.2 Hz, 1H), 5.28 (dt, J = 10.4 Hz, 1.2 Hz, 1H), 4.34 (br, 1H), 3.40 (dd, J = 3.6 Hz, 12.3 Hz, 
1H), 3.33 (dd, J = 7.2 Hz, 12.3 Hz, 1H), 2.08 (br, 1H). 
 
(E)-1-Azido-4-(prop-2-yn-1-yloxy)but-2-ene (trans-1) and 3-Azido-4-(prop-2-yn-1-
yloxy)but-1-ene (i-1). To a solution of a mixture of azides trans-1a, and i-1a (500 mg, 4.42 mmol) 
in anhydrous DMF (20 mL) at 0 °C under N2 atmosphere was added sodium hydride (60% in 
mineral oil, 221 mg, 5.52 mmol). After the resulting mixture was stirred at 0 °C for 30 min, 





mixture was stirred overnight, and quenched with saturated aqueous ammonium chloride. Products 
were extracted with diethyl ether three times. The combined organic layers were washed with 
brine, dried over anhydrous sodium sulfate and concentrated. The residue was purified by silica 
gel column chromatography (0.5-2% EtOAc/hexanes) to afford a mixture of azides trans-1, and i-
1 (60 mg, 34%, 83:17) as a colorless oil. Azide trans-1 and i-1: Rf = 0.30 (5% EtOAc/hexanes); 
IR (neat) 2859, 2100 cm-1; HRMS (ESI) m/z calculated for C7H10N3O (M+H)
+ 152.0824, found: 
152.0830. Azide trans-1: 1H NMR (400 MHz, CDCl3) δ 5.84 (q, J = 4.8 Hz, 2H), 4.17 (d, J = 2.4 
Hz, 2H), 4.11 (d, J = 4.1 Hz, 2H), 3.80 (d, J = 4.6 Hz, 2H), 2.46 (t, J = 2.4 Hz, 1H); 13C NMR (101 
MHz, CDCl3) δ 130.7, 126.6, 79.4, 74.7, 69.0, 57.3, 52.2. Azides i-1 (diagnostic peaks only): 
1H 
NMR (400 MHz, CDCl3) δ 5.79 (ddd, J = 17.3, 10.3, 7.1 Hz, 1H),  5.41 (dt, J = 17.1, 1.1 Hz, 2H), 
5.36 (dt, J = 10.3, 1.0 Hz, 2H), 4.23 (t, J = 2.4 Hz, 1H), 4.10-4.16 (m, 1H), 3.65 (dd, J = 9.9, 4.4 
Hz, 1H), 3.55 (dd, J = 9.9, 7.4 Hz, 1H), 2.48 (t, J = 2.4 Hz, 1H). 
 
7-Vinyl-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazine (11). A mixture of azides trans-
1, and i-1 (32 mg, 0.20 mmol) in chloroform (11 mL) under N2 atmosphere was refluxed for 4 h. 
After the reaction was cooled to room temperature, solvent was removed under reduced pressure. 
The residue was purified by silica gel column chromatography (20-50% EtOAc/hexanes) to afford 
triazole 11 (23 mg, 72%) as a colorless oil. Triazole 11: Rf = 0.45 (100% EtOAc); IR (neat) 2923 
cm-1; HRMS (ESI) m/z calcd for C7H10N3O [M + H]
+: 152.0824, found: 152.0824; 1H NMR (400 





= 6.1 Hz, 1H), 4.94 (s, 2H), 4.12 (dd, J = 12.1, 4.3 Hz, 1H), 3.90 (dd, J = 12.1, 6.0 Hz, 1H). 13C 
NMR (100 MHz, CDCl3) δ 132.3, 130.4, 128.1, 120.7, 68.3, 62.5, 58.6. 
Compounds 2a-g were prepared using the following general procedure. 3-Butyn-2-ol (2.0 
g, 2.23 mL, 2.85 mmol) was added dropwise via syringe to a suspension of NaH (60% in oil, 1.14 
g, 2.85 mmol) in dry THF (25 mL) at 0 °C. The mixture was stirred at 0 °C for 30 min and then 
(E)-1,4-dibromo-2-butene (13.41 g, 6.27 mmol) was added and the reaction was heated at 50 °C 
for 24 h. The mixture was allowed to cool and then quenched with a mixture of Et2O and H2O and 
then poured onto Et2O and 2M aq HCl. The aqueous layer was extracted with Et2O (3 × 10 mL) 
and the combined organic layer was washed with water (1 × 20 mL) and brine, and dried (Na2SO4). 
Filtration and concentration gave a residue, which was purified by automated chromatography 
(silica, hexane/EtOAc 9.5:0.5) to give (E)-1-bromo-4-(but-3-yn-2-yloxy)but-2-ene (2a, 1.82 g, 
20%) as a colorless oil. 
 
(E)-1-Bromo-4-(but-3-yn-2-yloxy)but-2-ene (2a). Obtained as a colorless oil (yield = 31%). 
Rf = 0.6 (10% EtOAc/hexanes); IR (neat) 3295, 2985, 1648 cm
-1; 1H NMR (400 MHz, CDCl3) δ 
5.98 (dtt, J = 14.0, 7.3, 1.4 Hz, 1H), 5.86 (dddt, J = 15.0, 6.0, 5.2, 0.9 Hz, 1H), 4.32 – 4.23 (m, 
1H), 4.19 (qd, J = 6.6, 2.0 Hz, 1H), 4.01 – 3.94 (m, 3H), 2.43 (d, J = 2.0 Hz, 1H), 1.45 (d, J = 6.6 






(E)-(1-(4-Bromobut-2-enyloxy)prop-2-ynyl)benzene (2b). Obtained as a colorless oil (yield 
= 30%). Rf = 0.70 (10% EtOAc/hexanes); IR (neat) 3290, 2857, 1648 cm
-1; 1H NMR (400 MHz, 
CDCl3) δ 7.52 (ddd, J = 7.6, 1.5, 0.7 Hz, 2H), 7.46 – 7.29 (m, 3H), 6.11 – 5.81 (m, 2H), 5.20 (d, J 
= 2.2 Hz, 1H), 4.26 – 4.17 (m, 1H), 4.17 – 4.05 (m, 1H), 3.96 (dd, J = 7.3, 0.8 Hz, 2H), 2.66 (d, J 
= 2.2 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 138.0, 131.2, 128.7, 128.6, 128.0, 127.5, 84.0, 76.6, 
70.9, 67.6, 32.0. 
 
(E)-(2-(4-Bromobut-2-enyloxy)but-3-yn-2-yl)benzene (2c). Obtained as a colorless oil 
(yield = 5%). Rf = 0.7 (10% EtOAc/hexanes); IR (neat) 3291, 2988 cm
-1; 1H NMR (400 MHz, 
CDCl3) δ 7.74 – 7.48 (m, 2H), 7.40 – 7.34 (m, 2H), 7.33 – 7.28 (m, 1H), 6.00 – 5.90 (m, 1H), 5.90 
– 5.81 (m, 1H), 4.24 – 4.05 (m, 1H), 4.05 – 3.85 (m, 2H), 3.79 – 3.58 (m, 1H), 2.73 (s, 1H), 1.76 
(s, 3H); 13C NMR (101 MHz, CDCl3) δ 142.4, 132.0, 128.5, 128.2, 128.1, 126.0, 83.9, 76.2, 75.8, 






(E)-2-(4-Bromobut-2-enyloxy)hex-3-yne (2d). Obtained as a colorless oil (yield = 5%). Rf = 
0.70 (10% EtOAc/hexanes); IR (neat) 2981 cm-1; 1H NMR (400 MHz, CDCl3) δ 6.08 – 5.79 (m, 
2H), 4.30 – 4.10 (m, 2H), 4.02 – 3.90 (m, 3H), 2.22 (qd, J = 7.5, 1.9 Hz, 2H), 1.41 (d, J = 6.5 Hz, 
3H), 1.14 (t, J = 7.5 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 131.8, 128.8, 87.4, 79.1, 67.8, 65.2, 
32.2, 22.6, 14.1, 12.5. 
 
(E)-4-(4-Bromobut-2-enyloxy)hex-2-yne (2e). Obtained as a colorless oil (yield = 15%). Rf 
= 0.70 (10% EtOAc/hexanes); IR (neat) 2969, 1724 cm-1; 1H NMR (400 MHz, CDCl3) δ 6.07 – 
5.78 (m, 2H), 4.34 – 4.19 (m, 1H), 4.03 – 3.88 (m, 4H), 1.86 (d, J = 2.1 Hz, 3H), 1.79 – 1.61 (m, 
2H), 0.99 (t, J = 7.4 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 131.9, 128.7, 82.1, 78.1, 70.9, 67.9, 
32.3, 29.2, 9.9, 3.7. 
 
(E)-(3-((4-Bromobut-2-en-1-yl)oxy)but-1-yn-1-yl)benzene (2f). Spectral data for 






(E)-(3-(4-Bromobut-2-enyloxy)-4-methylpent-1-ynyl)benzene (2g). Obtained as a 
colorless oil (yield = 11%). Rf = 0.75 (10% EtOAc/hexanes); IR (neat) 2962 cm
-1; 1H NMR (400 
MHz, CDCl3) δ 7.48 – 7.41 (m, 2H), 7.31 (dd, J = 4.0, 2.6 Hz, 3H), 6.20 – 5.77 (m, 2H), 4.39 – 
4.31 (m, 1H), 4.13 – 4.02 (m, 2H), 3.98 (d, J = 7.3 Hz, 2H), 2.08 – 1.99 (m, 1H), 1.11 – 1.03 (m, 
6H); 13C NMR (101 MHz, CDCl3) δ 132.0, 131.9, 128.7, 128.4, 128.3, 123.0, 87.1, 86.8, 75.4, 
68.3, 33.5, 32.3, 18.8, 18.1. 
 
Compounds 2-8 were prepared using the following general procedure. A suspension of 
(E)-1-bromo-4-(but-3-yn-2-yloxy)but-2-ene (2a, 1.47 g, 7.23 mmol) and sodium azide (1.41 g, 
2.17 mmol) in DMF (40 mL) was stirred for 3 h at room temperature. Saturated aq NH4Cl was 
added. The aqueous layer was extracted with Et2O (3 × 10 mL) and the combined organics washed 
with water (1 × 20 mL) and brine, and dried over Na2SO4. Filtration and concentration gave a 
residue, which was purified by automated chromatography (silica, hexane/EtOAc 9.5:0.5) to give 
mixture of azides trans-2, and  i-2 (0.89 g, 75%, 67:33) as a colorless oil. 
(E)-1-Azido-4-(but-3-yn-2-yloxy)but-2-ene (trans-2), 3-azido-4-(but-3-yn-2-yloxy)but-1-
ene (i-2). Obtained as a colorless oil. trans-2 and i-2 (67:33): Rf = 0.5 (10% EtOAc/hexanes); IR 
(neat) 2100 cm-1; HRMS (ESI) m/z calcd for C8H12N3O [M + H]
+ 166.0980, found 166.0976. trans-
2: 1H NMR (400 MHz, CDCl3) δ 5.94 – 5.75 (m, 2H), 4.34 – 4.24 (m, 1H), 4.20 (qd, J = 6.6, 2.0 
Hz, 1H), 4.06 – 3.92 (m, 1H), 3.83 – 3.76 (m, 2H), 2.43 (d, J = 2.0 Hz, 1H), 1.46 (d, J = 6.6 Hz, 





peaks only): 1H NMR (400 MHz, CDCl3) δ 3.90 (d, J = 7.4 Hz, 1H), 3.51 (dd, J = 10.0, 4.3 Hz, 
1H), 3.39 (dd, J = 9.9, 8.0 Hz, 1H). 
 
(E)-(1-(4-Azidobut-2-enyloxy)prop-2-ynyl)benzene (trans-3), (1-((2-azidobut-3-en-1-
yl)oxy)prop-2-yn-1-yl)benzene (i-3). Obtained as a colorless oil (yield = 70%). trans-3 and i-3 
(84:16): Rf = 0.6 (10% EtOAc/hexanes); IR (neat) 2097 cm
-1; HRMS (ESI) m/z calcd for 
C13H14N3O [M + H]
+ 228.1137, found 228.1152. trans-3: 1H NMR (400 MHz, CDCl3) δ 7.53 (dd, 
J = 8.1, 1.4 Hz, 2H), 7.47 – 7.30 (m, 3H), 6.03 – 5.74 (m, 2H), 5.22 (d, J = 2.2 Hz, 1H), 4.24 (ddt, 
J = 7.2, 5.1, 1.0 Hz, 1H), 4.14 (ddd, J = 6.4, 4.8, 0.7 Hz, 1H), 3.80 (d, J = 5.5 Hz, 2H), 2.66 (d, J 
= 2.2 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 138.1, 131.2, 128.8, 128.8, 127.6, 126.6, 81.5, 76.1, 
70.8, 67.8, 52.4. i-3 (diagnostic peaks only): 1H NMR (400 MHz, CDCl3) δ 5.75 (ddd, J = 13.9, 
6.9, 3.4 Hz, 2H), 5.40 (q, J = 1.1 Hz, 1H), 5.35 (q, J = 1.1 Hz, 1H), 5.33 (t, J = 1.1 Hz, 1H), 5.30 
(t, J = 1.2 Hz, 1H), 3.74 (dd, J = 9.9, 4.2 Hz, 1H), 3.69 – 3.60 (m, 2H), 3.55 (dd, J = 9.9, 7.7 Hz, 
1H), 2.68 (d, J = 2.2 Hz, 2H). 
 
(E)-(2-((4-Azidobut-2-en-1-yl)oxy)but-3-yn-2-yl)benzene (trans-4), (2-((2-azidobut-3-en-
1-yl)oxy)but-3-yn-2-yl)benzene (i-4). Obtained as a colorless oil (yield = 89%). trans-4 and i-4 
(64:36): Rf = 0.6 (10% EtOAc/hexanes); IR (neat) 2101 cm





C14H16N3O [M + H]
+ 242.1293, found 242.1322. trans-4: 1H NMR (400 MHz, CDCl3) δ .68 – 7.57 
(m, 2H), 7.38 (tt, J = 6.6, 1.0 Hz, 2H), 7.34 – 7.28 (m, 1H), 5.96 – 5.72 (m, 2H), 4.21 – 4.10 (m, 
1H), 3.78 (dd, J = 5.9, 1.3 Hz, 2H), 3.75 – 3.66 (m, 1H), 2.74 (s, 1H), 1.77 (s, 3H); 13C NMR (101 
MHz, CDCl3) δ 142.4, 132.0, 128.5, 128.1, 126.0, 125.3, 83.9, 76.2, 75.8, 64.9, 52.5, 33.0. i-4 
(diagnostic peaks only): 1H NMR (400 MHz, CDCl3) δ 7.53 – 7.46 (m, 1H), 3.27 (dd, J = 9.7, 4.3 
Hz, 1H), 3.18 (dd, J = 9.8, 7.9 Hz, 1H). 
 
(E)-2-((4-Azidobut-2-en-1-yl)oxy)hex-3-yne (trans-5), 2-((2-azidobut-3-en-1-yl)oxy)hex-
3-yne (i-5). Obtained as a colorless oil (yield = 64%). trans-5 and i-5 (69:31): Rf = 0.6 (10% 
EtOAc/hexanes); IR (neat) 2098 cm-1; HRMS (ESI) m/z calcd for C10H16N3O [M + H]
+ 194.1293, 
found 194.1302. trans-5: 1H NMR (400 MHz, CDCl3) δ 5.96 – 5.72 (m, 2H), 4.32 – 4.22 (m, 1H), 
4.18 (qt, J = 6.5, 1.9 Hz, 1H), 4.04 – 3.92 (m, 1H), 3.83 – 3.75 (m, 2H), 2.22 (qd, J = 7.5, 1.9 Hz, 
2H), 1.41 (d, J = 6.6 Hz, 3H), 1.14 (t, J = 7.5 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 131.8, 125.9, 
87.4, 79.2, 67.9, 65.1, 52.5, 22.6, 14.1, 12.5. i-5 (diagnostic peaks only): 1H NMR (400 MHz, 
CDCl3) δ 5.42 – 5.28 (m, 3H), 3.73 (dd, J = 10.1, 7.3 Hz, 1H), 3.49 (dd, J = 10.1, 4.4 Hz, 1H), 







2-yne (i-6). Obtained as a colorless oil (yield = 56%). trans-6 and i-6 (86:14): Rf = 0.55 (10% 
EtOAc/hexanes); IR (neat) 2099 cm-1; HRMS (ESI) m/z calcd for C10H16N3O [M + H]
+ 194.1293, 
found 194.1288. trans-6: 1H NMR (400 MHz, CDCl3) δ 5.95 – 5.73 (m, 2H), 4.32 – 4.20 (m, 1H), 
4.04 – 3.91 (m, 2H), 3.79 (d, J = 5.7 Hz, 2H), 1.86 (d, J = 2.0 Hz, 3H), 1.79 – 1.61 (m, 2H), 0.99 
(t, J = 7.4 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 131.9, 125.8, 82.1, 78.1, 70.8, 68.0, 52.5, 29.2, 
9.9, 3.7. i-6 (diagnostic peaks only): 1H NMR (400 MHz, CDCl3) δ 5.44 – 5.24 (m, 4H), 3.48 (dd, 
J = 10.0, 4.4 Hz, 1H), 3.36 (dd, J = 10.0, 8.0 Hz, 1H). 
 
 (E)-(3-(4-Azidobut-2-enyloxy)but-1-ynyl)benzene (trans-7), (3-((2-azidobut-3-en-1-
yl)oxy)but-1-yn-1-yl)benzene (i-7). Obtained as a colorless oil (yield = 52%). trans-7 and i-7 
(81:19): Rf = 0.6 (10% EtOAc/hexanes); IR (neat) 2095 cm
-1; HRMS (ESI) m/z calcd for 
C14H16N3O [M + H]
+ 242.1293, found 242.1303. trans-7: 1H NMR (400 MHz, CDCl3) δ 7.50 – 
7.37 (m, 2H), 7.36 – 7.29 (m, 3H), 6.06 – 5.75 (m, 2H), 4.44 (q, J = 6.6 Hz, 1H), 4.35 (ddd, J = 
13.0, 4.8, 1.1 Hz, 1H), 4.08 (ddd, J = 13.0, 5.7, 0.9 Hz, 1H), 3.80 (d, J = 5.7 Hz, 2H), 1.55 (d, J = 
6.6 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 131.9, 131.6, 128.5, 128.4, 126.2, 122.8, 100.1, 88.9, 
85.4, 68.3, 65.4, 52.5, 22.3. i-7 (diagnostic peaks only): 1H NMR (400 MHz, CDCl3) δ 5.48 – 5.38 
(m, 1H), 5.33 (ddt, J = 17.0, 2.2, 1.1 Hz, 2H), 5.30 – 5.23 (m, 2H), 3.83 (dd, J = 10, 4.1 Hz, 1H), 






 (E)-(3-((4-Azidobut-2-en-1-yl)oxy)-4-methylpent-1-yn-1-yl)benzene (trans-8), (3-((2-
azidobut-3-en-1-yl)oxy)-4-methylpent-1-yn-1-yl)benzene (i-8). Obtained as a colorless oil 
(yield = 43%). trans-8 and i-8 (74:26): Rf = 0.65 (10% EtOAc/hexanes); IR (neat) 2099 cm
-1; 
HRMS (ESI) m/z calcd for C16H20N3O [M + H]
+ 270.1606, found 270.1614. trans-8: 1H NMR 
(400 MHz, CDCl3) δ 7.45 (ddd, J = 3.7, 2.7, 1.1 Hz, 2H), 7.39 – 7.28 (m, 3H), 6.01 – 5.76 (m, 
2H), 4.43 – 4.30 (m, 1H), 4.15 – 4.01 (m, 2H), 3.86 – 3.74 (m, 2H), 2.04 (pd, J = 6.8, 5.8 Hz, 1H), 
1.07 (dd, J = 11.0, 6.8 Hz, 6H); 13C NMR (101 MHz, CDCl3) δ 131.9, 131.9, 128.4, 125.8, 123.0, 
87.1, 86.7, 75.3, 68.5, 52.5, 33.5, 18.8, 18.1. i-8 (diagnostic peaks only): 1H NMR (400 MHz, 
CDCl3) δ 5.45 – 5.26 (m, 4H), 3.94 (dd, J = 9.9, 4.0 Hz, 1H), 3.87 (dd, J = 10.0, 7.0 Hz, 1H), 3.58 
(dd, J = 10.0, 4.4 Hz, 1H), 3.46 (dd, J = 10.0, 8.0 Hz, 1H). 
 
Compounds 12-18 were prepared using the following general procedure. (E)-1-Azido-4-
(but-3-yn-2-yloxy)but-2-ene (trans-2, 0.22 g) was dissolved in toluene (15 mL). The reaction 
mixture was heated at reflux for 1 h. The solvent was evaporated after cooling the reaction mixture 
to room temperature. The residue was purified by automated chromatography (silica, 






(4S*,7S*)-4-methyl-7-vinyl-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazine (12b). 12a: 
Obtained as a colorless solid (0.13, 57%). Rf = 0.3 (10% EtOAc/hexanes); mp 82-84 °C; IR (neat) 
2985 cm-1; HRMS (ESI) m/z calcd for C8H12N3O [M + H]
+ 166.0980, found 166.0976. 1H NMR 
(400 MHz, CDCl3) δ 7.50 (d, J = 1.0 Hz, 1H), 5.93 (ddd, J = 17.1, 10.3, 7.8 Hz, 1H), 5.66 – 5.45 
(m, 2H), 4.98 (dddq, J = 9.8, 7.8, 5.0, 1.0 Hz, 1H), 4.89 (qt, J = 6.5, 1.0 Hz, 1H), 4.23 (dd, J = 
12.2, 5.0 Hz, 1H), 3.69 (dd, J = 12.2, 10.0 Hz, 1H), 1.57 (d, J = 6.6 Hz, 3H); 13C NMR (126 MHz, 
CDCl3) δ 135.7, 131.2, 128.8, 122.1, 69.4, 68.1, 59.3, 20.4. 12b: Obtained as a colorless oil (0.62, 
28%). Rf = 0.25 (10% EtOAc/hexane); IR (neat) 2973 cm
-1; HRMS (ESI) m/z calcd for C8H12N3O 
[M + H]+ 166.0980, found 166.0990; 1H NMR (500 MHz, CDCl3) δ 7.49 (d, J = 0.9 Hz, 1H), 6.05 
(ddd, J = 17.0, 10.4, 6.6 Hz, 1H), 5.35 (ddd, J = 10.3, 1.2, 0.7 Hz, 1H), 5.16 (ddd, J = 17.1, 1.3, 
0.6 Hz, 1H), 5.06 (ddd, J = 6.7, 3.4, 1.6 Hz, 1H), 4.90 (qt, J = 6.6, 0.9 Hz, 1H), 4.19 (dd, J = 12.1, 
1.6 Hz, 1H), 4.03 (dd, J = 12.1, 3.6 Hz, 1H), 1.58 (d, J = 6.6 Hz, 3H); 13C NMR (126 MHz, CDCl3) 
δ 135.3, 134.4, 128.5, 119.3, 69.3, 67.6, 57.8, 20.7. The indicated NOE correlations were used to 








(4S*,7S*)-4-phenyl-7-vinyl-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazine (13b). 13a: 
Obtained as a colorless solid (0.06, 46%). Rf = 0.3 (10% EtOAc/hexanes); mp 65-67 °C; IR (neat) 
2859, 1454 cm-1; HRMS (ESI) m/z calcd for C13H14N3O [M + H]
+ 228.1137, found 228.1138. 1H 
NMR (400 MHz, CDCl3) δ7.46 – 7.38 (m, 3H), 7.38 – 7.32 (m, 2H), 7.31 (d, J = 0.7 Hz, 1H), 6.02 
(ddd, J = 17.3, 10.3, 7.7 Hz, 1H), 5.82 (s, 1H), 5.57 (t, J = 13.8 Hz, 2H), 5.20 – 5.08 (m, 1H), 4.32 
(dd, J = 12.2, 4.9 Hz, 1H), 3.87 (dd, J = 12.2, 9.1 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 137.7, 
134.0, 131.5, 130.6, 129.7, 129.1, 127.9, 122.1, 75.7, 67.8, 59.4, 29.9. 13b: Obtained as a colorless 
solid (0.05, 38%). Rf = 0.25 (10% EtOAc/hexane); mp 136-138 °C; IR (neat) 1074 cm
-1; HRMS 
(ESI) m/z calcd for C13H14N3O [M + H]
+ 228.1137, found 228.1137; 1H NMR (500 MHz, CDCl3) 
δ 7.47 – 7.37 (m, 3H), 7.37 – 7.31 (m, 2H), 6.13 (ddd, J = 17.0, 10.4, 6.5 Hz, 1H), 5.84 (s, 1H), 
5.43 (dd, J = 10.4, 0.5 Hz, 1H), 5.35 – 5.25 (m, 1H), 5.22 – 5.12 (m, 1H), 4.20 (ddd, J = 15.9, 12.2, 
3.2 Hz, 2H); 13C NMR (126 MHz, CDCl3) δ 137.8, 134.1, 129.7, 129.2, 127.9, 119.9, 75.5, 67.3, 









c][1,4]oxazine (14b). Obtained as a colorless oil (0.07, 76%). Rf = 0.3 (10% EtOAc/hexanes); IR 
(neat) 2925 cm-1; HRMS (ESI) m/z calcd for C14H16N3O [M + H]
+ 242.1293, found 242.1318. 14a: 
1H NMR (400 MHz, CDCl3) δ 7.75 (s, 1H), 7.40 – 7.28 (m, 5H), 5.88 – 5.70 (m, 1H), 5.58 – 5.43 
(m, 2H), 5.01 – 4.97 (m, 1H), 4.00 (dd, J = 12.4, 5.3 Hz, 1H), 3.53 (dd, J = 12.5, 10.2 Hz, 1H), 
1.83 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 142.2, 136.7, 131.3, 130.7, 128.9, 128.5, 125.9, 122.1, 
63.8, 57.9, 31.6. 14b: 1H NMR (500 MHz, CDCl3) δ 7.74 (s, 1H), 7.39 – 7.29 (m, 5H), 6.12 (ddd, 
J = 17.0, 10.4, 6.6 Hz, 1H), 5.38 (d, J = 10.4 Hz, 1H), 5.23 – 5.13 (m, 1H), 5.08 – 5.02 (m, 1H), 
3.95 (dd, J = 12.4, 1.4 Hz, 1H), 3.88 (dd, J = 12.4, 3.6 Hz, 1H), 1.84 (s, 3H); 13C NMR (126 MHz, 
CDCl3) δ 142.1, 136.3, 134.6, 131.0, 128.8, 128.5, 125.9, 119.1, 63.7, 59.3, 31.4. The indicated 









(15b). 15a: Obtained as a colorless oil (0.03, 63%). Rf = 0.3 (10% EtOAc/hexanes); IR (neat) 2975 
cm-1; HRMS (ESI) m/z calcd for C10H16N3O [M + H]
+ 194.1293, found 194.1299. 1H NMR (400 
MHz, CDCl3) δ 5.93 (ddd, J = 17.1, 10.3, 7.7 Hz, 1H), 5.56 – 5.43 (m, 2H), 5.06 – 4.86 (m, 2H), 
4.17 (dd, J = 12.1, 4.7 Hz, 1H), 3.68 (dd, J = 12.1, 8.8 Hz, 1H), 2.70 (hept, J = 7.3 Hz, 2H), 1.58 
(d, J = 6.6 Hz, 3H), 1.27 (t, J = 7.6 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 143.4, 131.8, 130.5, 
121.4, 69.4, 67.3, 59.4, 19.6, 19.3, 14.1. 15b: Obtained as a colorless oil (0.01, 30%). Rf = 0.25 
(10% EtOAc/hexane); IR (neat) 2975 cm-1; HRMS (ESI) m/z calcd for C10H16N3O [M + H]
+ 
194.1293, found 194.1295; 1H NMR (500 MHz, CDCl3) δ 6.06 (ddd, J = 17.0, 10.3, 6.5 Hz, 1H), 
5.42 – 5.31 (m, 1H), 5.27 – 5.17 (m, 1H), 5.01 (dt, J = 5.8, 2.8 Hz, 1H), 4.93 (q, J = 6.6 Hz, 1H), 
4.11 (dd, J = 12.1, 2.5 Hz, 1H), 3.97 (dd, J = 12.1, 3.6 Hz, 1H), 2.70 (dq, J = 12.9, 7.4 Hz, 2H), 
1.58 (d, J = 6.5 Hz, 3H), 1.28 (t, J = 7.5 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 143.1, 134.1, 
130.3, 119.5, 69.2, 67.0, 58.2, 19.8, 19.2, 14. The indicated NOE correlations were used to assign 









(16b). 16a: Obtained as a colorless oil (0.09, 56%). Rf = 0.3 (10% EtOAc/hexanes); IR (neat) 2973 
cm-1; HRMS (ESI) m/z calcd for C10H16N3O [M + H]
+ 194.1293, found 194.1291. 1H NMR (400 
MHz, CDCl3) δ 5.92 (ddd, J = 17.1, 10.3, 7.7 Hz, 1H), 5.57 – 5.38 (m, 2H), 4.94 (dddd, J = 8.9, 
7.8, 4.7, 0.9 Hz, 1H), 4.79 (dd, J = 7.8, 3.2 Hz, 1H), 4.17 (dd, J = 12.1, 4.6 Hz, 1H), 3.66 (dd, J = 
12.0, 8.9 Hz, 1H), 2.32 (d, J = 0.8 Hz, 3H), 2.03 (dqd, J = 14.8, 7.4, 3.2 Hz, 1H), 1.86 (dp, J = 
14.7, 7.4 Hz, 1H), 0.98 (t, J = 7.4 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 137.4, 131.7, 130.0, 
121.5, 74.0, 67.3, 59.6, 26.0, 11.4, 8.9. 16b: Obtained as a colorless oil (0.05, 31%). Rf = 0.25 
(10% EtOAc/hexane); IR (neat) 2973 cm-1; HRMS (ESI) m/z calcd for C10H16N3O [M + H]
+ 
194.1293, found 194.1292; 1H NMR (500 MHz, CDCl3) δ 6.04 (ddd, J = 17.0, 10.4, 6.5 Hz, 1H), 
5.35 (dt, J = 10.4, 0.9 Hz, 1H), 5.20 (ddd, J = 17.1, 1.4, 0.7 Hz, 1H), 5.05 – 4.96 (m, 1H), 4.80 





J = 0.8 Hz, 3H), 2.01 (dtd, J = 14.8, 7.4, 3.3 Hz, 1H), 1.89 (dp, J = 14.6, 7.3 Hz, 1H), 0.95 (t, J = 
7.4 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 137.2, 134.2, 129.7, 119.4, 73.8, 66.9, 58.2, 26.1, 
11.3, 8.8. The indicated NOE correlations were used to assign stereoisomers 16a and 16b 
 
 
(4S*,7R*)-4-Methyl-3-phenyl-7-vinyl-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazine                                                                                                      
(17a), (4S*,7S*)-4-methyl-3-phenyl-7-vinyl-6,7-dihydro-4H-[1,2,3]triazolo[5,1-
c][1,4]oxazine (17b). 17a: Rf = 0.3 (10% EtOAc/hexanes); mp 83-84 °C; IR (neat) 2984, 1607 cm
-
1; HRMS (ESI) m/z calcd for C14H16N3O [M + H]
+ 242.1293, found 242.1305. 1H NMR (500 MHz, 
CDCl3) δ 7.63 – 7.55 (m, 2H), 7.48 – 7.40 (m, 2H), 7.39 – 7.32 (m, 1H), 6.18 – 5.83 (m, 1H), 5.59 
– 5.44 (m, 2H), 5.35 (q, J = 6.5 Hz, 1H), 5.21 – 4.95 (m, 1H), 4.22 (dd, J = 12, 4.5 Hz, 1H), 3.80 
(dd, J = 12, 8.0 Hz, 1H), 1.43 (d, J = 6.5 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 142.4, 132.0, 
131.36, 131.35, 128.85, 128.23, 127.9, 121.4, 69.8, 66.5, 59.7, 18.8. 17b: Rf = 0.25 (10% 
EtOAc/hexane); mp 103-105 °C; IR (neat) 2985, 1492 cm-1; HRMS (ESI) m/z calcd for C14H16N3O 
[M + H]+ 242.1293, found 242.1308; 1H NMR (500 MHz, CDCl3) δ 7.60 (dd, J = 8.3, 1.2 Hz, 2H), 





1H), 5.39 – 5.28 (m, 2H), 5.15 – 5.04 (m, 1H), 4.15 (dd, J = 12.0, 2.9 Hz, 1H), 4.06 (dd, J = 12.0, 
3.6 Hz, 1H), 1.46 (d, J = 6.5 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 142.1, 133.7, 131.3, 131.2, 
128.9, 128.2, 127.8, 120.1, 69.7, 66.5, 58.7, 19.0. The indicated NOE correlation were used to 





[1,2,3]triazolo[5,1-c][1,4]oxazine (18b). 18a: Obtained as a colorless solid (0.03, 56%). Rf = 0.3 
(10% EtOAc/hexanes); mp 160-162 °C; IR (neat) 2969, 1339 cm-1; HRMS (ESI) m/z calcd for 
C16H20N3O [M + H]
+ 270.1606, found 270.1584. 1H NMR (400 MHz, CDCl3) δ 7.57 – 7.53 (m, 
2H), 7.45 – 7.40 (m, 2H), 7.38 – 7.33 (m, 1H), 5.96 (ddd, J = 17.2, 10.3, 8.0 Hz, 1H), 5.69 – 5.46 
(m, 2H), 5.11 (dd, J = 2.4, 0.9 Hz, 1H), 5.07 – 4.97 (m, 1H), 4.23 (dd, J = 11.9, 4.6 Hz, 1H), 3.68 
(dd, J = 11.9, 10.0 Hz, 1H), 2.20 (pd, J = 7.3, 2.8 Hz, 1H), 1.05 (d, J = 7.0 Hz, 3H), 0.55 (d, J = 
6.8 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 142.5, 131.6, 131.1, 130.2, 128.8, 128.2, 128.1, 122.0, 





EtOAc/hexane); mp 154-156 °C; IR (neat) 1091 cm-1; HRMS (ESI) m/z calcd for C16H20N3O [M 
+ H]+ 270.1606, found 270.1609; 1H NMR (500 MHz, CDCl3) δ 7.51 – 7.45 (m, 2H), 7.39 – 7.34 
(m, 2H), 7.32 – 7.26 (m, 1H), 6.06 (ddd, J = 17.0, 10.4, 6.6 Hz, 1H), 5.42 – 5.20 (m, 2H), 5.03 (d, 
J = 2.4 Hz, 2H), 4.19 (dd, J = 11.9, 1.1 Hz, 1H), 3.96 (dd, J = 11.9, 3.2 Hz, 1H), 2.18 (pd, J = 6.9, 
2.4 Hz, 1H), 1.01 (d, J = 7.0 Hz, 3H), 0.51 (d, J = 6.8 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 
142.1, 134.3, 131.6, 130.0, 128.8, 128.2, 128.0, 119.6, 78.0, 67.3, 58.5, 29.8, 19.1, 15.5. Structures 
of 18a and 18b were defined by single X-ray crystallography. 
 
(E)-5-Azidopent-3-en-2-ol (trans-3a), 3-azidopent-4-en-2-ol (i-3a). To a solution of (1,3-
bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene)dichloro(o-
isopropoxyphenylmethylene)ruthenium (Hoveyda-Grubbs 2nd generation catalyst; HG-2) (0.21 g, 
0.33 mmol) in CH2Cl2 (50 mL) under N2 atmosphere at room temperature was slowly added a 
solution of but-3-en-2-ol (7.2 g, 100 mmol) and allyl bromide (300 mmol) in CH2Cl2 (10 mL). The 
resulting reaction mixture was stirred for 3 h. The solvent was concentrated in vacuum and the 
residue was dissolved in DMSO (10 mL) and DMF (10 mL), followed by addition of NaN3 (26 g, 
400 mmol) at room temperature. After being stirred for 3 h, Et2O and H2O were added and the 
aqueous layer was washed three times with Et2O. The combined organic layers was washed with 
brine, dried (Na2SO4) and concentrated. The residue was purified by automated chromatography 
(silica, hexane/EtOAc 9.5:0.5) to give mixture of trans-3a, and i-S3a (5.64 g, 44%, 57:43) as a 
colorless oil. trans-3a: Rf = 0.45 (50% EtOAc/hexanes); IR (neat) 2096 cm
-1. HRMS (ESI) m/z 
calcd for C10H19N6O2 [2M + H]





5.86 (m, 1H), 5.64-5.75 (m, 1H), 4.27-4.37 (m, 1H), 3.74 (d, J = 5.7 Hz, 2H), 2.46 (br, 1H), 1.23-
1.29 (m, 3H); 13C NMR (100 MHz, CDCl3) δ 139.5, 122.4, 67.7, 52.1, 23.3. i-3a: 
1H NMR (400 
MHz, CDCl3) δ 5.84 (ddd, J = 17.2, 10.3, 8.2 Hz, 1H), 5.76 (ddd, J = 16.6, 10.6, 8.2 Hz, 1H), 5.44 
(d, J = 10.1 Hz, 1H), 5.38 (d, J = 17.1 Hz, 1H), 5.33-5.40 (m, 2H), 3.86-3.91 (m, 1H), 3.80-3.85 
(m, 1H), 3.74 (t, J = 7.6 Hz, 1H), 3.63-3.70 (m, 1H), 2.53 (br, 1H), 2.20 (br, 1H), 1.17 (d, J = 6.2 
Hz, 3H), 1.17 (d, J = 6.3 Hz, 3H). 
 
(E)-4-Azido-1-phenylbut-2-en-1-ol (trans-3b), 2-azido-1-phenylbut-3-en-1-ol (i-3b). 
Obtained as a colorless oil (yield = 28%). trans-3b and i-3b (81:19): Rf = 0.3 (10% 
EtOAc/hexanes); IR (neat) 2097 cm-1. trans-3b: 1H NMR (400 MHz, CDCl3) δ 7.39 – 7.28 (m, 
5H), 5.99 (ddt, J = 15.3, 5.6, 1.2 Hz, 1H), 5.85 (dtd, J = 15.4, 6.2, 1.3 Hz, 1H), 5.30 – 5.23 (m, 
1H), 3.81 (dt, J = 6.4, 1.0 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ 142.4, 137.3, 128.8, 128.1, 
126.4, 124.1, 74.3, 52.2. i-3b (diagnostic peaks only): 1H NMR (400 MHz, CDCl3) δ 5.74 – 5.61 
(m, 2H), 4.73 (d, J = 5.2 Hz, 1H), 4.57 (d, J = 7.2 Hz, 1H). 
 
Compounds 9-10 were prepared using the following general procedure. Allylic azides 
trans-3a and i-3a (1.0 g, 7.86 mmol) were added dropwise via syringe to a suspension of NaH 





°C for 30 min and then propargyl bromide (80 wt % in toluene, 1.86 g, 15.7 mmol) was added and 
the reaction was stirred at room temperature for 12 h. The reaction mixture was quenched with a 
mixture of Et2O and H2O and then poured onto Et2O and 2M aq HCl. The aqueous layer was 
extracted with Et2O (3 X 10 mL) and the combined organic layer was washed with water (1 × 20 
mL) and brine, and dried (Na2SO4). Filtration and concentration gave a residue, which was purified 
by automated chromatography (silica, hexane/EtOAc 9.5:0.5) to give azides trans-9, and  i-9 (0.44 
g, 34%, 88:12) as a colorless oil. 
(E)-1-Azido-4-(prop-2-yn-1-yloxy)pent-2-ene (trans-9), 3-azido-4-(prop-2-yn-1-
yloxy)pent-1-ene (i-9). Obtained as a colorless oil. trans-9 and i-9: Rf = 0.6 (10% EtOAc/hexanes); 
IR (neat) 2100 cm-1; HRMS (ESI) m/z calcd for C8H12N3O [M + H]
+ 266.0980, found 266.1000. 
trans-9: 1H NMR (400 MHz, CDCl3) δ 5.83 – 5.70 (m, 1H), 5.64 (ddt, J = 15.4, 7.4, 1.1 Hz, 1H), 
4.28 – 3.95 (m, 3H), 3.88 – 3.72 (m, 2H), 2.41 (t, J = 2.4 Hz, 1H), 1.29 (d, J = 6.4 Hz, 3H); 13C 
NMR (101 MHz, CDCl3) δ 136.4, 125.8, 80.1, 74.6, 74.2, 6.4, 52.2, 21.5. i-9 (diagnostic peaks 
only): 1H NMR (400 MHz, CDCl3) δ 4.26 (dd, J = 3.5, 2.4 Hz, 1H), 4.23 (dd, J = 4.7, 2.4 Hz, 1H). 
 
(E)-(4-Azido-1-(prop-2-yn-1-yloxy)but-2-en-1-yl)benzene (trans-10) (2-azido-1-(prop-2-
yn-1-yloxy)but-3-en-1-yl)benzene (i-10). Obtained as a colorless oil (yield = 41%). trans-10 and 
i-10 (74:26): Rf = 0.6 (10% EtOAc/hexanes); IR (neat) 2101 cm
-1; HRMS (ESI) m/z calcd for 
C13H14N3O [M + H]
+ 228.1137, found 228.1164. trans-10: 1H NMR (400 MHz, CDCl3) δ 7.44 – 





4.07 (dd, J = 15.8, 2.4 Hz, 1H), 3.86 – 3.74 (m, 2H), 2.44 (t, J = 2.4 Hz, 1H); 13C NMR (101 MHz, 
CDCl3) δ 139.63, 135.08, 128.80, 128.33, 127.31, 125.91, 79.97, 79.69, 74.75, 55.53, 52.31. i-10 
(diagnostic peaks only): 1H NMR (400 MHz, CDCl3) δ 4.61 (d, J = 5.6 Hz, 1H), 4.54 (d, J = 7.0 




Azido-4-(prop-2-yn-1-yloxy)pent-2-ene (trans-9, 0.43 g) was dissolved in toluene (25 mL). The 
reaction mixture was heated at reflux for 1 h. The solvent was evaporated after cooling the reaction 
mixture to room temperature. The residue was purified by automated chromatography (silica, 
hexane:EtOAc/9:1) to give 19a (0.16 g, 38%) and 19b (0.18, 41%) as a colorless oil. 19a: Rf = 0.3 
(50% EtOAc/hexanes); IR (neat) 2984 cm-1; HRMS (ESI) m/z calcd for C8H12N3O [M + H]
+ 
166.0980, found 166.1012. 1H NMR (500 MHz, CDCl3) δ 7.51 (t, J = 0.9 Hz, 1H), 5.83 (ddd, J = 
17.0, 10.1, 8.6 Hz, 1H), 5.66 – 5.54 (m, 2H), 5.06 (d, J = 15.0 Hz, 1H), 4.83 (dt, J = 15.1, 1.0 Hz, 
1H), 4.55 (t, J = 8.9 Hz, 1H), 3.71 (dq, J = 9.1, 6.2 Hz, 1H), 1.41 (d, J = 6.2 Hz, 3H); 13C NMR 
(126 MHz, CDCl3) δ 131.7, 130.7, 128.3, 123.3, 74.4, 66.0, 61.8, 17.5. 19b: Rf = 0.25 (50% 
EtOAc/hexane); IR (neat) 2985 cm-1; HRMS (ESI) m/z calcd for C8H12N3O [M + H]
+ 166.0980, 
found 166.1016. 1H NMR (500 MHz, CDCl3) δ 7.48 (t, J = 0.9 Hz, 1H), 5.89 (ddd, J = 17.1, 10.2, 
8.1 Hz, 1H), 5.41 (dt, J = 10.2, 0.8 Hz, 1H), 5.29 (dt, J = 17.1, 1.0 Hz, 1H), 5.08 (dd, J = 15.1, 0.8 





(d, J = 6.5 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 131.2, 130.0, 127.9, 121.4, 72.8, 62.6, 62.2, 





Obtained as a colorless solid (yield = 82%; 1:1). 20a and 20b: Rf = 0.3 (50% EtOAc/hexanes); IR 
(neat) 2857 cm-1; HRMS (ESI) m/z calcd for C13H14N3O [M + H]
+ 228.1137, found 228.1171. 1H 
NMR (500 MHz, CDCl3) δ 7.61 – 7.55 (m, 2H), 7.47 – 7.31 (m, 10H), 5.86 (ddd, J = 17.1, 10.3, 
8.2 Hz, 1H), 5.66 (ddd, J = 17.0, 10.4, 6.5 Hz, 1H), 5.43 – 5.28 (m, 3H), 5.22 – 5.10 (m, 3H), 5.09 
– 4.94 (m, 4H), 4.83 (dt, J = 17.1, 1.0 Hz, 1H), 4.58 (d, J = 9.0 Hz, 1H); 13C NMR (126 MHz, 
CDCl3) δ 136.1, 136.1, 130.9, 130.7, 130.6, 130.2, 129.3, 128.8, 128.7, 128.5, 128.4, 128.0, 127.8, 






Methyl (E)-6-azidohex-4-enoate (trans-4a) methyl 4-azidohex-5-enoate (i-4a). Following 
the general procedure for 3a, methyl 4-pentenoate (2.0 g, 17.50 mmol), allyl bromide (6.35 g, 52.5 
mmol), HG-2 (0.22 g, 0.35 mmol), and NaN3 (4.55 g, 70 mmol) afforded trans-4a and i-4a (62:38 
ratio, 1.05 g, 39%) as a colorless oil. trans-4a and i-4a: Rf = 0.3 (10% EtOAc/hexanes); IR (neat) 
2098, 1738 cm-1. trans-4a: 1H NMR (400 MHz, CDCl3) δ 5.86 – 5.64 (m, 1H), 5.64 – 5.48 (m, 
1H), 3.87 – 3.69 (m, 2H), 3.68 (s, 3H), 2.56 – 2.32 (m, 4H); 13C NMR (101 MHz, CDCl3) δ 173.31, 
134.60, 124.37, 52.71, 51.79, 33.65, 27.57. i-4a (diagnostic peaks only): 1H NMR (400 MHz, 
CDCl3) δ 5.38 – 5.25 (m, 2H), 3.92 (q, J = 7.3 Hz, 1H), 3.88 – 3.82 (m, 1H), 1.94 – 1.78 (m, 2H). 
 
Methyl (E)-6-azido-2-(but-2-yn-1-yl)hex-4-enoate (trans-21) methyl 4-azido-2-(but-2-yn-
1-yl)hex-5-enoate (i-21). To a solution of diisopropylamine (0.25 g, 2.51 mmol) in anhydrous 
THF (6 mL) under N2 atmosphere at 0 °C was slowly added n-BuLi (0.9 mL, 2.5 M in hexane, 
2.32 mmol). The ice bath was removed after 10 min and the reaction stirred for another 20 min. In 
another flask trans-4a and i-4a (0.3 g, 1.92 mmol) were dissolved in THF (10 mL) at -78 °C and 
to this prepared LDA was slowly added at -78 °C. The reaction mixture was stirred for 30 min and 
then propargyl bromide (80 wt% in toluene, 0.44 g, 3.28 mmol) was added. The resulting mixture 
was stirred for 1 h at -78 °C. NH4Cl and H2O were added. The aqueous layer was extracted with 
Et2O (3 × 10 mL) and the combined organics washed with water (1 × 20 mL) and brine, and dried 
over Na2SO4. Filtration and concentration gave a residue, which was purified by automated 





71:29) as a colorless oil. trans-21 and i-21: Rf = 0.3 (10% EtOAc/hexanes); IR (neat) 2098, 1736 
cm-1; HRMS (ESI) m/z calcd for C11H16N3O [M + H]
+ 222.1243, found 222.1233. trans-21: 1H 
NMR (400 MHz, CDCl3) δ 5.79 – 5.50 (m, 2H), 3.77 – 3.62 (m, 5H), 2.69 – 2.55 (m, 1H), 2.54 – 
2.31 (m, 4H), 1.77 (t, J = 2.5 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 174.4, 132.6, 126.0, 77.8, 
75.7, 52.7, 52.0, 44.6, 33.7, 21.1, 3.6. i-21 (diagnostic peaks only): 1H NMR (400 MHz, CDCl3) δ 




carboxylate (25a), methyl (5S*,7R*)-3-methyl-7-vinyl-4,5,6,7-tetrahydro-[1,2,3]triazolo[1,5-
a]pyridine-5-carboxylate (25b). Azides trans-21 and i-21 (0.10 g, 0.45 mmol) were dissolved in 
toluene (10 mL). The reaction mixture was heated at reflux for 24 h. The solvent was evaporated 
after cooling the reaction mixture to room temperature. The residue was purified by automated 
chromatography (silica, hexane:EtOAc/9:1) to give 0.080 g (80%) of the title products (anti:syn 
1:1.5) as a colorless yellow solid. Rf = 0.3 (50% EtOAc/hexanes); IR (neat) 1734 cm
-1; HRMS 
(ESI) m/z calculated for (C11H15N3O+H)
+ 222.1243, found: 222.1286. 25a: 1H NMR (500 MHz, 
CDCl3) δ 6.05 (ddd, J = 17.4, 10.2, 7.5 Hz, 1H), 5.53 – 5.38 (m, 2H), 4.90 – 4.77 (m, 1H), 3.77 (s, 
3H), 3.16 – 3.07 (m, 1H), 2.93 – 2.77 (m, 2H), 2.59 – 2.49 (m, 1H), 2.27 (d, J = 2.9 Hz, 3H), 2.00 
(dt, J = 13.7, 11.7 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 173.4, 139.4, 135.3, 128.8, 119.5, 59.9, 





1H), 5.30 (d, J = 9.8 Hz, 2H), 4.90 – 4.83 (m, 1H), 3.76 (s, 3H), 3.07 (dd, J = 16.2, 5.5 Hz, 1H), 
3.03 – 2.95 (m, 1H), 2.87 (dd, J = 16.0, 9.9 Hz, 1H), 2.37 (d, J = 13.8 Hz, 1H), 2.27 (d, J = 2.7 Hz, 
4H); 13C NMR (126 MHz, CDCl3) δ 173.7, 139.2, 136.0, 128.5, 118.1, 56.9, 52.6, 33.8, 30.8, 22.5, 
10.1. The following NOE correlations were used to assign 25a and 25b: 
 
 
2-(But-3-en-2-yl)phenol (5a).49 Following the general procedure for 2a, phenol (10 g, 106 
mmol), crotyl chloride (14.43 g, 159.3 mmol), and NaH (3.8 g, 159.3 mmol) afforded (E)-(but-2-
en-1-yloxy)benzene (8.3 g), which was used as obtained in the next reaction. The crude obtain was 
dissolved in DMF (5 mL) and irradiated in microwave for 20 min at 250 °C. The reaction mixture 
was cooled and H2O was added. The aqueous layer was extracted with Et2O (3 × 10 mL) and the 
combined organics washed with water (1 × 20 mL) and brine, and dried over Na2SO4. Filtration 
and concentration gave a residue, which was purified by automated chromatography (silica, 
hexane/EtOAc 9.5:0.5) to give  2-(but-3-en-2-yl)phenol (5a, 5.2 g, 33%) as a colorless oil. Rf = 
0.30 (10% EtOAc/hexanes); IR (neat) 3466 cm-1; 1H NMR (400 MHz, CDCl3) δ7.22 – 7.08 (m, 





5.24 – 5.19 (m, 1H), 5.19 – 5.16 (m, 1H), 5.12 (s, 1H), 3.72 (ddt, J = 7.4, 5.9, 1.6 Hz, 1H), 1.41 
(d, J = 7.1 Hz, 3H).; 13C NMR (101 MHz, CDCl3) δ 153.8, 142.5, 130.5, 128.1, 127.7, 121.1, 
116.3, 114.5, 37.8, 18.9. 
 
2-(But-3-en-2-yl)phenyl trifluoromethanesulfonate (6a). 2-(But-3-en-2-yl)phenol (5a, 0.74 
g, 4.99 mmol) was dissolved in CH2Cl2 (20 mL) and cooled to 0 °C. Pyridine (0.79 g, 9.98 mmol) 
was added to it at 0 °C and Tf2O (1.69 g, 5.99 mmol) was added over 20 min. The reaction mixture 
was stirred for 10 min at 0 °C and quenched by aq HCl. The aqueous layer was extracted with 
CH2Cl2 (3 × 10 mL) and the combined organics washed with water (1 × 20 mL) and brine, and 
dried over Na2SO4. Filtration and concentration gave a residue, which was purified by automated 
chromatography (silica, hexane) to give 6a (1.0 g, 71%) of as a colorless oil. Rf = 0.8 (10% 
EtOAc/hexanes); IR (neat) 1213 cm-1; HRMS (ESI) m/z calculated for (C11H11F3O3S-H)
+ 
279.0303, found: 279.0301. 1H NMR (400 MHz, CDCl3) δ 7.37 – 7.32 (m, 2H), 7.32 – 7.26 (m, 
2H), 5.96 (ddd, J = 17.2, 10.4, 5.9 Hz, 1H), 5.18 – 5.04 (m, 2H), 3.87 (qdt, J = 7.1, 5.8, 1.6 Hz, 
1H), 1.37 (d, J = 7.0 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 147.4, 141.0, 138.3, 129.3, 128.7, 






1-(But-3-en-2-yl)-2-(phenylethynyl)benzene (7a).50 2-(But-3-en-2-yl)phenyl 
trifluoromethanesulfonate (6a, 1.51 g, 5.41 mmol) was dissolved in DMSO (10 mL) under N2 
atmosphere. Ethynylbenzene (0.83 g, 8.12 mmol), Pd(OAc)2 (0.04 g, 0.16 mmol), PPh3 (0.17 g, 
0.65 mmol), and K3PO4 (2.29 g, 6.49 mmol) were added and resulting reaction mixture was heated 
at 80 °C for 24 h. The reaction was quenched by H2O. The aqueous layer was extracted with Et2O 
(3 × 10 mL) and the combined organics washed with water (1 × 20 mL) and brine, and dried over 
Na2SO4. Filtration and concentration gave a residue, which was purified by automated 
chromatography (silica, hexane) to give 7a (1.0 g, 80%) of as a colorless oil. Rf = 0.8 (hexane); IR 
(neat) 1637 cm-1. 1H NMR (400 MHz, CDCl3) δ 7.66 – 7.48 (m, 3H), 7.47 – 7.13 (m, 6H), 6.11 
(ddd, J = 17.3, 10.3, 5.9 Hz, 1H), 5.26 – 5.05 (m, 2H), 4.18 (ttd, J = 7.1, 5.5, 1.7 Hz, 1H), 1.44 (d, 
J = 7.0 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 147.5, 142.4, 132.5, 131.6, 128.8, 128.5, 128.4, 
126.5, 126.1, 123.6, 122.4, 113.6, 93.4, 88.2, 40.6, 19.9. 
 
2-(2-(Phenylethynyl)phenyl)propanal (8a). 1-(But-3-en-2-yl)-2-(phenylethynyl)benzene 
(7a, 1.58 g, 6.77 mmol) was dissolved in anhydrous CH2Cl2 (100 mL) under an N2 atmosphere. 
The solution was cooled to -78 °C, and a stream of O3/O2 was introduced through a disposable 
pipet for a period of 20 min. The reaction was then purged with O2 followed by N2. The reaction 
was quenched with dimethylsulfide (2.1 g, 3.38 mmol). H2O was added to the reaction mixture. 
The aqueous layer was extracted with CH2Cl2 (3 × 10 mL) and the combined organic layers 





gave a residue, which was purified by automated chromatography (silica, hexane:EtOAc/9:1) to 
give 8a (0.46 g, 29%) of as a colorless oil. Rf = 0.6 (10% EtOAc/hexanes); IR (neat) 1637 cm
-1; 
HRMS (ESI) m/z calcd for C17H13O [M - H]
- 233.0967, found 233.0951. 1H NMR (400 MHz, 
CDCl3) δ 9.83 (s, 1H), 7.64 – 7.60 (m, 1H), 7.56 – 7.50 (m, 2H), 7.40 – 7.34 (m, 4H), 7.31 (td, J 
= 7.5, 1.5 Hz, 1H), 7.18 (dd, J = 7.6, 1.4 Hz, 1H), 4.20 (q, J = 7.1 Hz, 1H), 1.51 (d, J = 7.1 Hz, 
3H); 13C NMR (101 MHz, CDCl3) δ 201.3, 140.2, 133.0, 131.6, 129.2, 128.8, 128.6, 128.1, 127.6, 
123.6, 122.9, 94.3, 87.4, 51.4, 14.3. 
 
4-(2-(Phenylethynyl)phenyl)pent-1-en-3-ol (9a). To a stirred solution of vinylmagnesium 
bromide (0.74 g, 5.63 mmol) in anhydrous THF (30 mL) at -78 °C under N2 atmosphere was slowly 
added a solution of 2-(2-(phenylethynyl)phenyl)propanal (8a, 0.05 g, 0.21 mmol) in anhydrous 
THF (5 mL). The reaction mixture was stirred for 2 h at -78 °C and then brought to room 
temperature. The reaction was quenched with aq NH4Cl solution. The aqueous layer was extracted 
with EtOAc (3 × 10 mL) and the combined organic layers washed with water (1 × 20 mL) and 
brine, and dried over Na2SO4. Filtration and concentration gave a residue, which was purified by 
automated chromatography (silica, hexane:EtOAc/9:1) to give 9a (0.02 g, 29%) of as a colorless 
oil. Rf = 0.4 (10% EtOAc/hexanes); IR (neat) 3415 cm
-1; HRMS (ESI) m/z calcd for C19H22NO 
C13H17O3 [M + NH4]
+ 280.1702, found 280.1725. 1H NMR (400 MHz, CDCl3) δ 7.61 – 7.46 (m, 
3H), 7.44 – 7.29 (m, 5H), 7.22 (ddd, J = 7.6, 5.2, 3.4 Hz, 1H), 5.94 (ddd, J = 17.2, 10.5, 5.7 Hz, 





13C NMR (101 MHz, CDCl3) δ 145.7, 139.6, 132.6, 131.6, 128.6, 128.5, 128.5, 127.2, 126.4, 
123.4, 122.9, 115.4, 93.8, 88.2, 76.4, 42.8, 14.2. 
 
(E)-1-(5-Azidopent-3-en-2-yl)-2-(phenylethynyl)benzene (trans-22), 1-(3-azidopent-4-en-
2-yl)-2-(phenylethynyl)benzene (i-22). Triethylamine was added to a solution of 4-(2-
(phenylethynyl)phenyl)pent-1-en-3-ol (9a, 0.05 g, 0.20 mmol) and methanesulfonyl chloride (0.04 
g, 0.30 mmol) in CH2Cl2 (5 mL) under N2 atmosphere at 0 °C. The reaction mixture was stirred at 
room temperature for 2 h. H2O was added, and the aqueous layer was extracted with CH2Cl2 (3 × 
10 mL). The combined organic layers were washed with water (1 × 20 mL) and brine, and dried 
over Na2SO4. Filtration and concentration gave a residue. A suspension of the residue and sodium 
azide (0.04 g, 0.61 mmol) in DMF (10 mL) was stirred for 3 h at room temperature. Saturated 
solution of aq NH4Cl was added. The aqueous layer was extracted with Et2O (3 × 10 mL) and the 
combined organic layers were washed with water (1 × 20 mL) and brine, and dried over Na2SO4. 
Filtration and concentration gave a residue, which was purified by automated chromatography 
(silica, hexane/EtOAc 9.5:0.5) to give mixture of trans-22, and  i-22 (0.03 g, 52%, 85:15) as a 
colorless oil. trans-22 and i-22: Rf = 0.7 (10% EtOAc/hexanes); IR (neat) 2097 cm
-1; HRMS (ESI) 
m/z calcd for C19H18N3 [M + H]
+: 288.1501, found: 288.1513. trans-22: 1H NMR (400 MHz, 
CDCl3) δ 7.62 – 7.48 (m, 3H), 7.40 – 7.28 (m, 4H), 7.25 – 7.18 (m, 1H), 6.01 (ddt, J = 15.3, 6.1, 
1.2 Hz, 1H), 5.63 (dtd, J = 15.2, 6.6, 1.6 Hz, 1H), 4.20 (p, J = 6.9 Hz, 1H), 3.76 (dt, J = 6.6, 1.2 





128.9, 128.6, 128.5, 126.5, 126.3, 123.5, 122.4, 122.3, 93.7, 88.0, 52.9, 39.6, 20.4. i-22 (diagnostic 
peaks only): 1H NMR (400 MHz, CDCl3) δ 5.91 – 5.69 (m, 1H), 5.37 – 5.15 (m, 2H), 4.29 (t, J = 




a]isoquinoline (26b). Azides trans-22 and i-22 (0.03 g) were dissolved in toluene (10 mL). The 
reaction mixture was heated at reflux for 12 h. The solvent was evaporated after cooling the 
reaction mixture to room temperature. The residue was purified by automated chromatography 
(silica, hexane:EtOAc/8:2) to give 26a and 26b (0.02 g, 80%) (26a:26b/1.4:1) as a colorless solid. 
26a and 26b: Rf = 0.3 (20% EtOAc/hexanes); IR (neat) 2926 cm
-1; HRMS (ESI) m/z calcd for 
C19H18N3 [M + H]
+ 288.1501, found 288.1473. 26a: 1H NMR (500 MHz, CDCl3) δ 7.79 – 7.71 
(m, 3H), 7.51 – 7.40 (m, 4H), 7.37 – 7.29 (m, 2H), 5.81 (ddd, J = 17.1, 10.4, 5.8 Hz, 1H), 5.25 – 
5.20 (m, 1H), 5.13 (dt, J = 10.6, 0.8 Hz, 1H), 5.00 – 4.89 (m, 1H), 3.30 (qd, J = 7.2, 2.3 Hz, 1H), 
1.32 (d, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 143.2, 137.2, 134.8, 131.9, 129.6, 128.8, 
128.7, 128.6, 127.9, 127.6, 126.6, 124.7, 123.6, 118.2, 63.8, 40.4, 20.8. 26b (diagnostic peaks 
only): 1H NMR (500 MHz, CDCl3) δ5.89 – 5.83 (m, 1H), 5.34 – 5.26 (m, 2H), 5.23 (dq, J = 5.7, 
2.0 Hz, 2H), 3.52 (qd, J = 7.0, 4.9 Hz, 1H), 1.43 (d, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) 
δ 143.3, 136.8, 131.8, 131.0, 127.5, 124.5, 120.8, 63.4, 38.1, 14.4. The following NOE correlations 








yl)cyclohexan-1-one (i-10a). Following the general procedure for 3a, 2-allylyclohexanone (2.0 g, 
14.40 mmol), allyl bromide (5.25 g, 43.4 mmol), HG-2 (0.18 g, 0.28 mmol), and NaN3 (3.74 g, 
57.60 mmol) afforded azides trans-10a and i-10a (81:19 ratio, 1.53 g, 55%) as a colorless oil. 
trans-10a and i-10a: Rf = 0.3 (10% EtOAc/hexanes); IR (neat) 2096, 1709 cm
-1. trans-10a: 1H 
NMR (400 MHz, CDCl3) δ 5.84 – 5.65 (m, 1H), 5.61 – 5.46 (m, 1H), 3.68 (d, J = 6.6 Hz, 2H), 
2.53 (dtd, J = 14.4, 5.8, 1.3 Hz, 1H), 2.46 – 2.22 (m, 3H), 2.19 – 1.93 (m, 3H), 1.86 (dtd, J = 9.3, 
3.5, 1.9 Hz, 1H), 1.75 – 1.54 (m, 2H), 1.46 – 1.27 (m, 1H); 13C NMR (101 MHz, CDCl3) δ 212.2, 
134.6, 124.8, 52.8, 50.4, 42.2, 33.6, 32.3, 28.0, 25.1. i-10a (diagnostic peaks only): 1H NMR (400 









azidobut-3-en-1-yl)-1-(phenylethynyl)cyclohexan-1-ol (i-23b). Azides trans-10a and i-10 (0.3 
g, 1.55 mmol) were dissolved in THF (10 mL) at -78 °C and stirred for 30 min. Then lithium 
phenylacetylide (1M in THF, 0.17 g, 1.55 mmol) was added to the reaction mixture and stirred for 
2 h at -78 °C. The reaction was brought to room temperature and stirred for 2 h. NH4Cl and H2O 
were added. The aqueous layer was extracted with Et2O (3 × 10 mL) and the combined organics 
washed with water (1 × 20 mL) and brine, and dried over Na2SO4. Filtration and concentration 
gave a residue, which was purified by automated chromatography (silica, hexane/EtOAc 9:1) to 
give mixture of azides trans-23a, i-23a (0.12 g, 25%), and trans-23b, and i-23b (0.12 g, 26%) 
(23a:23b/1:1) of as a colorless oil. trans-23a and i-23a (81:19) : Rf = 0.3 (20% EtOAc/hexanes); 
IR (neat) 2100 cm-1; HRMS (ESI) m/z calcd for C18H22N3O [M + H]
+ 296.1763, found 296.1768. 
trans-23a: 1H NMR (400 MHz, CDCl3) δ 7.49 – 7.36 (m, 2H), 7.31 (ddd, J = 3.8, 2.6, 1.5 Hz, 3H), 
5.93 – 5.70 (m, 1H), 5.66 – 5.50 (m, 1H), 3.93 – 3.83 (m, 1H), 3.78 – 3.66 (m, 1H), 2.84 – 2.63 





CDCl3) δ 135.9, 131.8, 128.4, 128.4, 124.6, 122.9, 93.6, 84.0, 70.3, 53.0, 46.0, 40.0, 34.0, 26.1, 
25.0, 21.3. i-23a (diagnostic peaks only): 1H NMR (400 MHz, CDCl3) δ 5.53 – 5.37 (m, 1H), 5.36 
– 5.21 (m, 3H), 4.02 (q, J = 7.7 Hz, 1H), 3.94 (ddd, J = 11.1, 7.3, 4.2 Hz, 1H), 3.87 (d, J = 7.3 Hz, 
3H). trans-23b and i-23b (mixture; 83:17): Rf = 0.25 (20% EtOAc/hexanes); IR (neat) 2099 cm
-1; 
HRMS (ESI) m/z calcd for C18H22N3O [M + H]
+ 296.1763, found 296.1771. trans-23b: 1H NMR 
(400 MHz, CDCl3) δ 7.53 – 7.38 (m, 2H), 7.37 – 7.29 (m, 3H), 5.92 – 5.72 (m, 1H), 5.69 – 5.51 
(m, 1H), 3.73 (d, J = 6.6 Hz, 2H), 2.75 (dddd, J = 14.2, 6.8, 4.2, 1.4 Hz, 1H), 2.21 (s, 1H), 2.17 – 
1.98 (m, 2H), 1.90 – 1.58 (m, 5H), 1.35 – 1.13 (m, 2H); 13C NMR (101 MHz, CDCl3) δ 136.0, 
131.8, 128.5, 128.5, 124.7, 122.9, 90.1, 86.9, 73.3, 53.0, 48.0, 41.5, 34.2, 29.5, 25.6, 24.3. i-23b 
(diagnostic peaks only): 1H NMR (400 MHz, CDCl3) δ 5.36 – 5.24 (m, 3H), 4.09 (q, J = 7.5 Hz, 




[1,2,3]triazolo[5,1-a]isoquinolin-10a(5H)-ol (27b). Azides trans-23a and i-23a (0.09 g, 0.30 
mmol) were dissolved in toluene (10 mL) and heated at reflux for 15 h. The solvent was evaporated 
after cooling the reaction mixture to room temperature. The residue was purified by automated 
chromatography (silica, hexane:EtOAc/8:2) to give 27a (0.06 g, 65%) and 27b (0.03 g, 32%) 
(27a:27b 2.9:1) as a colorless solid. 27a: Rf = 0.3 (50% EtOAc/hexanes); mp 227-229 °C; IR (neat) 
981 cm-1; HRMS (ESI) m/z calculated for (C18H21N3O+H)





(500 MHz, CDCl3) δ 7.70 – 7.61 (m, 2H), 7.49 – 7.32 (m, 3H), 6.13 (ddd, J = 17.4, 10.2, 7.6 Hz, 
1H), 5.48 (dt, J = 17.2, 1.0 Hz, 1H), 5.40 (dt, J = 10.1, 0.9 Hz, 1H), 4.97 – 4.88 (m, 1H), 2.27 (dd, 
J = 13.9, 3.5 Hz, 1H), 1.99 (s, 1H), 1.85 (ddd, J = 13.9, 5.5, 2.3 Hz, 1H), 1.78 (dddd, J = 12.8, 
10.8, 4.3, 2.3 Hz, 2H), 1.70 – 1.45 (m, 4H), 1.38 – 1.14 (m, 3H); 13C NMR (126 MHz, CDCl3) δ 
144.5, 136.4, 135.3, 132.5, 129.8, 128.4, 128.3, 118.7, 67.0, 61.9, 42.0, 34.3, 32.2, 26.7, 25.5, 20.8. 
27b: Rf = 0.25 (50% EtOAc/hexane); mp 155-157 °C; HRMS (ESI) m/z calcd for C18H22N3O [M 
+ H]+ 296.1763, found 296.1776; 1H NMR (500 MHz, CDCl3) δ 7.81 – 7.63 (m, 2H), 7.55 – 7.33 
(m, 3H), 6.04 (ddd, J = 17.1, 10.3, 5.2 Hz, 1H), 5.39 – 5.25 (m, 2H), 4.95 (dd, J = 17.1, 1.5 Hz, 
1H), 2.51 – 2.39 (m, 1H), 2.32 (dt, J = 13.8, 3.5 Hz, 1H), 1.94 – 1.85 (m, 1H), 1.83 – 1.73 (m, 1H), 
1.74 – 1.42 (m, 4H), 1.39 – 1.17 (m, 4H); 13C NMR (126 MHz, CDCl3) δ 144.2, 136.7, 135.3, 




[1,2,3]triazolo[5,1-a]isoquinolin-10a(5H)-ol (28b). Azides trans-23b and i-23b (0.12 g, 0.40 
mmol) was dissolved in toluene (10 mL) and heated at reflux for 8 h. The solvent was evaporated 
after cooling the reaction mixture to room temperature. The residue was purified by automated 
chromatography (silica, hexane:EtOAc/8:2) to give 28a and 28b (0.11 g, 96%) (28a:28b 6.2:1) as 
a colorless solid. 28a and 28b: Rf = 0.3 (50% EtOAc/hexanes); mp 182-184 °C; IR (neat) 2900 
cm-1; HRMS (ESI) m/z calcd for C18H22N3O [M + H]





(500 MHz, CDCl3) δ 7.78 – 7.69 (m, 2H), 7.41 (tdd, J = 8.7, 6.6, 5.1 Hz, 3H), 6.09 (ddd, J = 16.9, 
10.3, 6.5 Hz, 1H), 5.37 (dt, J = 10.5, 0.9 Hz, 1H), 5.33 – 5.21 (m, 1H), 5.12 (d, J = 7.0 Hz, 1H), 
2.37 (s, 1H), 2.23 – 2.06 (m, 2H), 1.96 – 1.80 (m, 1H), 1.79 – 1.44 (m, 4H), 1.41 – 1.19 (m, 4H); 
13C NMR (126 MHz, CDCl3) δ 144.8, 136.7, 136.2, 132.3, 129.6, 128.4, 128.4, 118.3, 69.6, 57.5, 
35.4, 31.7, 31.0, 27.3, 22.8, 22.8, 14.3. 28b (diagnostic peaks only): 1H NMR (500 MHz, CDCl3) 
δ 7.89 – 7.80 (m, 2H), 6.15 (dd, J = 10.1, 7.4 Hz, 1H), 5.52 – 5.45 (m, 1H), 5.42 (d, J = 10.3 Hz, 
1H), 4.90 (dt, J = 10.6, 6.1 Hz, 1H), 4.12 (q, J = 7.2 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 
129.4, 128.5, 128.3, 119.0, 69.9, 61.1, 34.8, 34.2, 33.9, 26.7, 21.4, 14.4. 
 
Ethyl 3-Allyl-2-methyl-4-oxocyclohex-2-ene-1-carboxylate (11aa). Hagemann’s ester (10 
g, 54.80 mmol) was rapidly added to a stirred solution of potassium tert-butoxide ( 6.77 g, 60.30 
mmol) in dry tert-butanol (30 mL). The red solution so formed turned into a straw-yellow 
suspension few minutes later after the addition. The reaction mixture was stirred for 15 min and 
then ally bromide (7.29 g, 5.22 mmol) was added in a single portion. The mixture was allowed to 
reflux for 12 h. The reaction mixture was allowed to cool to room temperature and then aq HCl 
and CH2Cl2 were added. the aqueous layer was extracted with CH2Cl2 (3 × 10 mL). The combined 
organics washed with water (1 × 20 mL) and brine, and dried over Na2SO4. Filtration and 
concentration gave a residue, which was purified by automated chromatography (silica, 
hexane/EtOAc 9.5:0.5) to give 11aa (7.7 g, 63%) as a colorless oil. Rf = 0.6 (10% EtOAc/hexanes); 
IR (neat) 1729, 1669 cm-1; HRMS (ESI) m/z calcd for C13H19O3 [M + H]





223.1356. 1H NMR (400 MHz, CDCl3) δ 5.76 (ddt, J = 16.5, 10.5, 5.9 Hz, 1H), 5.05 – 4.89 (m, 
2H), 4.20 (q, J = 7.1 Hz, 2H), 3.31 (t, J = 5.0 Hz, 1H), 3.10 (ddt, J = 5.6, 3.5, 1.7 Hz, 2H), 2.59 
(ddd, J = 16.9, 11.7, 5.2 Hz, 1H), 2.45 – 2.35 (m, 1H), 2.35 – 2.15 (m, 2H), 1.97 (d, J = 0.7 Hz, 
3H), 1.28 (t, J = 7.1 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 197.1, 172.3, 151.7, 135.1, 135.0, 
114.8, 61.4, 47.9, 34.7, 29.3, 25.8, 20.6, 14.3.  
 
2-Allyl-3-methylcyclohex-2-en-1-one (12aa). The compound 12aa was prepared following 
the procedure reported by Aubé et al.40 The starting ester (11aa, 7.68 g, 34.50 mmol) was dissolved 
in 1/1 mixture of ethanol and water (40 mL) and LiOH·H2O (2.90 g, 6.91 mmol) was added as a 
powder. The mixture was stirred 3 h, concentrated, and the residue partitioned between water and 
Et2O. The aqueous phase was acidified with 6 M aq HCl and extracted with CH2Cl2. The organic 
extracts combined, dried over Na2SO4, and concentrated. The residue was dissolved in a mixture 
of concentrated HCl (3 mL) in THF (50 mL) and heated for 24 h at 90 °C. The reaction mixture 
was allowed to cool to room temperature and then aq HCl and CH2Cl2 were added. The aqueous 
layer was extracted with CH2Cl2 (3 × 10 mL). The combined organics washed with water (1 × 20 
mL) and brine, and dried over Na2SO4. Filtration and concentration gave a residue, which was 
purified by automated chromatography (silica, hexane/EtOAc 9:1) to give 12aa (3.86 g, 74%) as 
dark yellow oil. Rf = 0.5 (20% EtOAc/hexanes); IR (neat) 1662 cm
-1; HRMS (ESI) m/z calcd for 
C10H15O [M + H]
+ 151.1123, found 151.1145. 1H NMR (400 MHz, CDCl3) δ 5.75 (ddt, J = 17.7, 





1.94 (m, 2H), 1.93 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 198.4, 157.0, 135.9, 133.2, 114.4, 37.8, 
33.1, 29.4, 22.4, 21.3. 
 
2-Allyl-3,3-dimethylcyclohexan-1-one (13aa).  Compound 13aa prepared following the 
procedure reported by Reetz and Kindler.51 Lithium chloride (0.11 g, 2.66 mmol) and CuI (0.25 g, 
1.33 mmol) were dissolved in anhydrous THF (90 mL) under argon at room temperature. The 
resulting solution was cooled to -40 °C (dry ice/acetonitrile), ketone 12aa (2.0 g, 13.30 mmol) and 
TMSCl (1.59 g, 14.60 mmol) were added, and the solution was stirred for 10 min. MeMgCl (3 M 
in THF, 1.49 g, 19.90 mmol) was added dropwise and left stirring at -40 °C for 1.5 h. The reaction 
mixture was then poured into saturated aq NH4Cl (150 mL) and Et2O (150 mL). The aqueous layer 
was extracted with Et2O (3 × 10 mL). The combined organics washed with water (1 × 20 mL) and 
brine, and dried over Na2SO4. Filtration and concentration gave a residue, which was dissolved in 
THF (40 mL) and stirred with TBAF (1 M in THF, 20 mL, 19.9 mmol) at room temperature for 
30 min under N2 atmosphere. The mixture was poured into H2O and Et2O, and the aqueous layer 
was extracted with Et2O (3 × 10 mL). The combined organics washed with water (1 × 20 mL) and 
brine, and dried over Na2SO4. Filtration and concentration gave a residue, which was purified by 
automated chromatography (silica, hexane/EtOAc 9:1) to give 13aa (1.67 g, 76%) as a colorless 
oil. Rf = 0.5 (10% EtOAc/hexanes); IR (neat) 1709 cm
-1. 1H NMR (400 MHz, CDCl3) δ 5.76 (dddd, 
J = 17.2, 10.1, 7.2, 6.4 Hz, 1H), 5.11 – 4.77 (m, 2H), 2.45 (dddt, J = 14.1, 10.3, 6.4, 1.3 Hz, 1H), 





(m, 2H), 1.07 (s, 3H), 0.79 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 212.8, 138.0, 115.3, 61.1, 41.4, 
39.8, 39.3, 29.6, 28.8, 23.2, 22.2. 
 
(E)-2-(4-Azidobut-2-en-1-yl)-3,3-dimethylcyclohexan-1-one (trans-14aa), 2-(2-azidobut-
3-en-1-yl)-3,3-dimethylcyclohexan-1-one (i-14aa). Following the general procedure for 3a, 2-
allyl-3,3-dimethylcyclohexan-1-one (13aa, 1.66 g, 9.95 mmol), allyl bromide (3.61 g, 29.80 
mmol), HG-2 (0.12 g, 0.20 mmol), and NaN3 (2.59 g, 39.80 mmol) afforded azides trans-14aa and 
i-14aa (72:28 ratio, 1.32 g, 60%) as a colorless oil. Azides trans-14aa and i-14aa: Rf = 0.4 (10% 
EtOAc/hexanes); IR (neat) 2095, 1708 cm-1; HRMS (ESI) m/z calcd for C12H23N4O [M + H]
+ 
239.1872, found 239.1869. trans-14aa: 1H NMR (400 MHz, CDCl3) δ 5.72 (dddt, J = 15.1, 7.5, 
6.3, 1.2 Hz, 1H), 5.51 (dtt, J = 15.0, 6.7, 1.3 Hz, 1H), 3.71 – 3.57 (m, 2H), 2.54 – 2.41 (m, 1H), 
2.40 – 2.18 (m, 3H), 2.07 (dddd, J = 14.1, 7.7, 2.6, 1.2 Hz, 1H), 2.01 – 1.75 (m, 2H), 1.74 – 1.52 
(m, 2H), 1.08 (s, 3H), 0.77 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 212.3, 136.3, 123.9, 61.4, 52.8, 
41.6, 40.0, 39.8, 29.7, 27.0, 23.2, 21.7. i-14aa (diagnostic peaks only): 1H NMR (400 MHz, 








ol (i-24). Azides trans-14aa and i-14aa (1.31 g, 5.93 mmol) were dissolved in THF (20 mL) at -
78 °C and stirred for 30 min. Then lithium phenylacetylide (1M in THF, 5.93 mL, 5.93 mmol) was 
added to the reaction mixture and stirred for 2 h at -78 °C. The reaction was brought to room 
temperature and stirred for 2 h. NH4Cl and H2O were added. The aqueous layer was extracted with 
Et2O (3 × 10 mL) and the combined organics washed with water (1 × 20 mL) and brine, and dried 
over Na2SO4. Filtration and concentration gave a residue, which was purified by automated 
chromatography (silica, hexane/EtOAc 9:1) to give mixture of azides trans-24, and i-24 (1.12 g, 
58%) as a colorless oil. trans-24 and i-24 (mixture; 68:32) : Rf = 0.4 (10% EtOAc/hexanes); IR 
(neat) 3256, 2100 cm-1; HRMS (ESI) m/z calcd for C20H26N3O [M + H]
+: 324.2076, found: 
324.2051. trans-24: 1H NMR (400 MHz, CDCl3) δ 7.44 – 7.34 (m, 2H), 7.30 (dp, J = 5.3, 1.7 Hz, 
3H), 6.13 – 5.97 (m, 1H), 5.65 – 5.52 (m, 1H), 3.66 (d, J = 5.7 Hz, 2H), 2.75 – 2.59 (m, 1H), 2.42 
– 2.32 (m, 1H), 2.16 – 2.03 (m, 1H), 1.81 (dddd, J = 10.0, 5.1, 2.8, 1.3 Hz, 2H), 1.71 (d, J = 3.1 
Hz, 1H), 1.55 – 1.41 (m, 2H), 1.28 (ddt, J = 12.8, 9.2, 3.9 Hz, 1H), 1.03 (s, 3H), 0.95 (s, 3H); 13C 
NMR (101 MHz, CDCl3) δ 139.6, 131.6, 128.4, 128.4, 128.4, 122.7, 94.8, 83.5, 71.3, 54.2, 53.0, 
41.8, 41.6, 34.9, 32.5, 30.3, 22.1, 17.8. i-24 (diagnostic peaks only): 1H NMR (400 MHz, CDCl3) 








5-vinyl-6,6a,7,8,9,10-hexahydro-[1,2,3]triazolo[5,1-a]isoquinolin-10a(5H)-ol (29b). Azides 
trans-24 and i-24 (1.12 g, 3.46 mmol) was dissolved in toluene (10 mL). The reaction mixture was 
heated at reflux for 24 h. The solvent was evaporated after cooling the reaction mixture to room 
temperature. The residue was purified by automated chromatography (silica, hexane:EtOAc/8:2) 
to give 29a (0.63 g, 56%) and 29b (0.19 g, 17%) (29a:29b 2.5:1). 29a: Obtained as a colorless 
solid. Rf = 0.3 (50% EtOAc/hexanes); mp 162-164 °C; IR (neat) 3259 cm
-1; HRMS (ESI) m/z calcd 
for C20H26N3O [M + H]
+ 324.2076, found 324.2039. 1H NMR (500 MHz, CDCl3) δ 7.60 – 7.54 
(m, 2H), 7.44 – 7.33 (m, 3H), 6.11 (ddd, J = 17.2, 10.2, 7.7 Hz, 1H), 5.50 (d, J = 17.2 Hz, 1H), 
5.40 (d, J = 10.1 Hz, 1H), 4.84 (ddd, J = 11.7, 7.7, 5.5 Hz, 1H), 2.31 – 2.05 (m, 4H), 1.79 (qt, J = 
14.0, 3.6 Hz, 1H), 1.55 – 1.46 (m, 1H), 1.44 – 1.34 (m, 1H), 1.31 – 1.15 (m, 3H), 1.06 (s, 3H), 
0.99 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 143.7, 136.6, 136.5, 132.6, 129.9, 128.3, 128.3, 118.7, 
68.6, 62.7, 49.2, 40.9, 35.4, 33.2, 32.4, 26.5, 21.6, 17.7. 29b: Obtained as a colorless oil. Rf = 0.25 
(50% EtOAc/hexane); HRMS (ESI) m/z calcd for C20H26N3O [M + H]
+ 324.2076, found 324.2045; 
1H NMR (500 MHz, CDCl3) δ 7.75 – 7.59 (m, 2H), 7.51 – 7.32 (m, 3H), 5.97 (ddd, J = 17.1, 10.5, 
5.0 Hz, 1H), 5.29 (dd, J = 10.6, 1.6 Hz, 1H), 5.24 (ddt, J = 5.0, 3.3, 1.6 Hz, 1H), 4.93 (dd, J = 17.2, 
1.7 Hz, 1H), 2.41 (ddd, J = 14.0, 12.8, 6.3 Hz, 1H), 2.37 – 2.28 (m, 1H), 1.93 (dt, J = 14.0, 1.6 Hz, 





1H), 1.39 (dt, J = 13.9, 3.5 Hz, 1H), 1.31 – 1.10 (m, 2H), 1.05 (s, 3H), 0.92 (s, 3H); 13C NMR (126 
MHz, CDCl3) δ 143.4, 136.5, 136.3, 132.4, 129.8, 128.3, 128.3, 117.7, 68.5, 58.8, 44.6, 40.9, 35.0, 
32.9, 32.2, 23.8, 21.7, 17.7. 
 
(14Z,84Z,5E,12E)-2,9-Diphenyl-11H,81H-3,10-dioxa-1(4,1),8(1,4)-                                 
ditriazolacyclotetradecaphane-5,12-diene (32). Azides trans-3 and i-3 (0.50 g, 2.20 mmol) were 
dissolved in a mixture of tert-BuOH/H2O (1:1, 40 mL). CuSO4·5H2O (0.54 g, 2.20 mmol) and 
sodium L-ascorbate (0.87 g, 4.40 mmol) were added. The heterogenous mixture was stirred for 1 
h. Then CH2Cl2 was added to dissolve the crude product and the aqueous layer was extracted with 
CH2Cl2 (3 X 10 mL) and the combined organic layer was washed with aq NH4OH (1 × 20 mL) 
and brine, and dried (Na2SO4). Filtration and concentration gave a residue, which was purified by 
automated chromatography (silica, CH2Cl2:MeOH 9:1) to give 32 (0.35 g, 70%) as a yellow oil. 
Rf = 0.5 (10% MeOH/CH2Cl2); IR (neat) 1453 cm
-1; HRMS (ESI) m/z calcd for C26H27N6O2 [M + 
H]+ 455.2195, found 455.2199. 1H NMR (500 MHz, CDCl3) δ 7.45 – 7.27 (m, 5H), 5.83 (tdd, J = 
15.5, 12.9, 10.2, 7.2 Hz, 2H), 5.61 (s, 1H), 4.87 (d, J = 5.7 Hz, 2H), 4.04 (d, J = 4.9 Hz, 2H); 13C 







ditriazolacyclotetradecaphane-5,12-diene (31). Following the general procedure for 32, 
compound 31 (78%) was obtained as a yellow oil. Rf = 0.4 (10% MeOH/CH2Cl2); IR (neat) 1453 
cm-1; HRMS (ESI) m/z calcd for C16H23N6O2 [M + H]
+ 331.1882, found 331.1898. 1H NMR (500 
MHz, CDCl3) δ 7.52 (s, 1H), 5.92 (dt, J = 15.4, 6.2 Hz, 1H), 5.83 (dt, J = 15.5, 5.1 Hz, 1H), 5.04 
– 4.88 (m, 2H), 4.73 (q, J = 6.6 Hz, 1H), 4.02 (dt, J = 4.9, 1.5 Hz, 2H), 1.53 (d, J = 6.6 Hz, 3H); 
13C NMR (126 MHz, CDCl3) δ 150.3, 132.9, 125.1, 120.8, 70.3, 68.0, 51.9, 21.5. 
 
(E)-1-Bromo-4-(but-3-yn-1-yloxy)but-2-ene (15aa). Following the general procedure for 
2a, 3-butyn-1-ol (35, 2 g, 28.50 mmol), (E)-1,4-dibromobut-2-ene (12.19 g, 57 mmol), and NaH 
(1.14 g, 28.50 mmol) afforded 15aa (1.42 g, 24%) as a colorless oil. Rf = 0.7 (10% 
EtOAc/hexanes); IR (neat) 2864 cm-1. 1H NMR (400 MHz, CDCl3) δ 6.03 – 5.90 (m, 1H), 5.85 
(dtt, J = 15.3, 5.5, 0.8 Hz, 1H), 4.08 – 4.00 (m, 2H), 4.00 – 3.91 (m, 2H), 3.57 (t, J = 6.9 Hz, 2H), 
2.48 (td, J = 6.9, 2.7 Hz, 2H), 1.99 (t, J = 2.7 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 131.5, 128.9, 







1-ene (i-33). Following the general procedure for 2, (E)-1-bromo-4-(but-3-yn-1-yloxy)but-2-ene 
(15aa, 1.41 g, 6.90 mmol), and NaN3 (1.35 g, 20 mmol) afforded a mixture of azides trans-33 and 
i-33 (0.87, 76%, 84:16) as a colorless oil. trans-33 and i-33 : Rf = 0.6 (10% EtOAc/hexanes); IR 
(neat) 2098 cm-1; HRMS (ESI) m/z calcd for C8H12BrO [M + H]
+ 166.0980, found 166.1001. trans-
33: 1H NMR (400 MHz, CDCl3) δ 5.92 – 5.73 (m, 2H), 4.10 – 4.04 (m, 2H), 3.79 (d, J = 5.6 Hz, 
2H), 3.58 (t, J = 6.9 Hz, 2H), 2.48 (td, J = 6.8, 2.7 Hz, 2H), 1.99 (t, J = 2.7 Hz, 1H); 13C NMR 
(101 MHz, CDCl3) δ 131.6, 126.0, 81.3, 70.5, 69.5, 68.5, 52.4, 20.0. i-33 (diagnostic peaks only): 
1H NMR (400 MHz, CDCl3) δ 5.52 – 5.22 (m, 2H), 3.63 (t, J = 7.0 Hz, 2H), 3.49 (dd, J = 10.1, 
7.5 Hz, 1H). 
 
8-Vinyl-4,5,7,8-tetrahydro-[1,2,3]triazolo[1,5-d][1,4]oxazepine (34). Following the 
general procedure of 12, azides trans-33 and i-33 (0.13 g, 0.79 mmol) afforded 34 (0.11 g, 81%) 
as a colorless oil. Rf = 0.3 (50% EtOAc/hexanes); IR (neat) 2957 cm
-1; HRMS (ESI) m/z calcd for 
C8H12N3O [M + H]
+ 166.0980, found 166.0977. 1H NMR (500 MHz, CDCl3) δ 7.49 (s, 1H), 6.13 
(ddd, J = 17.2, 10.6, 4.6 Hz, 1H), 5.48 (dp, J = 4.9, 1.8 Hz, 1H), 5.35 (dd, J = 10.6, 2.0 Hz, 1H), 





(dd, J = 13.4, 1.6 Hz, 1H), 3.53 (ddd, J = 12.5, 10.7, 1.9 Hz, 1H), 3.17 – 2.91 (m, 2H); 13C NMR 
(101 MHz, CDCl3) δ 136.6, 133.5, 132.8, 118.5, 72.8, 70.2, 65.3, 26.2. 
 
(14Z,94Z,6E,14E)-11H,91H-4,12-Dioxa-1(4,1),9(1,4)-ditriazolacyclohexadecaphane-6,14-
diene (35). Following the general procedure for compound 32, compound 35 (78%) was obtained 
as a yellow oil. Rf = 0.4 (10% MeOH/CH2Cl2); IR (neat) 1552 cm
-1; HRMS (ESI) m/z calcd for 
C16H23N6O2 [M + H]
+: 331.1882, found: 331.1884. 1H NMR (400 MHz, CDCl3) δ 7.37 (s, 1H), 
5.92 – 5.74 (m, 2H), 4.94 (dq, J = 2.7, 1.3 Hz, 2H), 4.00 (dd, J = 2.0, 1.0 Hz, 2H), 3.78 – 3.63 (m, 
2H), 3.01 (t, J = 5.5 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ 146.1, 132.6, 124.2, 121.5, 70.0, 

















Intramolecular Friedel–Crafts acylation reaction promoted by hexafluoro-2-propanol 
2.1 Introduction 
Friedel–Crafts acylation 
The Friedel–Crafts (FC) acylation is one of the most highly investigated reactions for carbon-
carbon bond formation (Scheme 8).52  
Scheme 8. FC acylation reaction 
 
Grucarevic and Merz reported the first acylation reaction of aromatics with acid halides in 
1873.53 They used zinc dust to promote the reaction. Later, Zincke reported the treatment of 
benzene with benzoyl chloride using either copper, zinc, or silver in an attempt to prepare benzil, 
but instead obtained benzophenone (Scheme 9).54 In 1876, Doebner and Stackman reported the 
formation of o-hydroxybenzophenone from phenol and (trichloromethyl)benzene using zinc oxide, 
and they observed zinc chloride at the end of reaction.55 However, none of these researchers 
explained the importance of Lewis acids in acylation reaction until Charles Friedel and James 
Mason Crafts published their research in 1877.52,56-58 Following this initial work, Friedel and Crafts 
showed that the reaction could be extended to various aromatic compounds, as well as alkyl and 





Scheme 9. Zinc–catalyzed FC acylation54 
 
In an early paper by Friedel and Crafts, they reacted benzene and phosgene in presence of 
AlCl3 which led to the formation of benzophenone and a small amount of benzoic acid (Scheme 
10).57 Further, Wilson and Fuller reacted benzene and higher equivalence of phosgene using AlCl3 
in hopes of obtaining anthraquinone, but rather they obtained benzoquinone.60 Staudinger reported 
the reaction of anisole and oxalyl chloride using AlCl3 led to the formation of corresponding benzyl 
derivative.61 However, with polycyclic substrates, bridged ketones were obtained under Friedel–
Crafts conditions with oxalyl chloride.62 
Scheme 10. Early findings by Friedel and Crafts57 
 
Introduction of acyl group into aromatic system connected with many useful transformation 
that can be performed easily. For example, tetralone derivatives can be easily converted to amines 
by Beckmann rearrangement; acetophenone into phenols using the Baeyer–Villiger rearrangement 
as well as FC acylation followed by Schmidt reaction to obtain lactams (Scheme 11).63-65 The 






Scheme 11. Utilities of aromatic ketones in synthetic transformations 
 
FC alkylation chemistry can also be used for carbon-carbon bond formation. However, the 
major limitation of Friedel–Crafts alkylation reaction is that the product after the first installation 
of alkyl group is more nucleophilic compared to the substrate, which lead to overalkylation.66 This 
problem can be overcome by first performing a Friedel–Crafts acylation, followed by reduction of 
the keto group in product.67,68 
Acylating agents in Friedel–Crafts reactions 
The most commonly used acylating agents in FC acylation are acyl halides. The reactivity of 
acyl halides used with aluminum halides as catalysts was I ˃  Br ˃ Cl ˃ F, however in case of boron 





common acylating agents are anhydrides.63 In FC acylation reaction, carboxylic acids, esters and 
mixed anhydrides were successfully used to give ketone products (Scheme 12a).69-71 In addition, 
β-lactams were successfully used as acylating agents in the presence of triflic acid to give β-
aminoaromatic ketone derivatives (Scheme 12b).72 In the presence of AlCl3, ketene has been used 
to acetylated benzene to give acetophenone (Scheme 12c).73 Further, Szostak and coworkers 





Scheme 12. Various acylating agents in Friedel–Crafts acylation69-74 
 
Catalysts in Friedel–Crafts acylation 
In addition to AlCl3, other catalysts used in Friedel–Crafts acylation with acyl halides include 
AlBr3, TiCl4, ZrCl4, FeBr3, SbBr3, P2O5, H2SO4, Zn, ZnCl2, CuCl2, HgCl2.





with anhydrides as acylating agents include BF3, HF, ZnCl2, H3PO4, SnCl4, SOCl2, (CF3CO)2O, 
CF3COOH, HClO4, AgClO4.
75 Dermer and co-workers reported the relative efficiency of metal 
halides in catalyzing acylation of toluene by acetyl chloride as: ZnCl2 ˂ BiCl3 ˂ TeCl4 ˂ TiCl4 ˂ 
SnCl4 ˂ TeCl2 ˂ FeCl3 ˂ SbCl5 ˂ AlCl3.
76  
Heterogeneous catalysts 
Other catalysts like lanthanide trifluoromethanesulfonates alone77 or microencapsulated on 
polyacrylonitrile78 as reusable catalysts, and graphite as a solid catalyst79 were used to promote FC 
acylation. Various classes of heterogeneous catalyst were used for FC acylation, including zeolites, 
metal oxides, clays, heteropoly acids and Nafion.80 BEA zeolites are the most important zeolite 
catalyst for FC acylation both in academia and industries.81 Many metal triflates like La(OTf)3, 
Ce(OTf)4, Y(OTf)3 and Zn(OTf)2 were used with SBA-15 by incorporation into mesoporous pores 
as catalyst.82 Laszlo et al.83-86 described the use of clays in FC acylation. As FC acylation catalyst 
iron(III) oxide, zinc oxide, tin(II) oxide, or molybdenum(VI) oxide with iron(III) oxide possessed 
the great activity.87 Arata and co-workers shown that sulfated zirconia (SZ), prepared by treatment 
of zirconia with sulfuric acid or ammonium sulfate, exhibit good catalytic activity.88 Heteropoly 
acids (HPAs), bronsted acids composed of heteropoly anions and protons as counterions, were 
successfully used as catalyst in FC acylation.89 Nafion, a solid perfluorinated resinsulfonic acid, 
was also used as heterogeneous catalyst in FC acylation.90-92  
Catalytic Friedel–Crafts acylation 
The FC acylation could be described as a self-inhibitory reaction as the ketone product and 
catalyst can form a stable complex which requires the use of at least stoichiometric amount of 





need to be performed at high temperatures to promote the dissociation of the ketone-catalyst 
complex.59,93 
Pivsa-Art et al. reported the acylation of 2-methoxynaphthalene by benzoyl chloride  in the 
presence of 10 mol% of various Lewis acids (including AlCl3, FeCl3) at 160 °C and described the 
influence of Lewis acids on the regiochemical outcomes in product formation.94 Le Roux and co-
workers reported the acylation of toluene, xylene, mesitylene, naphthalene, anthracene, pyrene, 
and anisole using BiCl3 (10 mol%) at 120 °C.
95 They recovered catalyst by converting it to a water-
insensitive bismuth(III) oxychloride (BiOCl). The BiOCl can be used to carry out acylation 
reaction as procatalyst as it converts to active catalyst BiCl3 upon reacting with acyl chloride in-
situ.95  
The antimony pentachloride-benzyltriethylammonium chloride complex (SbCl5–TEBA) was 
reported to have catalytic activity in acylation of electron-rich arenes with acyl and sulfonyl 
chlorides.96 The reactions were carried out using SbCl5–TEBA (5 mol%) in boiling nitromethane 
to give ketone products in 37–96% yield. The advantages of this catalyst include ready access, 
minimal toxicity, reusability, insensitivity to atmosphere and moisture. Another antimony 
derivative, diphenylboryl hexachloroantimonate (Ph2BSbCl6) (25 mol%), was reported to catalyze 
FC acylation at room temperature.97 
Harada et al. reported the acylation of activated substrates (aromatic ethers and alkyl arenes) 
catalyzed by a combination of Lewis acid and silver perchlorates.98 In this reaction, acylation was 
carried out using gallium(III) trichloride (10 mol%) and silver perchlorate (10 mol%) to afford 
ketones in 80-100% yield at room temperature. In addition, good results were achieved in FC 





mol%) in refluxing methylene chloride.99 Arai et al. reported the catalytic efficiency of 
combination of niobium pentachloride (1 mol%) and silver perchlorate (3 mol%) at 80 °C in FC 
acylation reactions.100 
Furstner et al. reported the late-transition metal salts as catalysts in acylation of arenes and 
heteroarenes using anhydrides.101 Their rationale of using a late transition metal was that the 
mismatch between soft metal center and the hard ketone oxygen of products prevents the 
kinetically inert complex formation and results in catalytic turnover. Thus, acylation of various 
aromatic substrates were performed in refluxing DCM in presence of (PhCN)2PtCl2 (2.5 mol%) 
and AgSbF6 (5 mol%). However, N,N-dimethylaniline and indole were inert under this condition, 
probably due to inhibition of cationic platinum(II) species by coordination with the nitrogen atom 
in these substrates.  
The use of catalytic bismuth(III) triflate in FC acylation was reported by Desmurs.102 
Bismuth(III) triflates (10 mol%) was used to acylate both activated (electron-rich) and deactivated 
(electron-poor) aromatic compounds under heating condition to give product ketones in high yield 
(78%–95%) using acyl chlorides or anhydrides as acylating agents. The combination of 
titanium(IV) monochlorotriflate (TiCl(OTf)3) (1 mol%) with triflic acid (10 mol%) was reported 
to be an efficient catalyst in FC acylation at room temperature.103 
Similarly, the combination of hafnium triflate (10 mol%) and triflic acid (10 mol%) was used 
efficiently in acylation of benzene and unactivated benzenes such as chlorobenzene and 
fluorobenzene at 80–120  °C.104 The FC acylation of aromatics with acids have been reported to 






Kawada et al. reported FC acylations promoted by 20 mol% of lanthanide trifluoromethane 
sulfonate (Ln(OTf)3) at 50  °C.
77 Specifically, ytterbium triflate (20 mol%) catalyzed acetylation 
reactions of various aromatic systems using acetic anhydride as acylating agent. It has been shown 
that catalyst could be recovered and reused in further reaction without loss of efficiency. Scandium 
triflate (20 mol%) was also reported as catalyst in FC acylation of arenes using acyl chloride or 
anhydrides as acylating agents.106 The catalyst could be recovered and reused. In addition, 
combination of lanthanide triflates (20 mol%) with lithium perchlorates was reported to have 
greater catalytic activity than lanthanide triflate alone.  
An interesting result was obtained when lithium perchlorate was used as an additive while 
acetylating 2-methoxynaphthalein with acetic anhydride using antimony(III) triflate (Table 3). 
When the reaction was performed in nitromethane without an additive, product a was obtained 
preferentially. However, the regioselectivity changed when the same reaction was carried out in 
the presence of lithium perchlorate (600 mol%), and product b was obtained in 93% yield. The 
rationale given for this result was that the acetyl group migrates from kinetic product a to give 
thermodynamic product b during the reaction. It was reported that indium(III) triflate (1 mol%) in 
combination with lithium perchlorate could be efficiently used in FC acylation reactions.107 








Additive Solvent T (°C) Yield (%) 
Product distribution (%) 
 a                    b 
– MeNO2 rt 81 95 5 
LiClO4 MeNO2 50 93 0 100 
 
Fillion and co-workers reported the intramolecular FC acylation of benzyl Meldrum’s acids 
catalyzed by Sc(OTf)3 (12 mol%) under reflux condition in nitromethane to give 1-indanones.
109 
In addition, the method was extended to the synthesis of 1-tetralone and 1-benzosuberones.110 Xiao 
et al. reported the FC acylation catalyzed by Cu(OTf)3 (10 mol%) in an ionic liquid, [bmim][BF4] 
(bmim = 1-butyl-3-methylimidazolium) at 80 °C.111 
Cui et al. showned that Bi(NTf2)3 (1 mol%) catalyzed intramolecular FC acylation reactions 
of aryl butyric acids to give 1-tetralones at 180 °C.112 In addition, chroman-4-ones and 
thiochroman-4-ones were obtained under similar conditions. Ytterbium 
tris(perfluoroalkanesulfonyl)methide (10 mol%) was reported as effective catalyst in FC acylation 
of arenes with anhydrides.113 Kobayashi and coworkers reported that gallium 
nonafluorobutanesulfonate [Ga(OTf)3] (5 mol%) was efficient catalyst in the acylation of activated 
and deactivated aromatic compounds under reflux condition with acyl chlorides.114  
Earle and co-workers reported various metal bis[(trifluoromethyl)sulfonyl]amide complexes 
(5–15 mol%) as efficient catalyst in FC acylation reaction.115 
Hafniumtetra[bis(perfluorooctanesulfonyl)amide] (1 mol%) in fluorous solvent was reported to 
catalyze FC acylation at 70–120 °C.116 It was reported that indium (20 mol%) catalyzed 
benzoylation of various aromatic systems at 100 °C in dioxane.117 Deactivated aromatic systems 
like chlorobenzene and bromobenzene were inactive under these conditions. Dominguez et al. 





reflux condition.118 Halobenzenes were benzoylated selectively at para-position catalyzed by 
iron(III) sulfate (1 mol%) by different benzoyl chlorides under high temperature (135–150 °C).119 
Intramolecular FC acylation 
Intramolecular FC acylation leads to the formation of benzocyclic ketones such as 1-
indanones, 1-tetralones, 1-benzosuberones, and related compounds (Figure 9).75,120,121  
 
Figure 9. General products of intramolecular FC acylation reaction 
 
The products of intramolecular FC acylation reactions have been utilized for the synthesis of 
biologically active natural products and therapeutically useful compounds (Figure 10). Substituted 
1-tetralones have been used for the synthesis of natural product palmarumycin CP1 and series of 
antiapoptotic Bcl-2 family proteins inhibitors for their activity as anticancer agents.122,123 
Similarly, substituted 1-indanones have been used for the synthesis of ribasine and the 
angiogenesis inhibitor NM-3.124,125 
General aspects of the intermolecular FC acylation reaction applies to the intramolecular 
reaction as well.121 In general, 1-tetralones are easier to form than to 1-indanones and 1-
benzosuberones by FC acylation reactions.110 In case of intramolecular FC acylation, carboxylic 
acids,126-128 acid chlorides,129,130 ketenes,131,132 isocyanates,133-135 isothiocyanates,136,137 β-





catalyst in intramolecular FC acylation reactions include pyrophosphoric acid, Lewis acids, protic 
acids and heterogenous catalysts.91,92,120                          
 






Commonly used solvents in FC acylation reactions include carbon disulfide, carbon 
tetrachloride, dichloromethane, 1,2-dichloroethane, nitrobenzene and nitroalkanes.63,75 In addition, 
researchers have used ionic liquids as reaction media.111,142 In general, protic solvents are not 
compatible with FC acylation due to its nucleophilic nature that could compete with arenes to react 
with acylating agents. However, hexafluoro-2-propanol has been used in FC reactions due to its 
low nucleophilicity.143 
Hexafluoro-2-propanol (HFIP) 
HFIP is one of the most commonly used fluorinated alcohols due to its low cost and 
commercial availability.143,144 HFIP is a polar solvent with high ionizing power and low 
nucleophilicity.143 In addition, it is a poor hydrogen bond acceptor while a very strong hydrogen 
bond donor (Table 4).143 
Table 4. Properties of HFIP and isopropanol143,145-150 
Property HFIP isopropanol 
Melting point (°C) -4 -89.5 
Boiling point (°C) 58.6 82.5 
Density (g/mL) 1.61 0.781 
pKa 9.3 17 
Polarity, Ps 11.08 7.85 
Ionizing power (YOTs) 3.79 -2.83 
Nucleophilicity (NOTs) -4.23 0.2 
Dielectric constant (ε) 16.7 19.4 
Polarizability 0.65 0.48 
Dipole moment (μ) 2.03 1.68 
Hydrogen-bond donor (α) 1.96 0.76 






In 1993, Cativiela et al. studied the advantage of the HFIP solvent in Diels–Alder reactions to 
obtain good regio- and endo/exo selectivities.151 Interestingly, when they reacted furan and 
acrolein in HFIP, in addition to Diels–Alder products oxanorbornene derivatives, they also 
observed 3-(2-furyl)propanol, as Friedel–Crafts-type alkylation product (Scheme 13).  
Scheme 13. Diels-Alder and Friedel–Crafts alkylation in HFIP 
 
Li and Qu reported the regio- and stereoselective intra- and intermolecular Friedel–Crafts 
alkylation between electron-rich arenes and epoxides in HFIP at reflux condition (Scheme 14).152 
They attributed the weak acidity and high ionizing power of HFIP as being responsible for its 
catalytic activity in this reaction. 
Scheme 14. Intra- and intermolecular Friedel–Crafts alkylation between arenes and epoxides 
 
Trillo et al. reported the direct allylic substitution of allylic alcohol in HFIP as reaction media 





in HFIP at 50 °C, the para-substituted Friedel–Crafts alkylation product was obtained in 88% yield 
(Scheme 15b). 
Scheme 15. Friedel–Crafts-type alkylation in HFIP 
 
In 2014, Paquin and co-workers reported the Friedel–Crafts benzylation reaction between 
benzyl fluoride and arenes catalyzed by HFIP (Scheme 16).154 They proposed a mechanism where 
by HFIP activates the C–F bond through hydrogen bonding. HFIP was also used as a medium to 
promote an FC reaction catalyzed by Cu155,156 and Li157 Lewis acids. Recently, Khaledi reported 






Scheme 16. Friedel–Crafts benzylation catalyzed by HFIP154 
 
In addition, HFIP has been efficiently used for oxidation reaction with H2O2 (epoxidation of 
olefins, transformation of sulfides into sulfoxides, and Baeyer-Villiger oxidation) or sodium 

















Chakraborti and co-workers reported the cyclocondensation of o-phenylenediamine with 
aldehyde to give 1,2-disubstituted benzimidazoles promoted by HFIP at room temperature 
(Scheme 18a).166 Fustero et al. reported HFIP promoted regioselective pyrazoles formation from 
reaction of 1,3-diketones with hydrazines (Scheme 18b).167 HFIP has been utilized to promote 
imino-Diels-Alder reactions to synthesize tetrahydroquinolines from the reaction between N-
arylaldimine and alkyl vinyl ethers without Lewis acid under mild and neutral conditions (Scheme 
18c).168 
Saito and co-workers reported the synthesis of trans-2,3-disubstituted 2,3-dihydro-4-imino-
quinolines from ortho-alkynylanilines, aldehydes and amines via the three-component alkyne-
imine metathesis in HFIP without any additional catalysts (Scheme 18d).169 Khaksar and 
Rostamnezhad reported the synthesis of quinoxaline derivatives from 1,2-diamines and 1,2-
dicarbonyl compounds using HFIP at room temperature (Scheme 18e).170 Wang et al. reported the 
Pictet-Spengler reaction between tryptamine derivatives and aldehydes or activated ketones to give 












Scheme 18. HFIP-promoted heterocycles synthesis166-171 





2.2 Results and discussion 
As discussed earlier, an FC acylation reaction generally requires at least a stoichiometric 
amount of catalyst due to complex formation between product and catalyst, which leads to product 
inhibition. Most existing methods suffer from use of high temperature and requires water workup, 
which generates acidic waste. Similarly, the intramolecular Schmidt reaction suffered from the use 
of superstoichiometric amounts of catalyst due to product inhibition. Recently, Aubé and co-
workers utilized the strong hydrogen-bond donating solvent, HFIP, to overcome the product 
inhibition in these reactions and showed that high yields were achieved with the use of 
substoichiometric catalysts (Scheme 19).172 Based on this work, we thought to explore the utility 
of HFIP in promoting FC acylation reaction.173 This project was done in collaboration with Dr. 
Hashim Motiwala. 
Scheme 19. HFIP in an intramolecular Schmidt reaction 
 
We began by studying commercially available electron-rich 4-(3,4-
dimethoxyphenyl)butanoic acid 1a as a typical substrate for the intramolecular FC acylation. The 
corresponding acid chloride was obtained by oxalyl chloride treatment of 1a in DCM. The crude 
acid chloride 2a was dissolved in HFIP and the reaction allowed to stir for 2 h at room temperature. 





tetralone 3a in 95% yield (Table 5, entry 1). Different molar concentration of substrate had little 
effect on the product yield (Table 5, entries 1–3). Using DCM as solvent, different stoichiometries 
of HFIP was examined (Table 5, entries 3–6). In each case, comparable product yields were 
obtained in similar reaction time. Other representative solvents were screened in a 4:1 ratio of 
solvent: HFIP (Table 5, entries 7–10). The results reflected a qualitative decrease in reaction rate. 
Especially, THF had a deleterious effect on product yield. This is likely due to strong hydrogen 
bond acceptor effect of THF, which could form hydrogen bond with HFIP.174,175  





time (h) yield of 3ab 
1 HFIP (0.20 M)  2 95 
2 HFIP (0.40 M)  2 97 
3 HFIP (1.2 M)  2 95 
4 DCM/HFIP (4:1) 9.5 2 96 
5 DCM/HFIP (8.4:1) 5.0 2 95 
6 DCM/HFIP (22.8:1) 2.0 3 93 
7 CH3CN/HFIP (4:1) 9.5 6 93 
8 CH3NO2/HFIP (4:1) 9.5 6 91 
9 C6H5CF3/HFIP (4:1) 9.5 4 94 
10 THF/HFIP (4:1) 9.5 6 34 
aThe acid 1a (1.0 equiv) was converted to 2a using oxalyl chloride (2.0 equiv) and catalytic DMF 
in DCM under N2 atmosphere for 30 min. The reaction mixture was concentrated under N2 and 
vacuum; crude 2a was dissolved in the solvent(s) noted and stirred at rt for a specified period. 
bIsolated yield of purified 3a based on starting acid. Product were ≥96% pure by NMR except for 





Screening of alternative reagents, other alcohols and related agents that might, in principle, be 
expected to similarly promote FC acylation reactions of 1a, were performed. N-
Hydroxysuccinimide (NHS) and 1-hydroxybenzotriazole (HOBt), commonly used in peptide 
chemistry, gave low yield while perfluorophenol (PFP) gave moderate yield (Table 6, entries 1–
3).176 Squaric acid failed to give appreciable product yield (Table 6, entry 4). Aryl thiols, utilized 
in native chemical ligation,177 did not give any product (Table 6, entries 5–6). Of the various 
fluorinated alcohols investigated, only HFIP (Table 6, entry 8) and perfluoro-tert-butanol (PFTB, 
Table 6, entry 9) gave good yields. No product was obtained from the treatment of i-PrOH (Table 
6, entry 12). From these results, it is clear that the ability to promote the FC acylation is not depend 
on pKa rather it is depend on hydrogen bond donating ability of electron-poor alcohols (i.e., i-
PrOH gave no product vs. HFIP and PFTB gave excellent yields). 















solvent pKa time 
NMR yield 








5.0 equivc DCM 4.6 4 h 0 
3 C6H5OH (PFP) 5.0 equiv




5.0 equivc DCM 0.55 6 h 5 
5  
2-Mercaptopyridine 




5.0 equivc DCM 6.6 4 h 0 
7 CF3CH2OH (TFE) 0.50 mL –
d 12.4 4 h 31 
8 (CF3)2CHOH (HFIP) 0.50 mL –
 d 9.3 45 min 95 
9 (CF3)3COH (PFTB) 0.50 mL –
 d 5.4 45 min ˃98e 
10 C6H5C(CF3)2OH 0.50 mL –
 d – 4 h 60 
11 CF3CH2SH (TFET) 0.50 mL –




0.50 mL – d 16.5 4 h 0g 
aReaction was run on 0.100 mmol scale of 1a. Concentration of 2a was ca. 0.20 M. 
bNitromethane was used as an internal standard. cReagent (5.0 equiv) was used with DCM (0.50 
mL) as solvent. dReagent (0.50 mL) was used as a solvent. eOnly product peaks were observed in 
a crude 1H NMR. fA complex mixture was observed in a crude 1H NMR. gInstead of product 3a, 






After screening various reagents, it was found that only perfluoro-tert-butanol gave results 
comparable to HFIP. However, due to the high cost of perfluoro-tert-butanol (ca. 36× the cost of 
HFIP; Oakwood Products), we chose to use neat HFIP for our standard condition ([substrate] = 
0.40 M). 
The scope of this methodology was explored utilizing variety of different carboxylic acids 
(Figure 11). Both arenes and heteroarenes gave six-membered ketones in good yields (3a–3u). 
Thus, various tetralones (3a–3h), chromanone (3i), thiochromanones (3j–3m), thioxanthenone 
(3n), and anthracenone (3o) were obtained from their corresponding acids in good to excellent 
yields. In general, six-membered rings in an intramolecular FC acylation are easier to form than 
over five- and seven-membered rings.110 
In our conditions, seven-membered ketone products were obtained in good yields (3v–3ab). 
However, five-membered ketone product, thiophene fused cyclopentanone (3ac), obtained in poor 
yield. Fluorenones and related ketones (3af–3am) were obtained in good yields from their 
corresponding acids. 
The reaction was also scaled up to gram scale. Thus, 3a was obtained in 83% yield from         



















Figure 11. Yields and ratios of ketone products synthesized using standard conditions (Table 5, 
entry 2) 
The results in Figure 11, obtained from current methods are compared with those obtained 
from traditional Friedel–Crafts acylation reactions (Table 7). This exercise suggests that the 
current methodology seems to have a similar scope with that of traditional methods. 
Table 7. Comparison of product yields obtained from this work (Figure 11) compared to 
that reported in the literature, along with their corresponding reaction conditions.  
entry carboxylic acid product (% yield) 
time 
(h) 




I. 93% (PPA, DCM, reflux, 2h)178 
II. 97% (1.1 equiv trichloroacetic 




















I. 85% (H3PO4, Ac2O, 120–140 °C, 3 
h)181 
II. 76% (Eaton's reagent, 100 °C, 5 
min)182 
III. 62% (1.2 equiv SnCl2, EtOAc, 0 




I. 72% (SOCl2, 1 drop pyridine, 70 
°C, 24 h)184 
II. 71% (P2O5, MeSO3H, rt, 90 
min)185 
III. 78% (SOCl2, 4 drops pyridine, 
reflux, 8 h)186 
7 
  








I. 81% (H3PO4, P2O5, rt, 24 h)
188 
II. 53% (1 mol% Bi[N(SO2CF3)2], p-
xylene, 180 °C, 20 h)189 
III. 98% (10 mol% Eu(OTf)3, 180 °C, 
14 h)112 





























I. >99% (BF3·2CF3CH2OH, DCM, 
rt)193 
II. 90% (1.5 equiv POCl3, reflux, 30 
min)194 
III. 92% (Nafion-H, m-









I. 60% (PPA, 90°C, 1 h)196 







I. 99% (7.5 equiv AlCl3, 8.5 equiv 
NaCl, 200 °C, 25 min)198 













Reaction of ethyl ester of 1t in PPA 








I. 70% (1.1 equiv trichloroacetic 
anhydride, 70 °C, 6 h)179 





























I. 30% (MeSO3H, P2O5, rt, 1 h)
204 
II. 54% (MeSO3H, P2O5, rt, 40 
min)205 




I. 76% (PPA, toluene, reflux, 4 h)207 
















For 3agp: 94% (7.0 equiv 





















I. 100% (7.5 equiv AlCl3, 8.5 equiv 
NaCl, 180–190 °C, 20 min)198 










The generally accepted mechanism for the Friedel–Crafts acylation is shown in Figure 12.211-
213 The mechanism of present work studied based on the experiments in Scheme 20. Porco et al. 
showed that a preformed HFIP ester can undergo FC cyclization reaction in the presence of K3PO4 
at 60 ˚C.214 However, when we treated HFIP ester 4a in HFIP with 1.1 equiv of AcCl (HCl is 
generated in situ from the action of HFIP on AcCl172), 4a was quantitatively recovered. This result 
suggest that 4a is not an intermediate in the FC acylation reaction. 
Figure 12. General mechanism of Friedel–Crafts acylation 
  In comparison to HFIP, when HCl was used in FC acylation in DCM, it found modestly 
competent but still an inferior promotor (Scheme 20). In the presence of a proton scavenger, 
product conversion was diminished but the reaction was not completely inhibited (even with 1.0 
equiv of 2,6-di-tert-butyl-4-methylpyridine (DTBMP), 30% of 3a was obtained). When 2.0 equiv 
of pyridine (both a hydrogen bond acceptor (pKHB = 1.86) and a proton scavenger
215) was used, 





reaction was carried out with 3.0 equiv of the strong H-bond acceptor Ph3PO and excess of HFIP 
(9.5 equiv), product 3a was obtained in 96% yield. In contrast, when performed with a slight excess 
of Ph3PO, the reaction was almost completely inhibited. Considering above results, hydrogen bond 
donor properties of HFIP seems most critical in these FC reactions. 




3a 4a 1a 
Presence/absence of HFIP 
HFIP (1 equiv), DCM 71% – – 
4.0 M HCl in dioxane (1 equiv), DCM 40% – 44% 
Addition of proton 
scavenger 
DTBMP (0.50 equiv), DCM/HFIP 
(4:1) 
71% 22% – 
DTBMP (1.0 equiv), DCM/HFIP (4:1) 30% 66% – 
pyridine (2.0 equiv), DCM/HFIP (1:1) – 95% – 
Addition of strong H-bond 
acceptor 
Ph3PO (3.0 equiv), HFIP (9.5 equiv), 
DCM 
96% – – 
Ph3PO (6.0 equiv), HFIP (5.0 equiv), 
DCM 






It has been reported that the observed effects of HFIP are due to the higher order of its 
aggregates rather than in its monomeric form.216-218 Berkessel and coworkers done both theoretical 
and experimental studies to determine the influence of conformation and aggregation on hydrogen 
bond donor ability of HFIP.175 Based on DFT analysis, they observed an substantial effect of 
conformation along the CO-bond of HFIP on H-bond donor ability. Both DFT and single-crystal 
X-ray analyses revealed that the synclinal (or even synperiplanar) confirmation of HFIP is more 
dominant compare to antiperiplanar conformation because in synclinal conformation HFIP exist 
strong H-bond donor ability. X-ray analysis also revealed the presence of H-bonded aggregates of 
HFIP in helical forms. In addition, they observed cooperativity in H-bond donor ability of HFIP. 
In other words, coordination of second and third molecule of HFIP increases H-bond donor ability 
of terminal hydroxyl group while no further enhancement detected for aggregation beyond the 
HFIP trimers.  
Berkessel et al. studied the kinetics of olefin epoxidation with H2O2 in HFIP.
175 They found 
the kinetic rate order in HFIP to be 2.78 ± 0.23 when 1,2-dichlroethane was used as cosolvent. We 
briefly studied the kinetics of FC acylation reaction of 2a to give product 3a in HFIP using reactIR.  
A series of FC acylation reactions were performed in different amounts of HFIP using DCM, 
which is inert to the FC acylation conditions, as the cosolvent. In all reactions, the total volume of 
the HFIP/DCM mixture was kept constant. The reactions were monitored using in situ ReactIR 
(Mettler Toledo ReactIR iC10 with silicon probe) for the disappearance of the peak at 1801 cm-1, 






Figure 13. 3D-profile of the FC reaction of 4-(3,4-dimethoxyphenyl)butanoyl chloride (2a, 0.078 
g, 0.300 mmol, 1.0 equiv) promoted by HFIP (0.10 mL, 0.900 mmol, 3.0 equiv) in DCM (0.90 
mL) through in situ IR. 
Reactions were analyzed as first-order kinetics in substrate by plotting ln[100-(%conv)/100] 
vs time (Figure 14a-e). The kinetic rate order in HFIP was determined by plotting reaction rates as 
a function of the HFIP concentrations (Figure 14f). We found a kinetic rate order of 3 in HFIP 
which is in accord with previously reported olefin epoxidation studies in HFIP. This also suggest 








a                                                                            b 
   
c                                                                             d 
    
e                                                                             f 
    
Figure 14. FC acylation of 2a in different amount of HFIP using DCM as a cosolvent.  
As mentioned earlier, HFIP ester of acid chloride is not a reactive intermediate. Thus, Scheme 
21 shows plausible reaction mechanism. Path a, in agreement with traditionally believed FC 
acylation mechanism, HFIP could lead to the acyl cation formation.211-213 Also acyl cation could 
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be protonated by either HFIP or HCl to give a kinetically superior intermediate.219-221 In path b, 
aromatic ring could directly attack acyl chloride (activated through H-bonding with HFIP) to give 
a tetrahedral intermediate. At present, the operative pathway is not known. 
Scheme 21. Plausible reaction mechanism 
 
2.3 Conclusions 
In conclusion, an efficient and metal-free intramolecular FC acylation reaction was developed. 
These conditions do not require aqueous workup, which is common with traditional methods, thus 
avoid toxic water waste generation. Our method is mild compared to previous methods that involve 
excess of harsh acids. Preliminary mechanistic studies indicate the involvement of more than one 
molecule of HFIP in rate limiting step, however further studies need to be done to figure out 
complete picture of mechanism. 
2.4 Experimental Section 
General information. Reactions were performed under an inert atmosphere (argon or 
nitrogen) in oven-dried glassware. All chemicals were used as received from commercial source 





microns) with an organic binder. Visualization was accomplished using UV light or aqueous 
KMnO4 by heating. Purification was achieved by flash chromatography on a CombiFlash Rf 
(automated flash chromatography) system. IR spectra were acquired as thin films or solids. All 
NMR spectra (1H, 13C, DEPT, COSY, NOESY, HMBC, and HSQC) were acquired on either a 400 
MHz or a 500 MHz instrument. Chemical shifts are reported in parts per million (ppm) and are 
referenced to the center line of the solvent ( 7.26, 2.50, and 5.32 ppm with respect to CDCl3, 
DMSO-d6, and CD2Cl2 for 
1H NMR and  77.23, 39.52, and 55.84 ppm with respect to CDCl3, 
DMSO-d6, and CD2Cl2for 
13C NMR, respectively). Coupling constants are given in Hertz (Hz). 
HRMS data were collected with an electrospray ion source (ESI). Melting points were determined 
on an automated melting point apparatus and are uncorrected. Melting points were determined in 
open capillary tubes using an automated melting point apparatus and are uncorrected. 
Dr. Hashim Motiwala performed all experiments in Table 3 (screening of reaction conditions), 
Table 4 (screening of alternative reagents), and Scheme 13 (experiments to probe mechanism). 
Compounds 3a, 3d, 3j, 3k, 3l, 3m, 3n, 3r, 3t, 3u, 3v, 3w, 3ad, 3ag, 3ah, 3ai, 3aj, 3ak, and 3al 
were synthesized by him. He performed scale up reaction of 3a. 
General Procedure A for Solvent Screening (Table 5):  
Procedure (Step 1 → Synthesis of Acid Chloride): To a solution of acid 1a (67.3 mg, 0.300 
mmol, 1.0 equiv) in anhydrous DCM (1.5 mL) in a flame-dried N2-flushed 2-dram vial at rt under 
N2 blanket was added a small drop (using a 21G needle) of N,N-dimethylformamide (DMF). Then 
oxalyl chloride (50.8 μL, 0.600 mmol, 2.0 equiv) was added dropwise (gas evolution was 
observed; the cap was opened for a while under N2 blanket to release the pressure) and the reaction 





concentrator and the residue obtained was dried under vacuum for ca. 15 min. The crude acid 
chloride 2a was used as such for the Step 2.   
Procedure (Step 2 → Friedel–Crafts Acylation; For Entries 1, 9, and 10):  
To the same 2-dram vial containing the crude acid chloride intermediate 2a at rt was added a 
specified volume of HFIP quickly and the vial was capped immediately. The resultant reaction 
mixture was stirred at rt for 2 h. The reaction mixture was concentrated under N2 and the resulting 
residue was dissolved in a minimum quantity of DCM and loaded on a silica gel in a sample 
cartridge. Purification on a Combiflash purification system using a 4 g normal phase silica flash 
column (0–40% EtOAc/hexanes over 20 min) afforded 3a as a colorless solid following 
concentration and drying under vacuum. 
Procedure (Step 2 → Friedel–Crafts Acylation; For Entries 2–8):  
To the same 2-dram vial containing the crude acid chloride intermediate 2a at rt was added an 
appropriate volume of anhydrous solvent (DCM, acetonitrile, nitromethane, trifluorotoluene, or 
THF) followed by a quick addition of a specified volume of HFIP (total volume of solvents was 
1.5 mL) and the vial was immediately capped. The resultant reaction mixture was stirred at rt for 
2–6 h. Reaction mixture was concentrated under N2 and the resulting residue was dissolved in a 
minimum quantity of DCM and loaded on a silica gel in a sample cartridge. Purification on a 
Combiflash purification system using a 4 g normal phase silica flash column (0–40% 
EtOAc/hexanes over 20 min) afforded 3a as a colorless solid (in case of pure product) or a 
creamish-orange solid (in case of impure product) following concentration and drying under 






General Procedure B for Comparison with Alternative Reagents (Table 6):  
Procedure (Step 1 → Synthesis of Acid Chloride): To a solution of acid 1a (22.4 mg, 0.100 
mmol, 1.0 equiv) in anhydrous DCM (0.50 mL) in a flame-dried N2-flushed 1-dram vial at rt under 
N2 blanket was added a small drop (using a 21G needle) of DMF. Then oxalyl chloride (17 μL, 
0.200 mmol, 2.0 equiv) was added dropwise (gas evolution was observed; the cap was opened for 
a while under N2 blanket to release the pressure) and the reaction mixture was stirred at rt for 15 
min. Reaction mixture was concentrated under N2 using a sample concentrator and the residue 
obtained was dried under vacuum for ca. 15 min. The crude acid chloride 2a was used as such for 
the Step 2.    
Procedure (Step 2 → Friedel–Crafts Acylation; For Entries 1–6): To the same 1-dram vial 
containing the crude acid chloride intermediate 2a at rt was added anhydrous DCM (0.50 mL) 
followed by the addition of a reagent (0.50 mmol, 5.0 equiv) and the resultant reaction mixture 
was stirred at rt for 4 or 6 h. The reaction mixture was concentrated under N2 and the resulting 
residue was dried under vacuum. The residue was dissolved in CDCl3 (0.60 mL) followed by the 
addition of nitromethane (10 μL) as an internal standard. The mixture was homogenized and the 
CDCl3 suspension was filtered through a cotton plug into a NMR tube (if a solution was obtained, 
no filtration was carried out). 1H NMR was recorded and the NMR yield was determined where 
product was formed. 
















A = area under the peak or absolute integral for a signal, N = number of protons, MW = molecular 
weight, and W = weight or amount used. 
Procedure (Step 2 → Friedel–Crafts Acylation; For Entries 7–12):  
To the same 1-dram vial containing the crude acid chloride intermediate 2a at rt was added a 
reagent (0.50 mL) and the resultant reaction mixture was stirred at rt for 45 min or 4 h. The reaction 
mixture was concentrated under N2 or Genevac (for entry 10) and the resulting residue was dried 
under vacuum. The residue was dissolved in CDCl3 (0.60 mL) followed by the adddition of 
nitromethane (10 μL) as an internal standard. The mixture was homogenized and the solution was 
transferred to a NMR tube. 1H NMR was recorded and the NMR yield was determined where 
product was formed.  
 
Isopropyl 4-(3,4-dimethoxyphenyl)butanoate (4b):  
In case of entry 12, the residue obtained after drying was dissolved in a minimum quantity of DCM 
and loaded on a silica gel in a sample cartridge. Purification on a Combiflash purification system 
using a 4 g normal phase silica flash column (0–15% EtOAc/hexanes over 15 min) afforded 4b 
(24.5 mg, 92%) as a colorless oil. 1H NMR (400 MHz, CDCl3): δ 6.80–6.78 (m, 1H), 6.72–6.70 
(m, 2H), 5.01 (hept, J = 6.3 Hz, 1H), 3.87 (s, 3H), 3.85 (s, 3H), 2.59 (t, J = 7.6 Hz, 2H), 2.28 (t, J 
= 7.5 Hz, 2H), 1.92 (p, J = 7.5 Hz, 2H), 1.23 (d, J = 6.3 Hz, 6H); 13C NMR (101 MHz, CDCl3): δ 





(neat) 1725, 1514 cm–1; HRMS (ESI) m/z calcd for C15H23O4 [M + H]
+: 267.1596, found: 
267.1605. 
Experimental Procedures for Scheme 20 (Control Experiments to Probe the Hydrogen 
Bonding Mechanism):    
 
a. Reaction of 4a with acetyl chloride in HFIP: 
To a solution of 1,1,1,3,3,3-hexafluoropropan-2-yl 4-(3,4-dimethoxyphenyl)butanoate 4a (37.3 
mg, 0.100 mmol, 1.0 equiv) in HFIP (0.25 mL) in a flame-dried N2-flushed 1-dram vial at rt was 
added acetyl chloride (7.79 μL, 0.110 mmol, 1.1 equiv) and the resulting reaction mixture was 
stirred at rt for 1.5 h. No reaction was observed and crude 1H NMR only showed peaks 
corresponding to 4a. 
b. Reaction of 2a with 1 equiv of HFIP:  
Procedure (Step 1): Following the general procedure A for Step 1, 4-(3,4-
dimethoxyphenyl)butanoic acid 1a (67.3 mg, 0.300 mmol, 1.0 equiv) was converted to 4-(3,4-
dimethoxyphenyl)butanoyl chloride 2a using oxalyl chloride (50.8 μL, 0.600 mmol, 2.0 equiv) in 





Procedure (Step 2): To a solution of the crude acid chloride 2a in anhydrous DCM (1.5 mL) in a 
capped vial at rt was added HFIP (31.6 μL, 0.300 mmol, 1.0 equiv) using a microsyringe and the 
resultant reaction mixture was stirred at rt for 1.5 h. Reaction mixture was concentrated under N2 
and the resulting residue was dissolved in a minimum quantity of DCM and loaded on to silica gel 
in a sample cartridge. Purification on a Combiflash purification system using a 4 g normal phase 
silica flash column (0–40% EtOAc/hexanes over 20 min) afforded 3a (43.8 mg, 71%) as a colorless 
solid.  
 
c. Reaction of 2a with added HCl in the absence of HFIP:  
Procedure (Step 1): Following the general procedure A for Step 1, 4-(3,4-
dimethoxyphenyl)butanoic acid 1a (67.3 mg, 0.300 mmol, 1.0 equiv) was converted to 4-(3,4-
dimethoxyphenyl)butanoyl chloride 2a using oxalyl chloride (50.8 μL, 0.600 mmol, 2.0 equiv) in 
30 min.  
Procedure (Step 2): To a solution of the crude acid chloride 2a in anhydrous DCM (1.5 mL) at rt 
was added HCl (4.0 M solution in dioxane) (75.0 μL, 0.300 mmol, 1.0 equiv) and the resultant 
reaction mixture was stirred at rt for 1.5 h. Reaction mixture was partially concentrated under N2 
and the resulting solution including the rinsings in DCM was loaded on to silica gel in a sample 
cartridge. Purification on a Combiflash purification system using a 12 g normal phase silica flash 
column (0–60% EtOAc/hexanes over 30 min) afforded 3a (26.0 mg, 42%) as a colorless solid. 





d. Reaction of 2a in the presence of a proton scavenger, DTBMP:  
Procedure (Step 1): Following the general procedure A for Step 1, 4-(3,4-
dimethoxyphenyl)butanoic acid 1a (67.3 mg, 0.300 mmol, 1.0 equiv) was converted to 4-(3,4-
dimethoxyphenyl)butanoyl chloride 2a using oxalyl chloride (50.8 μL, 0.600 mmol, 2.0 equiv) in 
30 min.  
Procedure (Step 2): To the same 2-dram vial containing the crude acid chloride intermediate 2a 
at rt was added anhydrous DCM (1.2 mL) followed by the addition of 2,6-di-tert-butyl-4-
methylpyridine (DTBMP; 61.6 mg, 0.300 mmol, 1.0 equiv). To the resulting suspension was added 
HFIP (0.30 mL) and the reaction mixture was stirred at rt for 1.5 h. Reaction mixture was 
concentrated under N2 and the residue obtained was redissolved in DCM and loaded on to silica 
gel in a sample cartridge. Purification on a Combiflash purification system using a 12 g normal 
phase silica flash column (0–30% EtOAc/hexanes over 30 min) afforded 3a as an off-white solid 
(18.5 mg, 30%) and 4a as a colorless oil (74.5 mg, 66%). In a similar way as described above for 
Step-2, when 0.50 equiv DTBMP (30.8 mg, 0.150 mmol) was used, 3a (44.2 mg, 71%) was 






e. Reaction of 2a in the presence of pyridine:  
Procedure (Step 1): Following the general procedure B for Step 1, 4-(3,4-
dimethoxyphenyl)butanoic acid 1a (22.4 mg, 0.100 mmol, 1.0 equiv) was converted to 4-(3,4-
dimethoxyphenyl)butanoyl chloride 2a using oxalyl chloride (16.9 μL, 0.200 mmol, 2.0 equiv) in 
15 min.  
Procedure (Step 2): To the same 1-dram vial containing the crude acid chloride intermediate 2a 
at rt was added anhydrous DCM (0.25 mL) followed by the addition of pyridine (16.2 μL, 0.200 
mmol, 2.0 equiv). To the resulting solution was added HFIP (0.25 mL) and the reaction mixture 
was stirred at rt for 4 h. Reaction mixture was concentrated under N2 and the resulting residue was 
dissolved in a minimum quantity of DCM and loaded on to silica gel in a sample cartridge. 
Purification on a Combiflash purification system using a 4 g normal phase silica flash column (0–
15% EtOAc/hexanes over 15 min) afforded 1,1,1,3,3,3-hexafluoropropan-2-yl 4-(3,4-
dimethoxyphenyl)butanoate 4a (35.4 mg, 95%) as a colorless oil. TLC (30% EtOAc/hexanes) Rf 
= 0.76; 1H NMR (400 MHz, CDCl3): δ 6.80 (d, J = 7.9 Hz, 1H), 6.68–6.72 (m, 2H), 5.79 (hept, J 
= 6.2 Hz, 1H), 3.87 (s, 3H), 3.86 (s, 3H), 2.62 (t, J = 7.5 Hz, 2H), 2.52 (t, J = 7.4 Hz, 2H), 2.00 (p, 
J = 7.4 Hz, 2H); 13C NMR (101 MHz, CDCl3): δ 170.4, 149.3, 147.8, 133.4, 120.5, 116.4–124.9 
(m, 2C), 112.0, 111.6, 66.6 (p, J = 34.7 Hz, 1C), 56.1, 56.0, 34.5, 32.6, 26.5; IR (neat) 1779, 1516, 
1196, 1106 cm–1; HRMS (ESI) m/z calcd for C15H16F6O4 [M + H]







f. Reaction of 2a in the presence of a strong hydrogen bond acceptor, Ph3PO:  
Procedure (Step 1):  
Following the general procedure A for Step 1, 4-(3,4-dimethoxyphenyl)butanoic acid 1a (67.3 mg, 
0.300 mmol, 1.0 equiv) was converted to 4-(3,4-dimethoxyphenyl)butanoyl chloride 2a using 
oxalyl chloride (50.8 μL, 0.600 mmol, 2.0 equiv) in 30 min.  
Procedure (Step 2 for 9.5 Equiv of HFIP) To the same 2-dram vial containing the crude acid 
chloride intermediate 2a at rt was added anhydrous DCM (1.2 mL) followed by the addition of 
triphenylphosphine oxide (Ph3PO; 251 mg, 0.900 mmol, 3.0 equiv). To the resulting solution was 
added HFIP (0.300 mL, 2.85 mmol, 9.5 equiv) and the reaction mixture was stirred at rt for 1.5 h. 
Reaction mixture was concentrated under N2 and the residue obtained was dissolved in DCM and 
loaded on to silica gel in a sample cartridge. Purification on a Combiflash purification system using 
a 12 g normal phase silica flash column (0–40% EtOAc/hexanes over 20 min) afforded 3a (59.3 
mg, 96%) as a very pale yellow solid.   
Procedure (Step 2 for 5.0 Equiv of HFIP) To the same 2-dram vial containing the crude acid 
chloride intermediate 2a at rt was added anhydrous DCM (1.34 mL) followed by the addition of 
Ph3PO (501 mg, 1.80 mmol, 6.0 equiv). To the resulting solution was added HFIP (0.158 mL, 1.50 
mmol, 5.0 equiv) and the reaction mixture was stirred at rt for 1.5 h. Reaction mixture was 
concentrated under N2 and the residue obtained was dissolved in DCM and loaded on to silica gel 
in a sample cartridge. Purification on a Combiflash purification system using a 12 g normal phase 
silica flash column (0–60% EtOAc/hexanes over 30 min) afforded 3a (4.00 mg, 6%) as a colorless 
solid. Acid 1a was recovered in 73% yield (49.3 mg; corrected yield based on ca. 93% purity) as 





General procedure for the kinetic analysis of the FC acylation of 2a (Figure 14): 
4-(3,4-Dimethoxyphenyl)butanoyl chloride (2a): 
To a solution of 4-(3,4-dimethoxyphenyl)butanoic acid (0.5 g, 2.2 mmol, 1.0 equiv) in anhydrous 
DCM (5 mL) rt under N2 blanket was added DMF (2 drops). Then oxalyl chloride (0.28 mL, 
3.3 mmol, 1.5 equiv) was added dropwise (gas evolution was observed; the cap was opened for a 
while under N2 blanket to release the pressure) and the reaction mixture was stirred at rt for 30 
mins. Reaction mixture was concentrated and the residue obtained was dried under vacuum for 1 
h. To the crude pentane (3 mL) was added and resulting mixture was sonicated for 5 mins. Then 
the mixture was kept in freezer for 2 h. The clear pentane layer was removed and the residue was 
washed 3 times with fresh pentane. The remaining residue was dried under vacuum to give pure 
acid chloride (0.408 g, 75%) as a yellow oil. 1H NMR (400 MHz, CDCl3) δ 6.81 (d, J = 8.0 Hz, 
1H), 6.72 – 6.69 (m, 1H), 6.68 (d, J = 2.0 Hz, 1H), 3.88 (s, 3H), 3.86 (s, 3H), 2.88 (t, J = 7.2 Hz, 
2H), 2.63 (t, J = 7.5 Hz, 2H), 2.02 (p, J = 7.3 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ 173.9, 
149.1, 147.7, 133.0, 120.5, 111.8, 111.5, 56.1, 56.0, 46.3, 34.0, 26.9. 
To a solution of 4-(3,4-dimethoxyphenyl)butanoyl chloride (2a, 0.078 g, 0.300 mmol, 1.0 equiv) 
in DCM, was added HFIP (1, 2, 3, 5, or 10 equiv). The combined volume of DCM and HFIP was 
kept 1 mL in each case. The reaction mixture was stirred at rt and monitored by reactIR until the 
complete consumption of starting acyl chloride.  
entry HFIP (equiv) HFIP (mL) DCM (mL) 
1 1 0.03 0.97 
2 2 0.06 0.94 
3 3 0.10 0.90 
4 5 0.16 0.84 






Syntheses of compounds: 
 
4-(3,5-Dimethoxyphenyl)butanoic acid (1b):222  
To a cooled solution of (2-carboxyethyl)triphenylphosphonium bromide (1.50 g, 3.60 mmol, 1.2 
equiv) in DCM (5.0 mL) at 0 °C under N2 atmosphere was added 3,5-dimethoxybenzaldehyde 
(0.500 g, 3.00 mmol, 1.0 equiv). To the resulting mixture, potassium tert-butoxide (0.840 g, 7.50 
mmol, 2.5 equiv) was added portion wise and the reaction mixture was allowed to stir at rt for 12 
h. The reaction was quenched with water and DCM layer was separated and discarded. The 
aqueous layer was acidified with 1 M HCl to pH 1 and extracted with EtOAc (10 mL × 3). The 
combined organic layers were washed with water (10 mL × 1), brine (10 mL × 1), dried over 
Na2SO4, and concentrated. Purification on a Combiflash purification system using a silica flash 
column (70:30 hexanes/EtOAc) afforded (E)-4-(3,5-dimethoxyphenyl)but-3-enoic acid 9b223 
(0.153 g, 23%) as a colorless solid.  
To a solution of compound 9b (0.152 g, 0.680 mmol) in EtOAc (2.0 mL) under Ar atmosphere 
was added 10% of Pd/C (15.0 mg, 10 wt%) followed by EtOH (6.0 mL). The reaction mixture was 
evacuated under vacuum and flushed with H2 gas (3 cycles) and was continued to stir under H2 
atmosphere at rt for 1 h. The reaction mixture was filtered through a pad of Celite followed ringing 






4-(3,5-Dimethylphenyl)butanoic acid (1c):  
Following the procedure described for compound 1b, 3,5-dimethylbenzaldehyde (1.00 g, 7.45 
mmol, 1.0 equiv) was reacted with (2-carboxyethyl)triphenylphosphonium bromide (3.71 g, 8.94 
mmol, 1.2 equiv) in the presence of potassium tert-butoxide (2.09 g, 18.6 mmol, 2.5 equiv) to 
afford (E)-4-(3,5- dimethylphenyl)but-3-enoic acid 9c (0.475 g, 33%) as a colorless oil. TLC (50% 
EtOAc/hexanes) Rf = 0.30; 
1H NMR (400 MHz, CDCl3) δ 7.00 (dd, J = 1.7, 0.9 Hz, 2H), 6.93–
6.84 (m, 1H), 6.46 (dt, J = 15.8, 1.4 Hz, 1H), 6.25 (dt, J = 15.9, 7.1 Hz, 1H), 3.28 (dd, J = 7.1, 1.4 
Hz, 2H), 2.30 (d, J = 0.8 Hz, 6H); 13C NMR (101 MHz, CDCl3) δ 177.2, 138.2 (2C), 136.7, 134.3, 
129.6, 124.4 (2C), 120.5, 38.1, 21.4 (2C); IR (neat) 3700–2300, 1755 cm–1; HRMS (ESI) m/z calcd 
for C12H15O2 [M + H]
+: 191.1072, found: 191.1043.  
Compound 9c (0.420 g, 2.21 mmol) was then reduced with Pd/C (0.0420 g, 10 wt%) under H2 
atmosphere in EtOH to afford 1c (0.400 g, 94%) as a colorless solid. Mp 61–62 °C; TLC (50% 
EtOAc/hexanes) Rf = 0.50; 
1H NMR (400 MHz, CDCl3) δ 6.84 (d, J = 1.8 Hz, 1H), 6.82–6.77 (m, 
2H), 2.65–2.55 (m, 2H), 2.38 (t, J = 7.5 Hz, 2H), 2.29 (d, J = 0.8 Hz, 6H), 1.95 (p, J = 7.5 Hz, 2H); 
13C NMR (101 MHz, CDCl3) δ 180.0, 141.2, 138.0 (2C), 127.8, 126.5 (2C), 35.0, 33.6, 26.4, 21.4 
(2C); IR (neat) 3400–2300, 1687 cm–1; HRMS (ESI) m/z calcd for C12H17O2 [M + H]
+: 193.1229, 









3-(4,7-Dimethoxynaphthalen-1-yl)propanoic acid (1d):  
 
Following a modification of the literature procedure,224 3-(4,7-dimethoxynaphthalen-1-
yl)propanoic acid 1d was prepared from 4,7-dimethoxy-1-naphthaldehyde in the following 
manner: 
To a suspension of sodium hydride (60% dispersion in mineral oil) (72.0 mg, 1.80 mmol, 1.2 
equiv; washed with hexanes once) in anhydrous THF (4.0 mL) in a flame-dried RBF at rt under 
Ar was added a solution of triethyl phosphonoacetate (403 mg, 1.80 mmol, 1.2 equiv) in anhydrous 
THF (1.5 mL, including the washings) slowly over 5 min (effervescence was observed). The 
resulting solution was stirred at rt for 30 min. A solution of 4,7-dimethoxy-1-naphthaldehyde (324 
mg, 1.50 mmol, 1.0 equiv) in anhydrous THF (2.5 mL, including the washings) was added slowly 





4,7-dimethoxy-1-naphthaldehyde was observed by TLC, so additional sodium hydride (24.0 mg, 
0.600 mmol, 0.40 equiv) and triethyl phosphonoacetate (101 mg, 0.450 mmol, 0.30 equiv) was 
directly added into the reaction mixture and the reaction mixture was continued to stir at rt for 
another 1 h. Reaction mixture was concentrated, diluted with water (30 mL), and extracted with 
ether (25 mL × 2). The combined organic layers were washed with brine (30 mL × 1), dried over 
Na2SO4, and concentrated to afford 429 mg of crude intermediate A [(E)-ethyl 3-(4,7-
dimethoxynaphthalen-1-yl)acrylate] as a semisolid residue, which was used as such for the next 
hydrogenation step. 
To a solution of the crude Intermediate A (429 mg) in ethanol (8.0 mL) under N2 was added 10% 
of Pd/C (43.1 mg, 0.405 mmol, 10 wt%). The resulting suspension was evacuated under vacuum 
and flushed with H2 twice and was continued to stir under H2 atmosphere at rt for 3.5 h. The 
reaction mixture was filtered through a Celite bed followed by ether rinsings. Solvent evaporation 
afforded crude Intermediate B [(ethyl 3-(4,7-dimethoxynaphthalen-1-yl)propanoate] as an oily 
residue, which was used as such for the next saponification step.  
To a solution of Intermediate B in THF (4.0 mL) at rt in an open flask was added sodium hydroxide 
(2.0 M solution in deionized water; 6.00 mL, 12.00 mmol, 8.0 equiv) and the resulting biphasic 
solution was stirred at rt for 12 h. Reaction mixture was acidified with 1.0 M aqueous HCl with 
stirring until acidic (pH = 1) and the resulting aqueous suspension was extracted with DCM (25 
mL × 2). The combined organic layers were dried over Na2SO4 and concentrated to give a cream-
orange solid. The solid was suspended in DCM and loaded on a silica gel in a sample cartridge. 
Purification on a Combiflash purification system using a 12 g silica flash column (0–5% 
MeOH/DCM over 25 min) afforded 1d (347 mg, 89% over 3 steps) as a cream solid. Mp 148.5–
150 °C; TLC (30% EtOAc/hexanes) Rf = 0.21; 





8.10 (d, J = 9.2 Hz, 1H), 7.27 (d, J = 2.4 Hz, 1H), 7.24 (d, J = 7.9 Hz, 1H), 7.15 (dd, J = 9.2, 2.5 
Hz, 1H), 6.73 (d, J = 7.9 Hz, 1H), 3.91 (s, 3H), 3.90 (s, 3H), 3.17 (t, J = 7.5 Hz, 2H), 2.61 (t, J = 
7.6 Hz, 2H); 13C NMR (101 MHz, DMSO-d6) δ 174.0, 157.8, 153.8, 133.4, 127.4, 126.4, 123.8, 
120.1, 116.6, 102.7, 101.9, 55.3, 55.1, 34.4, 27.1; IR (neat) 3350–2350, 1710, 1692 cm–1; HRMS 
(ESI) m/z calcd for C15H17O4 [M + H]
+: 261.1127, found: 261.1118.   
 
4-(Thiophen-3-yl)butanoic acid (1f):  Following the procedure described for compound 1b, 3-
thiophenecarboxaldehyde (1.00 g, 8.92 mmol, 1.0 equiv) was reacted with (2-
carboxyethyl)triphenylphosphonium bromide (4.44 g, 10.7 mmol, 1.2 equiv) in the presence of 
potassium tert-butoxide (2.50 g, 22.3 mmol, 2.5 equiv) to afford (E)-4-(thiophen-3- yl)but-3-enoic 
acid 9f (0.375 g, 26%) as a golden brown solid. Mp 90–92 °C; TLC (50% EtOAc/hexanes) Rf = 
0.40; 1H NMR (400 MHz, CDCl3) δ 7.29–7.25 (m, 1H), 7.21 (dd, J = 5.1, 1.3 Hz, 1H), 7.14 (dd, J 
= 3.0, 1.3 Hz, 1H), 6.53 (dt, J = 15.9, 1.5 Hz, 1H), 6.13 (dt, J = 15.8, 7.2 Hz, 1H), 3.26 (dd, J = 
7.1, 1.5 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ 177.4, 139.4, 128.4, 126.2, 125.1, 122.3, 120.8, 
S17 38.0; IR (neat) 3400–2100, 1705 cm–1; HRMS (ESI) m/z calcd for C8H9O2S [M + H]
+: 
169.0323, found: 169.0309.     
Compound 9f (0.357 g, 2.12 mmol) was then reduced with Pd/C (0.0357 g, 10 wt%) under H2 
atmosphere in EtOH to afford 1f (0.360 g, 99%) as a colorless oil. TLC (50% EtOAc/hexanes) Rf 
= 0.60; 1H NMR (400 MHz, CDCl3) δ 7.28–7.24 (m, 1H), 6.95 (ddt, J = 8.0, 4.3, 2.2 Hz, 2H), 2.71 





179.1, 141.6, 128.2, 125.7, 120.7, 33.4, 29.5, 25.6; IR (neat) 3500–2300, 1700 cm–1; HRMS (ESI) 
m/z calcd for C8H11O2S [M + H]
+: 171.0480, found: 171.0463.  
 
4-(Benzo[b]thiophen-3-yl)butanoic acid (1g):225 
Following the procedure described for compound 1b, thianaphthene-3-carboxaldehyde (1.00 g, 
6.16 mmol, 1.0 equiv) was reacted with (2-carboxyethyl)triphenylphosphonium bromide (3.07 g, 
7.39 mmol, 1.2 equiv) in the presence of potassium tert-butoxide (1.73 g, 15.4 mmol, 2.5 equiv) 
to afford (E)-4- (benzo[b]thiophen-3-yl)but-3-enoic acid 9g (0.550 g, 41%) as an orange solid. Mp 
93–95 °C; TLC (50% EtOAc/hexanes) Rf = 0.30; 
1H NMR (400 MHz, CDCl3) δ 7.94–7.81 (m, 
2H), 7.44 (s, 1H), 7.43–7.33 (m, 2H), 6.80 (dq, J = 15.9, 1.3 Hz, 1H), 6.37 (dt, J = 15.9, 7.1 Hz, 
1H), 3.38 (dd, J = 7.2, 1.5 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ 176.1, 140.6, 137.7, 133.5, 
126.5, 124.6, 124.4, 123.0, 122.8, 122.5, 122.1, 38.2; IR (neat) 3300–2200, 1681 cm–1; HRMS 
(ESI) m/z calcd for C12H11O2S [M + H]
+: 219.0480, found: 219.0465.  
Compound 9g (0.424 g, 1.94 mmol) was then reduced with Pd/C (0.0424 g, 10 wt%) under H2 







4-(Benzofuran-2-yl)butanoic acid (1h):226 
Following the procedure described for compound 1b, 2-benzofurancarboxaldehyde (1.00 g, 6.84 
mmol, 1.0 equiv) were reacted with (2-carboxyethyl)triphenylphosphonium bromide (3.41 g, 8.21 
mmol, 1.2 equiv) in the presence of potassium tert-butoxide (1.92 g, 17.1 mmol, 2.5 equiv) to 
afford (E)-4- (benzofuran-2-yl)but-3-enoic acid 9h (0.450 g, 33%) as a yellow solid. Mp 110–112 
°C; TLC (50% EtOAc/hexanes) Rf = 0.40; 
1H NMR (400 MHz, CDCl3) δ 7.51 (ddd, J = 7.6, 1.4, 
0.7 Hz, 1H), 7.46–7.41 (m, 1H), 7.28–7.41 (m, 1H), 7.19 (td, J = 7.5, 1.0 Hz, 1H), 6.60–6.44 (m, 
3H), 3.35 (d, J = 6.3 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ 176.4, 155.0, 154.0, 128.9, 124.8, 
123.1, 123.0, 122.7, 121.1, 111.1, 104.7, 37.8; IR (neat) 3400–2100, 1687 cm–1; HRMS (ESI) m/z 
calcd for C12H9O3 [M – H]
–: 201.0552, found: 201.0556.  
Compound 9h (0.300 g, 1.48 mmol) was then reduced with Pd/C (0.0300 g, 10 wt%) under H2 
atmosphere in EtOH to afford 1h (0.235 g, 78%) as a colorless solid. Mp 76–78 °C; TLC (50% 
EtOAc/hexanes) Rf = 0.50; 
1H NMR (400 MHz, CDCl3) δ 7.53–7.46 (m, 1H), 7.44–7.39 (m, 1H), 
7.25– 7.12 (m, 2H), 6.43 (d, J = 0.9 Hz, 1H), 2.86 (t, J = 7.1 Hz, 2H), 2.47 (t, J = 7.4 Hz, 2H), 2.10 
(p, J = 7.4 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ 179.0, 158.1, 154.9, 128.9, 123.5, 122.7, 120.5, 
110.9, 102.8, 33.2, 27.8, 22.9; IR (neat) 3400–2300, 1692 cm–1; HRMS (ESI) m/z calcd for 
C12H11O3 [M – H]








3-Phenoxypropanoic acid (1i):227 
To a solution of phenol (0.500 g, 5.30 mmol, 1.0 equiv) and 3-bromopropionic acid (0.810 mg, 
5.30 mmol, 1.0 equiv) in DMF (5.0 mL) at rt under Ar atmosphere was added Cs2CO3 (3.46 g, 
10.6 mmol, 2.0 equiv) and the resulting suspension was continued to stir at rt for 15 h. The reaction 
mixture was quenched with 1 M HCl to pH 1 and the aqueous layer was extracted with EtOAc (10 
mL × 3). The combined organic layers were washed with water (10 mL × 1), brine once, dried 
over Na2SO4, and concentrated. Purification on a Combiflash purification system using a silica 
flash column (80:20 hexanes/EtOAc) afforded 1i (0.148 g, 17%) as a colorless solid. 
 
3-((2,5-Dimethoxyphenyl)thio)propanoic acid (1j): 
Following a reported procedure,192 to a suspension of 3-bromopropanoic acid (225 mg, 1.47 mmol, 
1.05 equiv) in deionized water (5.0 mL) at rt was added anhydrous sodium carbonate (163 mg, 
1.54 mmol, 1.1 equiv) slowly. After the effervescence ceased, the clear solution was cooled to ca. 
5–10 °C and this cold solution was added to a turbid solution of 2,5-dimethoxybenzenethiol (238 
mg, 1.40 mmol, 1.0 equiv) in sodium hydroxide (84.0 mg, 2.10 mmol, 1.5 equiv) and deionized 
water (3.0 mL) at rt in a microwave vial (10–20 mL capacity). The vial was sealed and the resulting 
turbid solution was stirred at refluxing temperature (100–105 °C) for 1.5 h. Reaction mixture was 
cooled to rt and extracted with EtOAc (30 mL × 1) and the EtOAc layer was discarded. The 
aqueous layer was acidified with 2 M aqueous HCl solution (10 mL) and the resulting turbid 
solution was extrated with DCM (25 mL × 3). The combined organic layers were washed with 





and loaded on to silica gel in a sample cartridge. Purification on a Combiflash purification system 
using a 12 g silica flash column (0–50% EtOAc/hexanes over 25 min) afforded 1j (257 mg, 76%) 
as a colorless crystalline solid. Mp 100–102 °C; TLC (50% EtOAc/hexanes) Rf = 0.37; 
1H NMR 
(400 MHz, CDCl3) δ 10.84 (brs, 1H), 6.91 (d, J = 2.9 Hz, 1H), 6.80 (d, J = 8.9 Hz, 1H), 6.74 (dd, 
J = 8.9, 2.9 Hz, 1H), 3.84 (s, 3H), 3.77 (s, 3H), 3.14 (t, J = 7.4 Hz, 2H), 2.68 (t, J = 7.4 Hz, 2H); 
13C NMR (101 MHz, CDCl3) δ 178.2, 153.8, 152.4, 124.1, 117.1, 112.4, 111.8, 56.4, 55.9, 34.2, 




3-((3-Methoxyphenyl)thio)-3-phenylpropanoic acid (1k): 
Following a modification of the reported procedure,228 to a mixture of 3-methoxybenzenethiol 
(421 mg, 3.00 mmol, 2.0 equiv) and trans-cinnamic acid (223 mg, 1.50 mmol, 1.0 equiv) in a dried 
N2-flushed 2-dram vial at rt was added 1.0 M solution of tetrabutylammonium fluoride in THF 
(0.751 mL, 0.751 mmol, 0.50 equiv) . The vial was capped and the resulting suspension was stirred 
at 50 °C under N2 for 6 h (most of the THF had evaporated within 2 h). The reaction mixture was 
dissolved in a minimum quantity of DCM and loaded on to silica gel in a sample cartridge. 
Purification on a Combiflash purification system using a 12 g silica flash column (0–30% 
EtOAc/hexanes over 30 min) afforded 1k (272 mg, 63%) as a colorless solid. Mp 81–83 °C; TLC 
(25% EtOAc/hexanes, run twice) Rf = 0.32; 
1H NMR (400 MHz, CDCl3) δ 10.64 (brs, 1H), 7.26–





3.65 (s, 3H), 2.94 (m, 2H); 13C NMR (101 MHz, CDCl3) δ 177.0, 159.8, 140.4, 134.7, 129.8, 128.7 
(2C), 127.9 (3C), 125.6, 118.3, 114.4, 55.4, 48.7, 40.8; IR (neat) 3500–2400, 1707 cm–1; HRMS 
(ESI) m/z calcd for C16H17O3S [M + H]
+: 289.0898, found: 289.0881. 
 
3-((3,4-Dimethylphenyl)thio)-2,2-dimethylpropanoic acid (1m):  
Following a reported procedure,192 to a suspension of 3-chloro-2,2-dimethylpropanoic acid (215 
mg, 1.58 mmol, 1.05 equiv) in deionized water (5.0 mL) at rt was added anhydrous Na2CO3 (175 
mg, 1.65 mmol, 1.1 equiv) slowly. After the effervescence ceased, the clear solution was cooled 
to ca. 5–10 °C and this cold solution was added to a turbid solution of 3,4-dimethylbenzenethiol 
(207 mg, 1.50 mmol, 1.0 equiv) in sodium hydroxide (90.0 mg, 2.25 mmol, 1.5 equiv) and 
deionized water (3.0 mL) at rt in a big microwave vial. The vial was sealed and the resulting turbid 
solution was stirred at refluxing temperature (100–105 °C) for 1.5 h. The reaction mixture was 
cooled to rt and acidified with 2 M aqueous HCl solution (10 mL). The resulting suspension was 
extracted with DCM (25 mL × 3). The combined organic layers were washed with brine (30 mL 
× 1), dried over Na2SO4, and concentrated. The oil obtained was dissolved in hexanes containing 
a small amount of DCM and the solution was loaded on a silica gel in a sample cartridge. 
Purification on a Combiflash purification system using a 12 g silica flash column (0–20% 
EtOAc/hexanes over 40 min) afforded 1m (330 mg, 92%) as an almost colorless crystalline solid. 
Mp 70–71.5 °C; TLC (30% EtOAc/hexanes) Rf = 0.51; 
1H NMR (400 MHz, CDCl3) δ 11.66 (brs, 





= 4.0 Hz, 6H), 1.31 (s, 6H); 13C NMR (101 MHz, CDCl3) δ 183.5, 137.4, 135.3, 133.7, 132.1, 
130.3, 128.4, 45.4, 44.2, 24.8 (2C), 19.9, 19.5; IR (neat) 3400–2300, 1693 cm–1; HRMS (ESI) m/z 
calcd for C13H19O2S [M + H]
+: 239.1106, found: 239.1080. 
 
Rel-(1S,2S)-2-((3,4-Dimethoxyphenyl)thio)cyclohexanecarboxylic acid (1n):  
Following a modification of the reported procedure,228 to a mixture of 3,4-dimethoxybenzenethiol 
(511 mg, 3.00 mmol, 2.0 equiv) and 1-cyclohexene-1-carboxylic acid (189.2 mg, 1.500 mmol, 1.0 
equiv) in a dried N2-flushed 2-dram vial at rt was added 1.0 M solution of tetrabutylammonium 
fluoride in THF (0.750 mL, 0.750 mmol, 0.50 equiv). The vial was capped and the resulting 
solution was stirred at 50 °C under N2 for 1 h. Reaction mixture was dissolved in a minimum 
quantity of DCM and loaded on a silica gel in a sample cartridge. Purification on a Combiflash 
purification system using a 12 g silica flash column (0–2% MeOH/DCM over 40 min) afforded 
impure 1n as a colorless solid. Recrystallization of the solid from DCM/hexanes mixture (solid 
was dissolved in a minimum quantity of DCM and then hexanes was added until the solution 
became slightly turbid) afforded pure 1n (275 mg, 62%) as a colorless crystalline solid after 
filtration and drying under vacuum. Mp 111.5–113.5 °C; TLC (2% MeOH/DCM) Rf = 0.22; 
1H 
NMR (400 MHz, CDCl3) δ 11.63 (brs, 1H), 7.06 (dd, J = 8.2, 2.1 Hz, 1H), 7.02 (d, J = 2.0 Hz, 
1H), 6.76 (d, J = 8.3 Hz, 1H), 3.85 (s, 3H), 3.84 (s, 3H), 3.59 (m, 1H), 2.79 (m, 1H), 2.00 (m, 1H), 
1.88–1.76 (complex, 4H), 1.69 (m, 1H), 1.50 (m, 1H), 1.36–1.24 (m, 1H); 13C NMR (101 MHz, 





21.8; IR (neat) 3450–2350, 1703 cm–1; HRMS (ESI) m/z calcd for C15H21O4S [M + H]
+: 297.1161, 
found: 297.1141.  
 
4-(3-Methyl-1H-indol-1-yl)butanoic acid (1p):197  
Following the literature procedure,197 3-methylindole (0.200 g, 1.52 mmol, 1.0 equiv) was reacted 
with γ-butyrolactone (0.262 g, 3.05 mmol, 2.0 equiv) in the presence of sodium hydride (60% 
dispersion in mineral oil) (0.122 g, 3.05 mmol, 2.0 equiv) to afford 1p (0.200 g, 61%) as a brown 
solid. Mp 82–84 °C; TLC (20% EtOAc/hexanes) Rf = 0.20; 
1H NMR (400 MHz, CDCl3) δ 7.57 
(dt, J = 7.9, 1.0 Hz, 1H), 7.30 (dt, J = 8.2, 0.9 Hz, 1H), 7.21 (ddd, J = 8.3, 7.0, 1.2 Hz, 1H), 7.11 
(ddd, J = 8.0, 7.0, 1.1 Hz, 1H), 6.86 (d, J = 1.1 Hz, 1H), 4.16 (t, J = 6.8 Hz, 2H), 2.40–2.29 (m, 
5H), 2.15 (p, J = 7.0 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ 178.4, 136.4, 129.0, 125.5, 121.7, 
119.3, 118.8, 110.8, 109.2, 45.0, 30.9, 25.4, 9.7; IR (neat) 3300–2200, 1702 cm–1; HRMS (ESI) 
m/z calcd for C13H16NO2 [M + H]
+: 218.1181, found: 218.1188.  
 
2-((3-Methyl-1H-indol-1-yl)methyl)benzoic acid (1q): To a cooled solution of 3-methylindole 
(0.200 g, 1.52 mmol, 1.0 equiv) in DMF (5.0 mL) at 0 °C under Ar atmosphere was added sodium 
hydride (60% dispersion in mineral oil) (0.0730 g, 1.83 mmol, 1.2 equiv). After stirring for 10 min 





reaction mixture was continued to stir at 0 °C for 15 min. The reaction mixture was warmed to rt 
and continued to stir at rt for 1 h. The reaction was quenched with water and the aqueous layer was 
extracted with EtOAc (10 mL × 3). The combined organic layers were washed with water (10 mL 
× 1), brine once, dried over Na2SO4, and concentrated. Purification on a Combiflash purification 
system using a silica flash column (90:10 hexanes/EtOAc) afforded ethyl 2-((3-methyl-1H-indol-
1-yl)methyl)benzoate 10q (0.340 g, 76%) as a colorless oil. TLC (10% EtOAc/hexanes) Rf = 0.50; 
1H NMR (400 MHz, CDCl3) δ 8.09–7.98 (m, 1H), 7.66–7.56 (m, 1H), 7.33–7.27 (m, 2H), 7.22–
7.05 (m, 3H), 6.90 (d, J = 1.1 Hz, 1H), 6.56–6.46 (m, 1H), 5.72 (d, J = 0.8 Hz, 2H), 4.42 (q, J = 
7.1 Hz, 2H), 2.37 (d, J = 1.1 Hz, 3H), 1.43 (t, J = 7.1 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 
167.3, 140.5, 136.9, 132.9, 131.0, 129.0, 128.3, 127.2, 127.2, 126.4, 121.8, 119.1, 119.0, 111.2, 
109.7, 61.3, 48.4, 14.5, 9.8; IR (neat) 1712 cm–1; HRMS (ESI) m/z calcd for C19H20NO2 [M + H]
+: 
294.1494, found: 294.1463.  
To a solution of 10q (0.330 g, 1.12 mmol, 1.0 equiv) in THF (6.0 mL) was added a suspension of 
LiOH (0.108 g, 4.50 mmol, 4.0 equiv) in water (2.0 mL) and the resulting mixture was stirred at 
50 °C for 24 h. The reaction mixture was acidified with 1 M HCl to pH 1 and the mixture was 
extracted with EtOAc (10 mL × 3). The combined organic layers were washed with water (10 mL 
× 1), brine once, dried over Na2SO4, and concentrated. Purification on a Combiflash purification 
system using a silica flash column (95:5 DCM/MeOH) afforded 1q (0.225 g, 76%) as a colorless 
solid. Mp 166–168 °C; TLC (10% EtOAc/hexanes) Rf = 0.10; 
1H NMR (400 MHz, CDCl3) δ 8.20 
(dt, J = 6.9, 1.4 Hz, 1H), 7.69–7.57 (m, 1H), 7.44–7.30 (m, 2H), 7.22–7.07 (m, 3H), 6.96–6.87 (m, 
1H), 6.51 (dd, J = 7.2, 2.0 Hz, 1H), 5.78 (s, 2H), 2.38 (t, J = 1.0 Hz, 3H); 13C NMR (101 MHz, 





119.1, 111.3, 109.7, 48.6, 9.8; IR (neat) 3200–2000, 1679 cm– 1; HRMS (ESI) m/z calcd for 
C17H16NO2 [M + H]
+: 266.1181, found: 266.1185.  
 
2-(3,4,5-Trimethoxyphenoxy)benzoic acid (1s):  
Following a modification of the reported procedure,229 to a solution of 2-bromobenzoic acid (0.500 
g, 2.48 mmol, 1.0 equiv) in DMF (15 mL) were added 3,4,5-trimethoxyphenol (0.916 g, 4.97 
mmol, 2.0 equiv), 1,8-diazabicyclo[5.4.0]undec-7-ene (1.14 g, 7.46 mmol, 3.0 equiv), pyridine 
(40.0 μL), copper (0) (20.0 mg), and copper iodide (20.0 mg) in succession and the resulting 
mixture was refluxed for 2 h. The reaction mixture was acidified with 1 M HCl to pH 1 and the 
mixture was extracted with EtOAc (10 mL × 3). The combined organic layers were washed with 
water (10 mL × 1), brine once, dried over Na2SO4, and concentrated. Purification on a Combiflash 
purification system using a silica flash column (50:50 hexanes/EtOAc) afforded 1s (0.350 g, 46%) 
as a colorless solid. Mp 144–145 °C; TLC (50% EtOAc/hexanes) Rf = 0.10; 
1H NMR (400 MHz, 
CDCl3) δ 8.16 (dd, J = 7.9, 1.8 Hz, 1H), 7.49 (ddd, J = 8.3, 7.3, 1.8 Hz, 1H), 7.23–7.16 (m, 1H), 
6.90 (dd, J = 8.4, 0.9 Hz, 1H), 6.35 (s, 2H), 3.84 (s, 3H), 3.81 (s, 6H); 13C NMR (101 MHz, CDCl3) 
δ 167.9, 157.6, 154.1, 151.2, 151.1, 135.3, 134.7, 133.2, 123.3, 119.8, 117.9, 97.8 (2C), 61.0, 56.2 
(2C); IR (neat) 3400–2200, 1692, 1670, 1596 cm–1; HRMS (ESI) m/z calcd for C16H17O6 [M + 






2-((3,4-Dimethoxyphenyl)thio)benzoic acid (1t):230  
Following a slight modification of the reported procedure,231 to a solution of 3,4-
dimethoxybenzenethiol (255 mg, 1.50 mmol, 1.0 equiv) and 2-iodobenzoic acid (372 mg, 1.50 
mmol, 1.0 equiv) in anhydrous DMF (2.5 mL) in a flame-dried N2-flushed microwave vial at rt 
was added potassium carbonate (207 mg, 1.50 mmol, 1.0 equiv) and copper(I) iodide (57.1 mg, 
0.300 mmol, 0.20 equiv). The vial was sealed with a N2 balloon inserted into a septum and the 
resulting suspension was stirred at 155 °C for 18 h (effervescence was observed and hood lights 
were kept off). Reaction mixture was quenched with 1.0 M aqueous HCl (10 mL), diluted with 
water (20 mL), and extracted with DCM (25 mL × 3). The combined organic layers were washed 
with water (60 mL × 3), brine (60 mL × 1), dried over Na2SO4, and concentrated. The residue 
obtained was suspended in DCM and loaded on a silica gel in a sample cartridge. Purification on 
a Combiflash purification system using a 12 g silica flash column (0–5% MeOH/DCM over 50 
min) afforded impure 1t as a brownish-grey solid. Trituration of the solid with ether twice and 
with ether containing few drops of DCM once afforded pure 1t (238 mg, 55%) as an off-white 
solid after filtration and drying under vacuum. Mp 216–220 °C (lit.230 Mp 215–217 °C); TLC (5% 
MeOH/DCM) Rf = 0.37; 
1H NMR (500 MHz, DMSO-d6) δ 13.16 (brs, 1H), 7.91 (dd, J = 7.8, 1.5 
Hz, 1H), 7.35 (td, J = 8.1, 7.4, 1.6 Hz, 1H), 7.08–7.18 (m, 4H), 6.69 (d, J = 8.1 Hz, 1H), 3.82 (s, 
3H), 3.74 (s, 3H); 13C NMR (126 MHz, DMSO-d6) δ 167.4, 150.1, 149.6, 143.5, 132.4, 130.9, 
128.9, 126.6, 126.0, 124.1, 122.0, 118.5, 112.8, 55.7, 55.6; IR (neat) 3350–2200, 1668 cm–1; 
HRMS (ESI) m/z calcd for C15H15O4S [M + H]






4-Chloro-2-(5-methylindolin-1-yl)benzoic acid (1u): 
Following a slight modification of the reported procedure,231 to a solution of 5-methylindoline 
(266 mg, 2.00 mmol, 1.0 equiv) and 4-chloro-2-iodobenzoic acid (565 mg, 2.00 mmol, 1.0 equiv) 
in anhydrous DMF (2.5 mL) in a flame-dried N2-flushed microwave vial at rt was added potassium 
carbonate (276 mg, 2.00 mmol, 1.0 equiv) and copper(I) iodide (76.0 mg, 0.400 mmol, 0.20 equiv). 
The vial was sealed with a N2 balloon inserted into a septum and the resulting suspension was 
stirred at 155 °C for 16 h (effervescence was observed and hood lights were kept off). Reaction 
mixture was quenched with 1.0 M aqueous HCl (10 mL), diluted with water (20 mL), and extracted 
with DCM (25 mL × 3). The combined organic layers were washed with water (50 mL × 3), brine 
(50 mL × 1), dried over Na2SO4, and concentrated. The residue obtained was redissolved in DCM 
and loaded on a silica gel in a sample cartridge. Purification on a Combiflash purification system 
using a 24 g silica flash column (0–2% MeOH/DCM over 40 min) afforded 1u as an orange oily 
solid, which showed some decomposition to a corresponding oxidized indole byproduct in CDCl3 
overtime at rt. Repurification of an impure sample of 1u on a Combiflash purification system using 
a 12 g silica flash column (100% DCM over 40 min) afforded a slightly impure (ca. 94% pure) 1u 
(195 mg, 34%; contaminated with ca. 6% of the corresponding indole byproduct) as a yellowish-
orange solid. Mp 131–139 °C; TLC (4% MeOH/DCM) Rf = 0.53; 
1H NMR (400 MHz, CDCl3) δ 
14.21 (brs, 1H), 8.27 (d, J = 8.5 Hz, 1H), 7.41 (dd, J = 8.5, 2.0 Hz, 1H), 7.32 (d, J = 2.0 Hz, 1H), 





7.9 Hz, 2H), 2.31 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 165.6, 149.3, 146.6, 140.6, 133.6, 133.4, 
132.2, 128.5, 128.4, 126.1, 126.0, 125.5, 113.2, 59.4, 29.4, 21.0; IR (neat) 3400–2200, 1721, 1688 
cm–1; HRMS (ESI) m/z calcd for C16H15ClNO2 [M + H]
+: 288.0791, found: 288.0784.  
 
2-((3-Methoxybenzyl)thio)benzoic acid (1v):  
Following a modification of the reported procedure,192 to a turbid solution of 2-mercaptobenzoic 
acid (200 mg, 1.30 mmol, 1.0 equiv) and sodium hydroxide (114 mg, 2.85 mmol, 2.2 equiv) in 
deionized water (5.0 mL) in a microwave vial at rt was added 3-methoxybenzyl bromide (274 mg, 
1.36 mmol, 1.05 equiv). The vial was sealed and the turbid biphasic solution was stirred at 
refluxing temperature (100–105 °C) for 1.5 h. Reaction mixture was cooled to rt and extracted 
with EtOAc (15 mL × 1) and the EtOAc layer was discarded. The aqueous layer was acidified with 
2 M aqueous HCl solution (10 mL) and the resulting turbid solution was extracted with EtOAc (30 
mL × 3). The combined organic layers were washed with brine (30 mL × 1), dried over Na2SO4, 
and concentrated. The solid obtained was suspended in DCM with few drops of MeOH and loaded 
on to silica gel in a sample cartridge. Purification on a Combiflash purification system using a 12 
g silica flash column (0–10% MeOH/DCM over 50 min) afforded 1v (313 mg, 88%) as a colorless 
fluffy solid. Mp 196–199 °C (lit.202  mp: 199–201 °C); TLC (3% MeOH/DCM) Rf = 0.45; 
1H NMR 
(500 MHz, DMSO-d6) δ 13.04 (s, 1H), 7.88 (dd, J = 7.8, 1.2 Hz, 1H), 7.52–7.47 (m, 2H), 7.26–
7.19 (m, 2H), 7.01–6.99 (m, 2H), 6.84 (m, 1H), 4.17 (s, 2H), 3.74 (s, 3H); 13C NMR (126 MHz, 





112.6, 55.0, 35.7; IR (neat) 3400–2350, 1685 cm–1; HRMS (ESI) m/z calcd for C15H15O3S [M + 
H]+: 275.0742, found: 275.0742.  
 
5-(1,3-Benzodioxol-5-yl)pentanoic acid (1w):232  
To a suspension of 5-(1,3-benzodioxol-5-yl)-2,4-pentadienoic acid (218 mg, 1.00 mmol, 1.0 equiv) 
in ethanol (5.0 mL) in an oven-dried 25 mL under N2 was added Pd/C (10 wt%) (21.3 mg, 0.200 
mmol, 0.20 equiv). The resulting suspension was evacuated under vacuum and flushed with H2 
twice and was continued to stir under H2 atmosphere at rt for 5 h. Reaction mixture was 
concentrated and the residue obtained was diluted with DCM and loaded on a silica gel in a sample 
cartridge. Purification on a Combiflash purification system using a 12 g silica flash column (0–
30% EtOAc/hexanes over 30 min) afforded 1w (203 mg, 91%) as a colorless crystalline solid. Mp 
95–97 °C; TLC (30% EtOAc/hexanes, run twice) Rf = 0.50; 
1H NMR (400 MHz, CDCl3) δ 11.71 
(brs, 1H), 6.72 (d, J = 7.9 Hz, 1H), 6.67 (d, J = 1.5 Hz, 1H), 6.62 (dd, J = 7.9, 1.7 Hz, 1H), 5.92 
(s, 2H), 2.56 (t, J = 7.1 Hz, 2H), 2.37 (t, J = 7.0 Hz, 2H), 1.65 (m, 4H); 13C NMR (101 MHz, 
CDCl3) δ 180.2, 147.8, 145.8, 136.0, 121.3, 109.0, 108.3, 100.9, 35.4, 34.1, 31.2, 24.3; IR (neat) 
3300–2400, 1702 cm–1; HRMS (ESI) m/z calcd for C12H13O4 [M – H]






5-(3,4-Dimethoxyphenyl)pentanoic acid (1x):233 
Following the procedure described for compound 1b, 3,4-dimethoxylbenzaldehyde (1.00 g, 6.02 
mmol, 1.0 equiv) was reacted with (2-carboxypropyl)triphenylphosphonium bromide (3.10 g, 7.22 
mmol, 1.2 equiv) in the presence of potassium tert-butoxide (1.69 g, 15.0 mmol, 2.5 equiv) to 
afford (E)-5-(3,4- dimethoxyphenyl)pent-4-enoic acid 9x (0.615 g, 43%) as a colorless solid. Mp 
114–116 °C; TLC (50% EtOAc/hexanes) Rf = 0.30; 
1H NMR (400 MHz, CDCl3) δ 6.95–6.85 (m, 
2H), 6.80 (d, J = 8.2 Hz, 1H), 6.39 (d, J = 15.5 Hz, 1H), 6.16–6.01 (m, 1H), 3.88 (d, J = 9.6 Hz, 
6H), 2.54 (d, J = 0.7 Hz, 4H); 13C NMR (101 MHz, CDCl3) δ 178.5, 149.2, 148.7, 131.0, 130.6, 
126.2, 119.3, 111.4, 108.9, 56.1, 56.0, 33.9, 28.0; IR (neat) 2934, 1719, 1695, 1512 cm–1; HRMS 
(ESI) m/z calcd for C13H17O4 [M + H]
+: 237.1127, found: 237.1106.  
Compound 9x (0.600 g, 2.54 mmol) was then reduced with Pd/C (0.0600 g, 10 wt%) under H2 
atmosphere in EtOH to afford 1x (0.530 g, 88%) as a colorless solid.  
 
5-(3,5-Dimethoxyphenyl)pentanoic acid (1y):234  
Following the procedure described for compound 1b, 3,5-dimethoxylbenzaldehyde (0.500 g, 3.01 
mmol, 1.0 equiv) was reacted with (2-carboxypropyl)triphenylphosphonium bromide (1.55 g, 3.61 
mmol, 1.2 equiv) in the presence of potassium tert-butoxide (0.844 g, 7.52 mmol, 2.5 equiv) to 
afford (E)-5-(3,5- dimethoxyphenyl)pent-4-enoic acid 9y (0.370 g, 52%) as a colorless solid. Mp 
104–106 °C; TLC (50% EtOAc/hexanes) Rf = 0.30; 





Hz, 2H), 6.42–6.33 (m, 2H), 6.25–6.15 (m, 1H), 3.79 (s, 6H), 2.61–2.47 (m, 4H); 13C NMR (101 
MHz, CDCl3) δ 178.7, 161.1 (2C), 139.5, 131.3, 128.7, 104.4 (2C), 99.7, 55.5 (2C), 33.8, 28.0; IR 
(neat) 3300–2100, 1701, 1579 cm–1; HRMS (ESI) m/z calcd for C13H17O4 [M + H]
+: 237.1127, 
found: 237.1098.  
Compound 9y (0.300 g, 1.27 mmol) was then reduced with Pd/C (0.0300 g, 10 wt%) under H2 
atmosphere in EtOH to afford 1y (0.295 g, 98%) as a colorless solid.  
 
5-(Thiophen-3-yl)pentanoic acid (1z):235 
Following the procedure described for compound 1b, 3-thiophenecarboxaldehyde (1.00 g, 8.92 
mmol, 1.0 equiv) was reacted with (2-carboxypropyl)triphenylphosphonium bromide (4.59 g, 10.7 
mmol, 1.2 equiv) in the presence of potassium tert-butoxide (2.50 g, 22.3 mmol, 2.5 equiv) to 
afford (E)-5-(thiophen-3- yl)pent-4-enoic acid 9z236 (1.01 g, 62%) as a brown solid.  
Compound 9z (0.657 g, 3.95 mmol) was then reduced with Pd/C (0.0657 g, 10 wt%) under H2 








5-(Benzo[b]thiophen-3-yl)pentanoic acid (1aa):  
Following the procedure described for compound 1b, thianaphthene-3-carboxaldehyde (1.00 g, 
6.16 mmol, 1.0 equiv) was reacted with (2-carboxypropyl)triphenylphosphonium bromide (3.17 
g, 7.39 mmol, 1.2 equiv) in the presence of potassium tert-butoxide (1.73 g, 15.4 mmol, 2.5 equiv) 
to afford (E)-5- (benzo[b]thiophen-3-yl)pent-4-enoic acid 9aa (0.750 g, 52%) as a colorless solid. 
Mp 97–98 °C; TLC (50% EtOAc/hexanes) Rf = 0.30; 
1H NMR (400 MHz, CDCl3) δ 7.91–7.81 
(m, 2H), 7.45–7.30 (m, 3H), 6.72 (dd, J = 15.9, 1.2 Hz, 1H), 6.34–6.21 (m, 1H), 2.67–2.55 (m, 
4H); 13C NMR (101 MHz, CDCl3) δ 178.3, 140.6, 137.9, 134.1, 130.1, 124.5, 124.3, 123.7, 123.0, 
122.1, 121.4, 33.8, 28.4; IR (neat) 3300– 2100, 1701 cm–1; HRMS (ESI) m/z calcd for C13H11O2S 
[M – H]–: 231.0480, found: 231.0489.  
Compound 9aa (0.300 g, 1.29 mmol) was then reduced with Pd/C (0.0300 g, 10 wt%) under H2 
atmosphere in EtOH to afford 1aa (0.300 g, 99%) as a colorless solid. Mp 99–100 °C; TLC (20% 
EtOAc/hexanes) Rf = 0.40; 
1H NMR (400 MHz, CDCl3) δ 7.92–7.80 (m, 1H), 7.79–7.69 (m, 1H), 
7.45– 7.30 (m, 2H), 7.10 (d, J = 1.1 Hz, 1H), 2.95–2.78 (m, 2H), 2.43 (t, J = 6.9 Hz, 2H), 1.80 (m, 
4H); 13C NMR (101 MHz, CDCl3) δ 179.0, 140.7, 139.1, 136.5, 124.3, 124.0, 123.0, 121.7, 121.3, 
33.9, 28.7, 28.4, 24.7; IR (neat) 3200–2200, 1699, 1687 cm–1; HRMS (ESI) m/z calcd for 
C13H13O2S [M – H]







5-(Benzofuran-2-yl)pentanoic acid (1ab):  
Following the procedure described for compound 1b, 2-benzofurancarboxaldehyde (1.00 g, 6.84 
mmol, 1.0 equiv) was reacted with (2-carboxypropyl)triphenylphosphonium bromide (3.53 g, 8.21 
mmol, 1.2 equiv) in the presence of potassium tert-butoxide (1.92 g, 17.1 mmol, 2.5 equiv) to 
afford (E)-5- (benzofuran-2-yl)pent-4-enoic acid 9ab (0.950 g, 64%) as a colorless solid. Mp 106–
108 °C; TLC (50% EtOAc/hexanes) Rf = 0.30; 
1H NMR (400 MHz, CDCl3) δ 7.52–7.48 (m, 1H), 
7.42 (dq, J = 8.2, 0.9 Hz, 1H), 7.26–7.16 (m, 2H), 6.54–6.32 (m, 3H), 2.60 (m, 4H); 13C NMR 
(101 MHz, CDCl3) δ 179.0, 154.8, 154.6, 130.6, 129.1, 124.4, 122.9, 120.9, 120.1, 111.0, 103.8, 
33.5, 27.9; IR (neat) 3300–2100, 1697 cm–1; HRMS (ESI) m/z calcd for C13H13O3 [M + H]
+: 
217.0865, found: 217.0835.  
Compound 9ab (0.300 g, 1.39 mmol) was then reduced with Pd/C (0.0300 g, 10 wt%) under H2 
atmosphere in EtOH to afford 1ab (0.150 g, 50%) as a colorless solid. Mp 124–126 °C; TLC (20% 
EtOAc/hexanes) Rf = 0.40; 
1H NMR (400 MHz, CDCl3) δ 11.15 (brs, 1H), 7.52–7.45 (m, 1H), 
7.43–7.38 (m, 1H), 7.24–7.15 (m, 2H), 6.40 (d, J = 1.0 Hz, 1H), 2.88–2.73 (m, 2H), 2.42 (t, J = 
7.1 Hz, 2H), 1.89– 1.67 (m, 4H); 13C NMR (101 MHz, CDCl3) δ 179.6, 158.9, 154.8, 129.0, 123.3, 
122.6, 120.4, 110.9, 102.3, 33.7, 28.2, 27.2, 24.3; IR (neat) 3300–2100, 1705 cm–1; HRMS (ESI) 
m/z calcd for C13H15O3 [M + H]







2,2-Dimethyl-3-(3-methyl-1H-indol-1-yl)propanoic acid (1ae): 
Following a modification of the reported procedure,237 to a cooled solution of 3-methylindole 
(0.300 g, 2.29 mmol, 1.0 equiv) in DMF (5 mL) at 0 °C under Ar atmosphere was added sodium 
hydride (60% dispersion in mineral oil) (0.320 g, 8.00 mmol, 3.5 equiv). After stirring for 10 min 
at 0 °C, 3-chloro-2,2- dimethylpropionic acid (0.344 g, 2.51 mmol, 1.1 equiv) and potassium iodide 
(0.0380 g, 0.228 mmol, 0.10 equiv) were added and the reaction mixture was continued to stir at 
0 °C for 15 min. The reaction mixture was then heated to 50 °C and continued to stir at 50 °C for 
24 h. The reaction was quenched with water and acidified with 1 M HCl to pH 1. The aqueous 
layer was extracted with EtOAc (10 mL × 3) and the combined organic layers were washed with 
(10 mL × 1), brine once, dried over Na2SO4, and concentrated. Purification on a Combiflash 
purification system using a silica flash column (90:10 hexanes/EtOAc) afforded 1ae (0.0850 g, 
16%) as a colorless solid. Mp 72–74 °C; TLC (10% EtOAc/hexanes) Rf = 0.20; 
1H NMR (400 
MHz, CDCl3) δ 7.54 (dt, J = 7.8, 1.0 Hz, 1H), 7.33 (dt, J = 8.2, 0.9 Hz, 1H), 7.19 (ddd, J = 8.2, 
7.0, 1.2 Hz, 1H), 7.09 (ddd, J = 7.9, 7.0, 1.0 Hz, 1H), 6.88 (d, J = 1.1 Hz, 1H), 4.27 (s, 2H), 2.31 
(d, J = 1.1 Hz, 3H), 1.29 (s, 6H); 13C NMR (101 MHz, CDCl3) δ 181.8, 137.7, 128.7, 126.6, 121.7, 
119.1, 118.9, 111.2, 109.7, 53.6, 45.3, 23.8 (2C), 9.7; IR (neat) 3300–2100, 1700 cm–1; HRMS 
(ESI) m/z calcd for C14H18NO2 [M + H]







2-(3-Methyl-1H-indol-1-yl)benzoic acid (1af): 
Following a slight modification of the reported procedure,231 to a solution of 3-methyl-1H-indole 
(197 mg, 1.50 mmol, 1.0 equiv) and 2-iodobenzoic acid (372 mg, 1.50 mmol, 1.0 equiv) in 
anhydrous DMF ( 2.5 mL) in a flame-dried N2-flushed microwave vial at rt was added potassium 
carbonate (207 mg, 1.50 mmol, 1.0 equiv) and copper(I) iodide (57.1 mg, 0.300 mmol, 0.20 equiv). 
The vial was sealed with a N2 balloon inserted into a septum and the resulting suspension was 
stirred at 155 °C for 18 h (effervescence was observed and hood lights were kept off). Reaction 
mixture was quenched with 1.0 M aqueous HCl (10 mL), diluted with water (20 mL), and extracted 
with DCM (25 mL × 3). The combined organic layers were washed with water (60 mL × 3), brine 
(60 mL × 1), dried over Na2SO4, and concentrated. The oily residue obtained was dissolved in 
DCM and loaded on a silica gel in a sample cartridge. Purification on a Combiflash purification 
system using a 12 g silica flash column (0–2.5% MeOH/DCM over 50 min) afforded impure 1af 
as an orange-brown oil. Repurification on a Combiflash purification system using a 12 g silica 
flash column (0–40% EtOAc/hexanes over 40 min) afforded a partial separation of pure 1af (112 
mg, 30%) as a creamish-orange solid. Mp 102–108 °C; TLC (5% MeOH/DCM) Rf = 0.41; 
1H 
NMR (400 MHz, CDCl3) δ 10.66 (brs, 1H), 8.05–8.08 (m, 1H), 7.64–7.68 (m, 2H), 7.45–7.49 (m, 
2H), 7.16–7.23 (m, 3H), 7.00 (d, J = 1.1 Hz, 1H), 2.42 (d, J = 1.1 Hz, 3H); 13C NMR (101 MHz, 
CDCl3) δ 171.4, 139.7, 137.5, 133.8, 132.2, 129.6, 128.8, 127.3 (2C), 126.7, 122.5, 119.8, 119.3, 
113.0, 109.9, 9.8; IR (neat) 3500–2200, 1690, 1600 cm–1; HRMS (ESI) m/z calcd for C16H14NO2 






3',4'-Dimethoxy-[1,1'-biphenyl]-2-carboxylic acid (1ag):238  
Following a modification of the reported procedure,239 to a solution of (3,4-
dimethoxyphenyl)boronic acid (287 mg, 1.58 mmol, 1.05 equiv) and 2-iodobenzoic acid (372 mg, 
1.50 mmol, 1.0 equiv) in degassed THF (2.0 mL) in a flame-dried microwave vial at rt under Ar 
was added a sonicated solution of lithium hydroxide (90.0 mg, 3.75 mmol, 2.5 equiv) in degassed 
deionized water (2.0 mL) (solvents were degassed with Ar under sonication for 5 min) and the 
resulting slightly turbid solution was stirred at rt for 5 min (until effervescence ceased). The 
solution was degassed with Ar for 2 min followed by the addition of 
tris(dibenzylideneacetone)dipalladium (0) (20.6 mg, 0.0220 mmol, 0.015 equiv). The vial was 
sealed with a septum and the resulting suspension was stirred at 80 °C for 14 h. Reaction mixture 
was partially concentrated under N2 and acidified with 2 M aqueous HCl solution (10 mL) 
followed by the addition of water (25 mL). The resulting suspension was extracted with DCM (25 
mL × 3). The combined organic layers were washed with brine (50 mL × 1), dried over Na2SO4, 
and concentrated. The solid residue obtained was suspended in DCM containing few drops of 
MeOH and loaded on a silica gel in a sample cartridge. Purification on a Combiflash purification 
system using a 12 g silica flash column (0–2% MeOH/DCM over 40 min) afforded 1ag (235 mg, 
61%) as a colorless solid with light orange tinge. Mp 164–166 °C (lit.238 mp: 162–165 °C); TLC 
(4% MeOH/DCM, run twice) Rf = 0.52; 
1H NMR (500 MHz, DMSO-d6) δ 12.77 (brs, 1H), 7.65 





1H), 6.92 (d, J = 2.0 Hz, 1H), 6.86 (dd, J = 8.2, 2.1 Hz, 1H), 3.78 (s, 3H), 3.76 (s, 3H); 13C NMR 
(126 MHz, DMSO-d6) δ 170.2, 148.3, 148.2, 140.4, 133.2, 132.7, 130.6, 130.3, 128.7, 126.8, 
120.5, 112.2, 111.6, 55.5, 55.4; IR (neat) 3315, 1719 cm–1; HRMS (ESI) m/z calcd for C15H15O4 
[M + H]+: 259.0970, found: 259.0957.   
 
3-Fluoro-3'-isopropoxy-[1,1'-biphenyl]-2-carboxylic acid (1ah): 
Following a modification of the reported procedure,239 to a solution of (3-
isopropoxyphenyl)boronic acid (283 mg, 1.58 mmol, 1.05 equiv) and 2-fluoro-6-iodobenzoic acid 
(399 mg, 1.50 mmol, 1.0 equiv) in degassed THF (2.0 mL) in a flame-dried microwave vial at rt 
under Ar was added a sonicated solution of lithium hydroxide (90.0 mg, 3.75 mmol, 2.5 equiv) in 
degassed deionized water (2.0 mL) (solvents were degassed with Ar under sonication for 5 min) 
and the resulting solution was stirred at rt for 5 min (until effervescence ceased). The solution was 
degassed with Ar for 1 min followed by the addition of tris(dibenzylideneacetone)dipalladium (0) 
(20.6 mg, 0.0220 mmol, 0.015 equiv). The vial was sealed with a septum and the resulting 
suspension was stirred at 80 °C for 13 h. Reaction mixture was partially concentrated under N2 
and acidified with 2 M aqueous HCl solution (15 mL) followed by the addition of water (20 mL). 
The resulting suspension was extracted with DCM (25 mL × 3). The combined organic layers were 
washed with brine (50 mL × 1), dried over Na2SO4, and concentrated. The oily residue obtained 





Combiflash purification system using a 24 g silica flash column (0–3% MeOH/DCM over 60 min) 
afforded impure 1ah as a pale orange oil. Impure 1ah was dissolved in 1.5 mL DMSO and loaded 
on a 50 g HP C18 Gold column. Repurification was carried out on a reverse-phase Combiflash 
system (0% ACN/H2O both containing 0.1% CF3CO2H over 2 min followed by 0–70% ACN/H2O 
both containing 0.1% CF3CO2H from 2–32 min). Elutions containing product were concentrated 
under vacuum in Genevac. The resulting colorless solid was dissolved in DCM and filtered through 
a short bed containing a mixture of Na2SO4 and silica gel using a phase separator. Concentration 
and drying under vacuum afforded pure 1ah (262 mg, 64%) as a colorless partially oily crystalline 
solid. Mp 103–105 °C; TLC (3% MeOH/DCM) Rf = 0.19; 
1H NMR (400 MHz, CDCl3) δ 11.91 
(brs, 1H), 7.47 (m, 1H), 7.31 (t, J = 7.8 Hz, 1H), 7.21 (d, J = 7.7 Hz, 1H), 7.14 (m, 1H), 6.99–6.92 
(m, 3H), 4.57 (m, 1H), 1.35 (d, J = 6.1 Hz, 6H); 13C NMR (101 MHz, CDCl3) δ 171.5, 160.0 (d, J 
= 252.5 Hz, 1C), 158.1, 143.0 (d, J = 2.3 Hz, 1C), 140.5 (d, J = 2.2 Hz, 1C), 131.9 (d, J = 9.1 Hz, 
1C), 129.8, 125.9 (d, J = 3.1 Hz, 1C), 120.7, 120.5 (d, J = 15.8 Hz, 1C), 116.3, 115.8, 114.9 (d, J 
= 21.6 Hz, 1C), 70.4, 22.2 (2C); IR (neat) 3400–2400, 1738, 1704, 1573 cm–1; HRMS (ESI) m/z 
calcd for C16H14FO2 [M – OH]
+: 257.0972, found: 257.0952.  
 
3',5'-Dimethoxy-[1,1'-biphenyl]-2-carboxylic acid (1ai):240  
Following a modification of the reported procedure,239 to a suspension of (3,5-
dimethoxyphenyl)boronic acid (287 mg, 1.58 mmol, 1.05 equiv) and 2-iodobenzoic acid (372 mg, 





was added a a sonicated solution of lithium hydroxide (90.0 mg, 3.75 mmol, 2.5 equiv) in degassed 
deionized water (2.0 mL) (solvents were degassed with Ar under sonication for 5 min) and the 
resulting slightly turbid solution was stirred at rt for 5 min (until effervescence ceased). The 
solution was degassed with Ar for 2 min followed by the addition of 
tris(dibenzylideneacetone)dipalladium (0) (20.6 mg, 0.0220 mmol, 0.015 equiv). The vial was 
sealed with a septum and the resulting suspension was stirred at 80 °C for 14 h. Reaction mixture 
was partially concentrated under N2 and acidified with 2 M aqueous HCl solution (10 mL) followed 
by the addition of water (15 mL). The resulting suspension was extracted with DCM (25 mL × 3). 
The combined organic layers were washed with brine (50 mL × 1), dried over Na2SO4, and 
concentrated. The residue obtained was redissolved in DCM and loaded on a silica gel in a sample 
cartridge. Purification on a Combiflash purification system using a 24 g silica flash column (0–1% 
MeOH/DCM over 40 min) afforded impure 1ai as a cream solid. Recrystallization of the solid 
from DCM/ether mixture (suspended solid in ether was dissolved by the dropwise addition of 
DCM. Hexanes was then added until the solution became slightly turbid) afforded pure 1ai (232 
mg, 60%) as a colorless small plate-like crystals after filtration and drying under vacuum. Mp 
145.5–147 °C; TLC (3% MeOH/DCM) Rf = 0.32; 
1H NMR (400 MHz, CDCl3) δ 11.81 (brs, 1H), 
7.93 (dd, J = 7.8, 1.1 Hz, 1H), 7.55 (td, J = 7.5, 1.4 Hz, 1H), 7.45–7.38 (m, 2H), 6.51 (d, J = 2.2 
Hz, 2H), 6.47 (t, J = 2.2 Hz, 1H), 3.80 (s, 6H); 13C NMR (101 MHz, CDCl3) δ 173.8, 160.6 (2C), 
143.23, 143.18, 132.1, 131.1, 130.6, 129.7, 127.5, 107.0 (2C), 99.9, 55.6 (2C); IR (neat) 3300–
2300, 1682, 1592 cm–1; HRMS (ESI) m/z calcd for C15H15O4 [M + H]






5-Chloro-3',5'-dimethyl-[1,1'-biphenyl]-2-carboxylic acid (1aj): 
Following a modification of the reported procedure,239 to a solution of (3,5-
dimethylphenyl)boronic acid (236 mg, 1.58 mmol, 1.05 equiv) and 4-chloro-2-iodobenzoic acid 
(424 mg, 1.50 mmol, 1.0 equiv) in degassed THF (2.0 mL) in a flame-dried microwave vial at rt 
under Ar was added a a sonicated solution of lithium hydroxide (90.0 mg, 3.75 mmol, 2.5 equiv) 
in degassed deionized water (2.0 mL) (solvents were degassed with Ar under sonication for 5 min) 
and the resulting solution was stirred at rt for 5 min (until effervescence ceased). The solution was 
degassed with Ar for 2 min followed by the addition of tris(dibenzylideneacetone)dipalladium (0) 
(20.6 mg, 0.0220 mmol, 0.015 equiv). The vial was sealed with a septum and the resulting 
suspension was stirred at 80 °C for 14 h. Reaction mixture was partially concentrated under N2 
and acidified with 2 M aqueous HCl solution (10 mL) followed by the addition of water (25 mL). 
The resulting suspension was extracted with DCM (25 mL × 3). The combined organic layers were 
washed with brine (50 mL × 1), dried over Na2SO4, and concentrated. The solid residue obtained 
was suspended in DCM and loaded on a silica gel in a sample cartridge. Purification on a 
Combiflash purification system using a 12 g silica flash column (0–40% EtOAc/hexanes over 40 
min) afforded impure 1aj as a creamish-orange solid. Impure 1aj was dissolved in 1.5 mL DMSO 
and loaded on a 50 g HP C18 Gold column. Repurification was carried out on a reverse-phase 
Combiflash system (0% ACN/H2O both containing 0.1% CF3CO2H over 2 min followed by 0–





concentrated under vacuum in Genevac. The resulting creamish solid was dissolved in ether and 
filtered through a short bed containing a mixture of Na2SO4 and silica gel using a phase separator 
tabless. Concentration and drying under vacuum afforded pure 1aj (320 mg, 82%) as a pale 
creamish-orange crystalline solid. Mp 154–156 °C; TLC (30% EtOAc/hexanes) Rf = 0.22; 
1H 
NMR (400 MHz, CDCl3) δ 11.20 (brs, 1H), 7.88 (m, 1H), 7.39–7.36 (m, 2H), 7.01 (s, 1H), 6.93 
(s, 2H), 2.34 (s, 6H); 13C NMR (101 MHz, CDCl3) δ 173.3, 145.7, 139.8, 138.4, 137.8 (2C), 132.3, 
131.5, 129.7, 127.7, 127.3, 126.3 (2C), 21.5 (2C); IR (neat) 3350–2150, 1687 cm–1; HRMS (ESI) 
m/z calcd for C15H12ClO [M – OH]
+: 243.0571, found: 243.0566.  
 
3-(3,5-Dimethoxyphenyl)thiophene-2-carboxylic acid (1ak): 
Following a modification of the reported procedure,239 to a suspension of (3,5-
dimethoxyphenyl)boronic acid (287 mg, 1.58 mmol, 1.05 equiv) and 3-bromothiophene-2-
carboxylic acid (311 mg, 1.50 mmol, 1.0 equiv) in degassed THF (2.0 mL) in a flame-dried 
microwave vial at rt under Ar was added a sonicated solution of lithium hydroxide (90.0 mg, 3.75 
mmol, 2.5 equiv) in degassed deionized water (2.0 mL) (solvents were degassed with Ar under 
sonication for 5 min) and the resulting slightly turbid solution was stirred at rt for 5 min (until 
effervescence ceased). The solution was degassed with Ar for 2 min followed by the addition of 
tris(dibenzylideneacetone)dipalladium (0) (20.6 mg, 0.0220 mmol, 0.015 equiv). The vial was 
sealed with a septum and the resulting suspension was stirred at 80 °C for 14 h. Reaction mixture 





by the addition of water (15 mL). The resulting suspension was extracted with DCM (25 mL × 3). 
The combined organic layers were washed with brine (50 mL × 1), dried over Na2SO4, and 
concentrated. The solid residue obtained was suspended in DCM containing few drops of MeOH 
and loaded on a silica gel in a sample cartridge. Purification on a Combiflash purification system 
using a 12 g silica flash column (0–2% MeOH/DCM over 40 min) afforded impure 1ak as a cream-
orange solid. Impure 1ak was dissolved in 2.0 mL DMSO and loaded on a 50 g HP C18 Gold 
column. Repurification on a Combiflash system (0% ACN/H2O both containing 0.1% CF3CO2H 
over 2 min followed by 0–70% ACN/H2O both containing 0.1% CF3CO2H from 2–32 min). 
Elutions containing product were concentrated under vacuum in Genevac. The resulting colorless 
solid was dissolved in DCM and filtered through a short bed containing a mixture of Na2SO4 and 
silica gel using a phase separator tabless. Concentration and drying under vacuum afforded pure 
1ak (120 mg, 30%) as a colorless solid. Mp 147.5–149 °C; TLC (3% MeOH/DCM) Rf = 0.29; 
1H 
NMR (400 MHz, CDCl3) δ 12.18 (brs, 1H), 7.57 (d, J = 5.1 Hz, 1H), 7.10 (d, J = 5.1 Hz, 1H), 6.61 
(d, J = 2.3 Hz, 2H), 6.50 (t, J = 2.3 Hz, 1H), 3.81 (s, 6H); 13C NMR (101 MHz, CDCl3) δ 167.7, 
160.4 (2C), 149.8, 137.4, 132.1, 131.9, 126.9, 107.7 (2C), 100.6, 55.6 (2C); IR (neat) 3300–2300, 
1686, 1597 cm–1; HRMS (ESI) m/z calcd for C13H13O4S [M + H]








2-(3',5'-dimethoxy-[1,1'-biphenyl]-2-yl)acetic acid (1am):  
Following a modification of the reported procedure,239 to a solution of (3,5-
dimethoxyphenyl)boronic acid (147 mg, 0.807 mmol, 1.05 equiv) and 2-iodophenylacetic acid 
(200 mg, 0.763 mmol, 1.0 equiv) in degassed THF (2.0 mL) in a flame-dried microwave vial at rt 
under Ar was added a sonicated solution of lithium hydroxide (46.0 mg, 1.91 mmol, 2.5 equiv) in 
degassed deionized water (2.0 mL) (solvents were degassed with Ar under sonication for 5 min) 
and the resulting slightly turbid solution was stirred at rt for 5 min (until effervescence ceased). 
The solution was degassed with Ar for 2 min followed by the addition of 
tris(dibenzylideneacetone)dipalladium (0) (10.5 mg, 0.0114 mmol, 0.015 equiv). The vial was 
sealed with a septum and the resulting suspension was stirred at 80 °C for 14 h. The reaction 
mixture was partially concentrated under N2 and acidified with 2 M aqueous HCl solution (10 mL) 
followed by the addition of water (25 mL). The resulting suspension was extracted with DCM (25 
mL × 3). The combined organic layers were washed with brine (50 mL × 1), dried over Na2SO4, 
and concentrated. Purification on a Combiflash purification system using a silica flash column 
(50:50 hexanes/EtOAc) afforded 1am (150 mg, 72%) as a colorless solid. Mp 128–130 °C; TLC 
(50% EtOAc/hexanes) Rf = 0.70; 
1H NMR (400 MHz, CDCl3) δ 7.41–7.27 (m, 4H), 6.47 (s, 3H), 
3.78 (s, 6H), 3.65 (s, 2H); 13C NMR (101 MHz, CDCl3) δ 177.8, 160.7 (2C), 143.0, 142.7, 131.1, 
130.5, 130.1, 127.8, 127.5, 107.5 (2C), 99.8, 55.5 (2C), 38.5; IR (neat) 3400–2200, 1687, 1592 
cm–1; HRMS (ESI) m/z calcd for C16H17O4 [M + H]







General procedure C for the Friedel–Crafts reaction in HFIP (Figure 11): Procedure (Step 
1 → Synthesis of Acid Chloride):  
To a solution of acid 1 (0.300 mmol, 1.0 equiv) in anhydrous DCM (1.5 mL) in a flame-dried N2-
flushed 2-dram vial at rt under N2 blanket was added a small drop (using a 21G needle) of DMF. 
Then oxalyl chloride (0.390 or 0.600 mmol, 1.3 or 2.0 equiv) was added dropwise (gas evolution 
was observed; the cap was opened for a while under N2 blanket to release the pressure) and the 
reaction mixture was stirred at rt for a specified period (25–90 min). The reaction mixture was 
concentrated under N2 using sample concentrator and the residue obtained was dried under vacuum 
for ca.15–20 min. The crude acid chloride 2 was used as such for the Step 2.  
Procedure (Step 2 → Friedel–Crafts Acylation):  
To the same 2-dram vial containing the crude acid chloride intermediate 2 at rt was added HFIP 
(0.75 mL, substrate concentration is 0.40 M) quickly and the vial was capped immediately. The 
resultant reaction mixture was stirred at rt for 2–6 h. The reaction mixture was concentrated under 
N2 and the resulting residue was dissolved in a minimum quantity of DCM or ether and loaded on 
a silica gel in a sample cartridge. Purification on a Combiflash purification system using a normal 
phase silica flash column (4, 12, or 24 g) afforded the cyclized product 3 after concentration and 








Following the general procedure C, 4-(3,4-dimethoxyphenyl)butanoic acid 1a (67.3 mg, 0.300 
mmol, 1.0 equiv) was converted to 4-(3,4-dimethoxyphenyl)butanoyl chloride 2a using oxalyl 
chloride (50.8 μL, 0.600 mmol, 2.0 equiv) in 30 min. The crude acid chloride 2a was dissolved in 
HFIP (0.75 mL) and the resultant reaction mixture was stirred at rt for 2 h. Purification on a 
Combiflash purification system using a 4 g silica flash column (0–40% EtOAc/hexanes over 20 
min) afforded 3a (59.9 mg, 97%) as a colorless solid. The spectral data matched literature values. 
 
6,8-Dimethoxy-3,4-dihydronaphthalen-1(2H)-one (3b):180  
Following the general procedure C, 4-(3,5-dimethoxyphenyl)butanoic acid 1b (67.3 mg, 0.300 
mmol, 1.0 equiv) was converted to 4-(3,5-dimethoxyphenyl)butanoyl chloride 2b using oxalyl 
chloride (50.8 μL, 0.600 mmol, 2.0 equiv) in 30 min. The crude acid chloride 2b was dissolved in 
HFIP (0.75 mL) and the resultant reaction mixture was stirred at rt for 5 h. Purification on a 
Combiflash purification system using a silica flash column (50:50 hexanes/EtOAc) afforded 3b 
(53.0 mg, 86%) as a brown solid. Mp 64–66 °C; TLC (50% EtOAc/hexanes) Rf = 0.30; 
1H NMR 
(400 MHz, CDCl3) δ 6.36–6.28 (m, 2H), 3.88 (s, 3H), 3.84 (s, 3H), 2.92–2.83 (m, 2H), 2.63–2.52 
(m, 2H), 2.06–1.96 (m, 2H); 13C NMR (101 MHz, CDCl3) δ 196.2, 164.0, 162.8, 149.4, 116.6, 
104.8, 97.4, 56.1, 55.5, 40.9, 31.8, 23.0; IR (neat) 1665, 1596 cm–1; HRMS (ESI) m/z calcd for 
C12H15O3 [M + H]







Following the general procedure C, 4-(3,5-dimethylphenyl)butanoic acid 1c (57.6 mg, 0.300 
mmol, 1.0 equiv) was converted to 4-(3,5-dimethylphenyl)butanoyl chloride 2c using oxalyl 
chloride (50.8 μL, 0.600 mmol, 2.0 equiv) in 30 min. The crude acid chloride 2c was dissolved in 
HFIP (0.75 mL) and the resultant reaction mixture was stirred at rt for 5 h. Purification on a 
Combiflash purification system using a silica flash column (80:20 hexanes/EtOAc) afforded 3c 
(38.0 mg, 73%) as a yellow oil. The spectral data matched literature values. 
 
6,9-Dimethoxy-2,3-dihydro-1H-phenalen-1-one (3d):  
Following the general procedure C, 3-(4,7-dimethoxynaphthalen-1-yl)propanoic acid 1d (78.1 mg, 
0.300 mmol, 1.0 equiv) was converted to 3-(4,7-dimethoxynaphthalen-1-yl)propanoyl chloride 2d 
using oxalyl chloride (50.8 μL, 0.600 mmol, 2.0 equiv) in 30 min. The crude acid chloride 2d was 
dissolved in HFIP (0.75 mL) and the resultant reaction mixture was stirred at rt for 4 h. Purification 
on a Combiflash purification system using a 12 g silica flash column (0–50% EtOAc/hexanes over 
50 min) afforded 3d (37.0 mg, 51%) as an olive green solid. Mp 124–127 °C; TLC (30% 
EtOAc/hexanes) Rf = 0.22; 





2H), 6.64 (d, J = 7.8 Hz, 1H), 4.03 (s, 3H), 3.96 (s, 3H), 3.24 (apparent t, J = 7.2 Hz, 2H), 2.85 
(apparent t, J = 7.2 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ 198.1, 158.3, 154.6, 134.6, 130.2, 
126.4, 124.5, 120.1, 115.8, 112.6, 102.1, 56.7, 55.7, 40.8, 28.8; IR (neat) 1676, 1588, 1248, 1042 
cm–1; HRMS (ESI) m/z calcd for C15H15O3 [M + H]
+: 243.1021, found: 243.1006.  
 
6,7-Dihydrobenzo[b]thiophen-4(5H)-one (3e):183 
Following the general procedure C, 4-(2-thienyl)butyric acid 1e (51.1 mg, 0.300 mmol, 1.0 equiv) 
was converted to 4-(2-thienyl)butanoyl chloride 2e using oxalyl chloride (50.8 μL, 0.600 mmol, 
2.0 equiv) in 30 min. The crude acid chloride 2e was dissolved in HFIP (0.75 mL) and the resultant 
reaction mixture was stirred at rt for 3 h. Purification on a Combiflash purification system using a 
12 g silica flash column (0–15% EtOAc/hexanes over 30 min) afforded 3e (37.0 mg, 81%) as a 
pale yellow oil. The spectral data matched literature values. 
 
5,6-Dihydrobenzo[b]thiophen-7(4H)-one (3f):185  
Following the general procedure C, 4-(thiophen-3-yl)butanoic acid 1f (51.0 mg, 0.300 mmol, 1 
equiv) was converted to 4-(thiophen-3-yl)butanoyl chloride 2f using oxalyl chloride (50.8 μL, 
0.600 mmol, 2.0 equiv) in 30 min. The crude acid chloride 2f was dissolved in HFIP (0.75 mL) 





system using a silica flash column (80:20 hexanes/EtOAc) afforded 3f (33.0 mg, 72%) as a 
colorless oil. TLC (20% EtOAc/hexanes) Rf = 0.40;
 1H NMR (400 MHz, CDCl3) δ 7.60 (d, J = 4.9 
Hz, 1H), 6.97 (d, J = 4.9 Hz, 1H), 2.88 (t, J = 6.1 Hz, 2H), 2.69–2.50 (m, 2H), 2.18 (tt, J = 6.5, 5.7 
Hz, 2H); 13C NMR (101 MHz, CDCl3) δ 192.4, 152.7, 136.7, 133.9, 128.3, 38.4, 26.2, 24.5; IR 
(neat) 1653 cm–1; HRMS (ESI) m/z calcd for C8H9OS [M + H]
+: 153.0374, found: 153.0350. 
 
2,3-Dihydrodibenzo[b,d]thiophen-4(1H)-one (3g):225 
Following the general procedure C, 4-(benzo[b]thiophen-3-yl)butanoic acid 1g (66.0 mg, 0.300 
mmol, 1.0 equiv) was converted to 4-(benzo[b]thiophen-3-yl)butanoyl chloride 2g using oxalyl 
chloride (50.8 μL, 0.600 mmol, 2.0 equiv) in 30 min. The crude acid chloride 2g was dissolved in 
HFIP (0.75 mL) and the resultant reaction mixture was stirred at rt for 5 h. Purification on a 
Combiflash purification system using a silica flash column (50:50 hexanes/EtOAc) afforded 3g 
(60.0 mg, 99%) as a colorless solid. The spectral data matched literature values. 
 
3,4-Dihydrodibenzo[b,d]furan-1(2H)-one (3h):242 
Following the general procedure C, 4-(benzofuran-2-yl)butanoic acid 1h (61.0 mg, 0.300 mmol, 





μL, 0.600 mmol, 2.0 equiv) in 30 min. The crude acid chloride 2h was dissolved in HFIP (0.75 
mL) and the resultant reaction mixture was stirred at rt for 5 h. Purification on a Combiflash 
purification system using a silica flash column (80:20 hexanes/EtOAc) afforded 3h (50.0 mg, 90%) 
as a colorless oil. The spectral data matched literature values. 
 
Chroman-4-one (3i):243 
Following the general procedure C, 3-phenoxypropanoic acid 1i (49.8 mg, 0.300 mmol, 1.0 equiv) 
was converted to 3-phenoxypropanoyl chloride 2i using oxalyl chloride (50.8 μL, 0.600 mmol, 2.0 
equiv) in 30 min. The crude acid chloride 2i was dissolved in HFIP (0.75 mL) and the resultant 
reaction mixture was stirred at rt for 5 h. Purification on a Combiflash purification system using a 
silica flash column (80:20 hexanes/EtOAc) afforded 3i (31.0 mg, 70%) as a colorless oil. The 
spectral data matched literature values. 
 
5,8-Dimethoxythiochroman-4-one (3j):191 
Following the general procedure C, 3-((2,5-dimethoxyphenyl)thio)propanoic acid 1j (72.7 mg, 
0.300 mmol, 1.0 equiv) was converted to 3-((2,5-dimethoxyphenyl)thio)propanoyl chloride 2j 





dissolved in HFIP (0.75 mL) and the resultant reaction mixture was stirred at rt for 5 h. Purification 
on a Combiflash purification system using a 12 g silica flash column (0–50% EtOAc/hexanes over 
50 min) afforded 3j (35.5 mg, 53%) as a creamish yellow solid. Mp 133–136 °C; TLC (40% 
EtOAc/hexanes) Rf = 0.31; 
1H NMR (400 MHz, CDCl3) δ 6.89 (d, J = 9.0 Hz, 1H), 6.64 (d, J = 
9.0 Hz, 1H), 3.83 (s, 3H), 3.82 (s, 3H), 3.16–3.13 (m, 2H), 2.93–2.90 (m, 2H); 13C NMR (101 
MHz, CDCl3) δ 194.2, 155.4, 149.0, 133.7, 122.2, S39 115.1, 108.4, 56.8, 56.7, 41.0, 25.5; IR 
(neat) 1677, 1575 cm–1; HRMS (ESI) m/z calcd for C11H13O3S [M + H]
+: 225.0585, found: 
225.0578.  
 
7-Methoxy-2-phenylthiochroman-4-one (3kp) and 5-Methoxy-2-phenylthiochroman-4-one 
(3ko):  
Following the general procedure C, 3-((3-methoxyphenyl)thio)-3-phenylpropanoic acid 1k (86.5 
mg, 0.300 mmol, 1.0 equiv) was converted to 3-((3-methoxyphenyl)thio)-3-phenylpropanoyl 
chloride 2k using oxalyl chloride (50.8 μL, 0.600 mmol, 2.0 equiv) in 30 min. The crude acid 
chloride 2k was dissolved in HFIP (0.75 mL) and the resultant reaction mixture was stirred at rt 
for 4 h. Purification on a Combiflash purification system using a 12 g silica flash column (0–20% 
EtOAc/hexanes over 40 min) afforded 3kp (50.0 mg, 62%) and 3ko (10.8 mg, 13%) as light yellow 
solids (combined yield = 60.8 mg, 75%; 3kp:3ko = 82:18). For 3kp: Mp 82.5–84.5 °C; TLC (20% 
EtOAc/hexanes) Rf = 0.52; 
1H NMR (400 MHz, CDCl3) δ 8.10–8.13 (m, 1H), 7.31–7.43 (m, 5H), 





3.15 (dd, J = 16.5, 3.1 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 193.2, 163.7, 144.4, 138.7, 131.5, 
129.1, 128.6, 127.6, 124.3, 112.9, 110.6, 55.7, 46.6, 45.9; IR (neat) 1665, 1587 cm–1; HRMS (ESI) 
m/z calcd for C16H15O2S [M + H]
+: 271.0793, found: 271.0787. For 3ko: Mp 110.5–113.5 °C; TLC 
(20% EtOAc/hexanes) Rf = 0.22; 
1H NMR (400 MHz, CDCl3) δ 7.29–7.43 (m, 6H), 6.87 (dd, J = 
7.9, 1.0 Hz, 1H), 6.74 (m, 1H), 4.69 (dd, J = 13.0, 3.2 Hz, 1H), 3.91 (s, 3H), 3.34 (dd, J = 15.7, 
13.0 Hz, 1H), 3.18 (dd, J = 15.7, 3.2 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 194.4, 161.6, 144.3, 
138.7, 133.9, 129.2, 128.6, 127.6, 121.0, 119.5, 109.0, 56.4, 48.9, 45.4; IR (neat) 1672, 1579 cm–
1; HRMS (ESI) m/z calcd for C16H15O2S [M + H]
+: 271.0793, found: 271.0789.   
 
2,3-Dihydro-1H-benzo[f]thiochromen-1-one (3l):192 
Following the general procedure C, 3-(2-naphthylthio)propionic acid 1l (69.7 mg, 0.300 mmol, 
1.0 equiv) was converted to 3-(2-naphthylthio)propionyl chloride 2l using oxalyl chloride (50.8 
μL, 0.600 mmol, 2.0 equiv) in 30 min. The crude acid chloride 2l was dissolved in HFIP (0.75 
mL) and the resultant reaction mixture was stirred at rt for 3 h. Purification on a Combiflash 
purification system using a 4 g silica flash column (0–5% EtOAc/hexanes over 50 min) afforded 
3l (59.4 mg, 92%) as a pale yellow turbid oil. TLC (10% ether/hexanes, run twice) Rf = 0.38; 
1H 
NMR (400 MHz, CDCl3) δ 9.17 (m, 1H), 7.73 (m, 2H), 7.60 (ddd, J = 8.6, 6.9, 1.5 Hz, 1H), 7.44 
(ddd, J = 8.0, 6.9, 1.1 Hz, 1H), 7.26 (d, J = 8.7 Hz, 1H), 3.27 (m, 2H), 3.09 (m, 2H); 13C NMR 





41.4, 26.5; IR (neat) 1657, 1588 cm–1; HRMS (ESI) m/z calcd for C13H11OS [M + H]
+: 215.0531, 
found: 215.0528.   
 
3,3,6,7-Tetramethylthiochroman-4-one (3mp) and 3,3,5,6-Tetramethylthiochroman-4-one 
(3mo):  
Following the general procedure C, 3-((3,4-dimethylphenyl)thio)-2,2-dimethylpropanoic acid 1m 
(71.5 mg, 0.300 mmol, 1.0 equiv) was converted to 3-((3,4-dimethylphenyl)thio)-2,2-
dimethylpropanoyl chloride 2m using oxalyl chloride (50.8 μL, 0.600 mmol, 2.0 equiv) in 30 min. 
The crude acid chloride 2m was dissolved in HFIP (0.75 mL) and the resultant reaction mixture 
was stirred at rt for 3 h. Purification on a Combiflash purification system using a 24 g silica flash 
column (0–10% EtOAc/hexanes over 20 min) afforded a partial separation of 3mp (39.5 mg) as a 
colorless solid and 3mo (19.0 mg) as a colorless oily solid and a small amount (5.00 mg) was 
obtained as a mixture of 3mp and 3mo (combined yield = 63.5 mg, 96%; 3mp:3mo = 64:36). For 
3mp: Mp 89–90.5 °C; TLC (4% EtOAc/hexanes) Rf = 0.35; 
1H NMR (400 MHz, CDCl3) δ 7.85 (s, 
1H), 6.98 (s, 1H), 3.04 (s, 2H), 2.23 (d, J = 3.5 Hz, 6H), 1.30 (s, 6H); 13C NMR (101 MHz, CDCl3) 
δ 198.6, 143.1, 138.5, 133.9, 130.9, 128.0, 127.7, 41.1, 39.6, 23.8 (2C), 20.0, 19.3; IR (neat) 1671, 
1597 cm–1; HRMS (ESI) m/z calcd for C13H17OS [M + H]
+: 221.1000, found: 221.0970. For 3mo: 
TLC (4% EtOAc/hexanes) Rf = 0.43; 
1H NMR (400 MHz, CDCl3) δ 7.08 (d, J = 8.0 Hz, 1H), 6.98 





CDCl3) δ 203.3, 140.4, 138.7, 135.4, 133.2, 132.1, 124.8, 44.7, 40.5, 24.3 (2C), 20.6, 18.0; IR 
(neat) 1676 cm–1; HRMS (ESI) m/z calcd for C13H17OS [M + H]
+: 221.1000, found: 221.0992.  
 
Rel-(4aS,9aS)-6,7-Dimethoxy-2,3,4,4a-tetrahydro-1H-thioxanthen-9(9aH)-one (3nα) and 
Rel- (4aS,9aR)-6,7-Dimethoxy-2,3,4,4a-tetrahydro-1H-thioxanthen-9(9aH)-one (3nβ):  
Following the general procedure C, rel-(1S,2S)-2-((3,4-
dimethoxyphenyl)thio)cyclohexanecarboxylic acid] 1n (88.9 mg, 0.300 mmol, 1.0 equiv) was 
converted to rel-(1S,2S)-2-((3,4-dimethoxyphenyl)thio)cyclohexanecarbonyl chloride] 2n with 
oxalyl chloride (50.8 μL, 0.600 mmol, 2.0 equiv) in 30 min. The crude acid chloride 2n was 
dissolved in HFIP (0.75 mL) and the resultant reaction mixture was stirred at rt for 3 h. Purification 
on a Combiflash purification system using a 12 g silica flash column (0–20% EtOAc/hexanes over 
40 min) afforded a partial separation of 3nα (17.5 mg) and remaining as a mixture of 3nα and 3nβ 
(65.4 mg) as very pale orange viscous oils (combined yield = 82.9 mg, 99%; 3nα:3nβ = 93:7). For 
3nα: TLC (20% EtOAc/hexanes, run twice) Rf = 0.59; 
1H NMR (500 MHz, CDCl3) δ 7.59 (s, 1H), 
6.63 (s, 1H), 3.90 (s, 3H), 3.88 (s, 3H), 3.73 (brs, 1H), 2.82 (m, 1H), 2.24 (m, 1H), 1.90–1.74 
(complex, 3H), 1.65 (m, 1H), 1.57–1.48 (complex, 2H), 1.47–1.40 (m, 1H); 13C NMR (126 MHz, 
CDCl3) δ 195.9, 153.9, 147.2, 135.2, 123.0, 110.8, 109.0, 56.4, 56.2, 48.9, 43.2, 29.9, 24.9, 23.9, 
23.2; IR (neat) 1656, 1592 cm–1; HRMS (ESI) m/z calcd for C15H19O3S [M + H]
+: 279.1055, found: 
279.1046. For 3nβ: TLC (20% EtOAc/hexanes, run twice) Rf = 0.64; Characteristic peaks only for 
3nβ in a mixture (3nα:3nβ = ca. 91:9): 





3.87 (s, 3H), 3.86 (s, 3H), 3.31 (td, J = 12.2, 4.0 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 195.0, 
153.6, 135.3, 123.8, 110.9, 108.6, 51.7, 45.3, 32.2, 26.4, 25.5, 25.4.    
 
Anthracen-9(10H)-one (3o):244 
Following the general procedure C, α-phenyl-o-toluic acid 1o (63.6 mg, 0.300 mmol, 1.0 equiv) 
was converted to 2-benzylbenzoyl chloride 2o using oxalyl chloride (50.8 μL, 0.600 mmol, 2.0 
equiv) in 30 min. The crude acid chloride 2o was dissolved in HFIP (0.75 mL) and the resultant 
reaction mixture was stirred at rt for 5 h. Purification on a Combiflash purification system using a 
silica flash column (90:10 hexanes/EtOAc) afforded 3o (45.0 mg, 77%) as a colorless solid. The 
spectral data matched literature values.  
 
10-Methyl-7,8-dihydropyrido[1,2-a]indol-9(6H)-one (3p):245 
Following the general procedure C, 4-(3-methyl-1H-indol-1-yl)butanoic acid 1p (65.0 mg, 0.300 
mmol, 1.0 equiv) was converted to 4-(3-methyl-1H-indol-1-yl)butanoyl chloride 2p using oxalyl 
chloride (50.8 μL, 0.600 mmol, 2.0 equiv) in 30 min. The crude acid chloride 2p was dissolved in 





Combiflash purification system using a silica flash column (80:20 hexanes/EtOAc) afforded 3p 
(43.0 mg, 72%) as a brown solid. The spectral data matched literature values. 
 
12-Methylindolo[1,2-b]isoquinolin-11(6H)-one (3q):  
Following the general procedure C, 2-((3-methyl-1H-indol-1-yl)methyl)benzoic acid 1q (79.6 mg, 
0.300 mmol, 1.0 equiv) was converted to 2-((3-methyl-1H-indol-1-yl)methyl)benzoyl chloride 2q 
using oxalyl chloride (50.8 μL, 0.600 mmol, 2.0 equiv) in 90 min. The crude acid chloride 2q was 
dissolved in HFIP (0.75 mL) and the resultant reaction mixture was stirred at rt for 5 h. Purification 
on a Combiflash purification system using a silica flash column (50:50 hexanes/EtOAc) afforded 
3q (54.0 mg, 73%) as a yellow solid. Mp 203–205 °C; TLC (50% EtOAc/hexanes) Rf = 0.70; 
1H 
NMR (400 MHz, CDCl3) δ 8.36 (dd, J = 7.9, 1.4 Hz, 1H), 7.79 (dd, J = 8.1, 1.0 Hz, 1H), 7.63 (td, 
J = 7.5, 1.4 Hz, 1H), 7.56–7.50 (m, 1H), 7.49–7.41 (m, 3H), 7.25–7.20 (m, 1H), 5.46 (s, 2H), 2.90–
2.77 (m, 3H); 13C NMR (101 MHz, CDCl3) δ 178.9, 136.8, 136.1 (2C), 133.0, 131.8, 128.2, 128.1, 
127.3, 126.3, 126.2, 121.7, 120.8, 120.3, 110.1, 44.6, 10.5; IR (neat) 1644 cm–1; HRMS (ESI) m/z 
calcd for C17H14NO [M + H]








Following the general procedure C, 2-phenoxybenzoic acid 1r (64.3 mg, 0.300 mmol, 1.0 equiv) 
was converted to 2-phenoxybenzoyl chloride 2r using oxalyl chloride (50.8 μL, 0.600 mmol, 2.0 
equiv) in 45 min. The crude acid chloride 2r was dissolved in HFIP (0.75 mL) and the resultant 
reaction mixture was stirred at rt for 4 h. Purification on a Combiflash purification system using a 
4 g silica flash column (0– 5% EtOAc/hexanes over 50 min) afforded 3r (45.4 mg, 77%) as a 
colorless solid. The spectral data matched literature values. 
 
1,2,3-Trimethoxy-9H-xanthen-9-one (3s):200 
Following the general procedure C, 2-(3,4,5-trimethoxyphenoxy)benzoic acid 1s (91.0 mg, 0.300 
mmol, 1.0 equiv) was converted to 2-(3,4,5-trimethoxyphenoxy)benzoyl chloride 2s using oxalyl 
chloride (50.8 μL, 0.600 mmol, 2.0 equiv) in 60 min. The crude acid chloride 2s was dissolved in 
HFIP (0.75 mL) and the resultant reaction mixture was stirred at rt for 5 h. Purification on a 
Combiflash purification system using a silica flash column (50:50 hexanes/EtOAc) afforded 3s 
(80.0 mg, 93%) as a colorless solid. Mp 125–127 °C; TLC (50% EtOAc/hexanes) Rf = 0.60; 
1H 
NMR (400 MHz, CDCl3) δ 8.29 (dd, J = 8.0, 1.7 Hz, 1H), 7.65 (ddd, J = 8.6, 7.1, 1.7 Hz, 1H), 
7.41–7.37 (m, 1H), 7.34 (ddd, J = 8.1, 7.1, 1.1 Hz, 1H), 6.74 (s, 1H), 4.03 (s, 3H), 3.98 (s, 3H), 
3.91 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 175.5, 158.9, 155.3, 154.7, 153.7, 139.7, 134.0, 126.8, 
124.0, 122.6, 117.2, 111.0, 96.2, 62.2, 61.7, 56.4; IR (neat) 2946, 1650, 1598 cm–1; HRMS (ESI) 
m/z calcd for C16H15O5 [M + H]







Following the general procedure C, 2-((3,4-dimethoxyphenyl)thio)benzoic acid 1t (87.1 mg, 0.300 
mmol, 1.0 equiv) was converted to 2-((3,4-dimethoxyphenyl)thio)benzoyl chloride 2t using oxalyl 
chloride (50.8 μL, 0.600 mmol, 2.0 equiv) in 60 min. The crude acid chloride 2t was dissolved in 
HFIP (0.75 mL) and the resultant reaction mixture was stirred at rt for 2.5 h. Purification on a 
Combiflash purification system using a 12 g silica flash column (0–40% EtOAc/hexanes over 40 
min) afforded 3t (76.3 mg, 93%) as a creamish-yellow solid. Mp 174.5–177.5 °C (lit.201 mp: 172–
173 °C); TLC (2% MeOH/DCM) Rf = 0.25; 
1H NMR (400 MHz, CDCl3) δ 8.58 (m, 1H), 7.99 (s, 
1H), 7.56–7.48 (m, 2H), 7.43 (m, 1H), 6.84 (s, 1H), 3.98 (s, 3H), 3.95 (s, 3H); 13C NMR (101 
MHz, CDCl3) δ 178.7, 153.5, 148.8, 137.1, 131.7, 131.4, 129.8, 128.8, 126.2, 125.9, 123.3, 110.2, 
106.7, 56.4, 56.3; IR (neat) 1625, 1588 cm–1; HRMS (ESI) m/z calcd for C15H13O3S [M + H]
+: 








9-Chloro-4-methyl-1H-pyrrolo[3,2,1-de]acridin-6(2H)-one (3u):  
Following the general procedure C, 4-chloro-2-(5-methylindolin-1-yl)benzoic acid (ca. 94% pure) 
1u (86.3 mg, 0.300 mmol, 1.0 equiv) was converted to 4-chloro-2-(5-methylindolin-1-yl)benzoyl 
chloride 2u using oxalyl chloride (33.0 μL, 0.390 mmol, 1.3 equiv) in 25 min (oxalyl chloride was 
added over 5 min). The crude acid chloride 2u was dissolved in HFIP (0.75 mL) and the resultant 
reaction mixture was stirred at rt for 3 h. Purification on a Combiflash purification system using a 
12 g silica flash column (0– 5% MeOH/DCM over 50 min) provided impure 3u as an insoluble 
yellow fluorescent solid. Trituration of impure 3u with CD2Cl2 and filtration under suction 
(including additional washings by CD2Cl2) afforded pure 3u (66.2 mg, 82%) as a bright yellow 
fluorescent solid (almost insoluble in all solvents). TLC (2% MeOH/DCM) Rf = 0.27; 
1H NMR 
(500 MHz, CD2Cl2) δ 8.41 (d, J = 8.7 Hz, 1H), 7.83 (m, 1H), 7.39 (m, 1H), 7.30 (d, J = 1.9 Hz, 
1H), 7.21 (dd, J = 8.7, 1.9 Hz, 1H), 4.49 (dd, J = 8.4, 7.7 Hz, 2H), 3.57 (t, J = 8.0 Hz, 2H), 2.47 
(s, 3H); 13C NMR (126 MHz, CD2Cl2) δ 176.7, 144.1, 140.8, 139.6, 133.1, 132.5, 130.2, 130.0, 
122.3, 121.7, 121.5, 119.1, 114.1, 49.0, 28.1, 21.6; IR (neat) 1627, 1610 cm–1; HRMS (ESI) m/z 
calcd for C16H13ClNO [M + H]
+: 270.0686, found: 270.0678.  
 
8-Methoxydibenzo[b,e]thiepin-11(6H)-one (3v):179,202  
Following the general procedure C, 2-((3-methoxybenzyl)thio)benzoic acid 1v (82.3 mg, 0.300 
mmol, 1.0 equiv) was converted to 2-((3-methoxybenzyl)thio)benzoyl chloride 2v with oxalyl 





HFIP (0.75 mL) and the resultant reaction mixture was stirred at rt for 4 h. Purification on a 
Combiflash purification system using a 12 g silica flash column (0–10% EtOAc/hexanes over 50 
min) afforded 3v (62.3 mg, 81%) as a colorless solid. The spectral data matched literature values. 
 
6,7,8,9-Tetrahydro-5H-cyclohepta[4,5]benzo[1,2-d][1,3]dioxol-5-one (3w):  
Following the general procedure C, 5-(benzo[d][1,3]dioxol-5-yl)pentanoic acid 1w (66.7 mg, 
0.300 mmol, 1.0 equiv) was converted to 5-(benzo[d][1,3]dioxol-5-yl)pentanoyl chloride 2w using 
oxalyl chloride (50.8 μL, 0.600 mmol, 2.0 equiv) in 30 min. The crude acid chloride 2w was 
dissolved in HFIP (0.75 mL) and the resultant reaction mixture was stirred at rt for 6 h. Purification 
on a Combiflash purification system using a 12 g silica flash column (0–20% EtOAc/hexanes over 
40 min) afforded 3w (36.3 mg, 59%) as a pale yellow viscous oil. TLC (30% EtOAc/hexanes) Rf 
= 0.66; 1H NMR (400 MHz, CDCl3) δ 7.26 (s, 1H), 6.63 (s, 1H), 5.97 (s, 2H), 2.84 (m, 2H), 2.68 
(m, 2H), 1.86–1.73 (complex, 4H); 13C NMR (101 MHz, CDCl3) δ 203.9, 151.1, 146.8, 138.4, 
132.8, 109.8, 108.8, 101.8, 40.8, 32.7, 25.2, 20.6; IR (neat) 1660, 1615 cm–1; HRMS (ESI) m/z 
calcd for C12H13O3 [M + H]







2,3-Dimethoxy-6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-one (3x):246  
Following the general procedure C, 5-(3,4-dimethoxyphenyl)pentanoic acid 1x (71.4 mg, 0.300 
mmol, 1.0 equiv) was converted to 5-(3,4-dimethoxyphenyl)pentanoyl chloride 2x using oxalyl 
chloride (50.8 μL, 0.600 mmol, 2.0 equiv) in 30 min. The crude acid 2x was dissolved in HFIP 
(0.75 mL) and the resultant reaction mixture was stirred at rt for 5 h. Purification on a Combiflash 
purification system using a silica flash column (80:20 hexanes/EtOAc) afforded 3x (37.0 mg, 56%) 
as a colorless solid. The spectral data matched literature values.  
 
2,4-Dimethoxy-6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-one (3y): 
Following the general procedure C, 5-(3,5-dimethoxyphenyl)pentanoic acid 1y (65.0 mg, 0.300 
mmol, 1.0 equiv) was converted to 5-(3,5-dimethoxyphenyl)pentanoyl chloride 2y using oxalyl 
chloride (50.8 μL, 0.600 mmol, 2.0 equiv) in 30 min. The crude acid chloride 2y was dissolved in 
HFIP (0.75 mL) and the resultant reaction mixture was stirred at rt for 5 h. Purification on a 
Combiflash purification system using S46 a silica flash column (50:50 hexanes/EtOAc) afforded 
3y (40.0 mg, 61%) as a colorless oil. TLC (50% EtOAc/hexanes) Rf = 0.40; 
1H NMR (400 MHz, 
CDCl3) δ 6.36 (d, J = 2.2 Hz, 1H), 6.26 (d, J = 2.2 Hz, 1H), 3.83 (s, 3H), 3.79 (s, 3H), 2.72 (dd, J 
= 7.1, 5.4 Hz, 2H), 2.67–2.54 (m, 2H), 1.77 (m, 4H); 13C NMR (101 MHz, CDCl3) δ 206.7, 162.3, 
158.6, 142.0, 122.5, 105.8, 97.1, 56.1, 55.5, 42.3, 33.0, 25.5, 22.2; IR (neat) 2935, 1683, 1597    
cm-1; HRMS (ESI) m/z calcd for C13H17O3 [M + H]







Following the general procedure C, 5-(thiophen-3-yl)pentanoic acid 1z (55.3 mg, 0.300 mmol, 1.0 
equiv) was converted to 5-(thiophen-3-yl)pentanoyl chloride 2z using oxalyl chloride (50.8 μL, 
0.600 mmol, 2.0 equiv) in 30 min. The crude acid chloride 2z was dissolved in HFIP (0.75 mL) 
and the resultant reaction mixture was stirred at rt for 5 h. Purification on a Combiflash purification 
system using a silica flash column (90:10 hexanes/EtOAc) afforded 3z (36.0 mg, 72%) as a 
colorless oil. The spectral data matched literature values. 
 
7,8,9,10-Tetrahydro-6H-benzo[b]cyclohepta[d]thiophen-6-one (3aa):  
Following the general procedure C, 5-(benzo[b]thiophen-3-yl)pentanoic acid 1aa (70.0 mg, 0.300 
mmol, 1.0 equiv) was converted to 5-(benzo[b]thiophen-3-yl)pentanoyl chloride 2aa using oxalyl 
chloride (50.8 μL, 0.600 mmol, 2.0 equiv) in 30 min. The crude acid chloride 2aa was dissolved 
in HFIP (0.75 mL) and the resultant reaction mixture was stirred at rt for 5 h. Purification on a 
Combiflash purification system using a silica flash column (50:50 hexanes/EtOAc) afforded 3aa 
(44.0 mg, 68%) as an off-white solid. Mp 82–83 °C; TLC (50% EtOAc/hexanes) Rf = 0.60; 
1H 





(m, 2H), 2.17–1.94 (m, 4H); 13C NMR (101 MHz, CDCl3) δ 197.4, 143.3, 141.6, 141.2, 140.1, 
127.5, 124.6, 124.0, 123.2, 42.3, 27.1, 25.6, 21.8; IR (neat) 1689, 1616 cm–1; HRMS (ESI) m/z 
calcd for C13H13OS [M + H]
+: 217.0687, found: 217.0693.  
 
6,7,8,9-Tetrahydro-10H-cyclohepta[b]benzofuran-10-one (3ab):  
Following the general procedure C, 5-(benzofuran-2-yl)pentanoic acid 1ab (65.5 mg, 0.300 mmol, 
1.0 equiv) was converted to 5-(benzofuran-2-yl)pentanoyl chloride 2ab using oxalyl chloride (50.8 
μL, 0.600 mmol, 2.0 equiv) in 30 min. The crude acid chloride 2ab was dissolved in HFIP (0.75 
mL) and the resultant reaction mixture was stirred at rt for 5 h. Purification on a Combiflash 
purification system using a silica flash column (50:50 hexanes/EtOAc) afforded 3ab (43.0 mg, 
72%) as a colorless solid. Mp 73– 75 °C; TLC (50% EtOAc/hexanes) Rf = 0.30; 
1H NMR (400 
MHz, CDCl3) δ 8.29–8.21 (m, 1H), 7.43– 7.36 (m, 1H), 7.33–7.26 (m, 2H), 3.25–3.15 (m, 2H), 
2.91–2.81 (m, 2H), 2.17–2.05 (m, 2H), 2.05–1.95 (m, 2H); 13C NMR (101 MHz, CDCl3) δ 197.7, 
166.2, 153.9, 127.0, 125.0, 124.3, 122.9, 118.3, 110.5, 45.1, 30.1, 24.8, 22.8; IR (neat) 1638, 1580 
cm–1; HRMS (ESI) m/z calcd for C13H13O2 [M + H]









Following the general procedure C, 3-(3-thienyl)propanoic acid 1ac (47.0 mg, 0.300 mmol, 1.0 
equiv) was converted to 3-(thiophen-3-yl)propanoyl chloride 2ac using oxalyl chloride (38.1 μL, 
0.450 mmol, 1.5 equiv) in 15 min. The crude acid chloride 2ac was dissolved in HFIP (1.5 mL) 
and the resultant reaction mixture was stirred at rt for 16 h. Purification on a Combiflash 
purification system using a silica flash column (90:10 hexanes/EtOAc) afforded 3ac (6.00 mg, 
14%) as a colorless solid. The spectral data matched literature values. 
 
4-Methyl-1,2-dihydrocyclopenta[b]indol-3(4H)-one (3ad):207,208 
Following the general procedure C, 3-(1-methyl-1H-indol-3-yl)propanoic acid 1ad (61.0 mg, 
0.300 mmol, 1.0 equiv) was converted to 3-(1-methyl-1H-indol-3-yl)propanoyl chloride 2ad using 
oxalyl chloride (50.8 μL, 0.600 mmol, 2.0 equiv) in 30 min. The crude acid chloride 2ad was 
dissolved in HFIP (0.75 mL) and the resultant reaction mixture was stirred at rt for 4 h. Purification 
on a Combiflash purification system using a 4 g silica flash column (0–30% EtOAc/hexanes over 








dihydro-6Hpyrrolo[ 3,2,1-ij]quinolin-6-one (3ae2 and 3ae7):  
Following the general procedure C, 2,2-dimethyl-3-(3-methyl-1H-indol-1-yl)propanoic acid 1ae 
(69.0 mg, 0.300 mmol, 1.0 equiv) was converted to 2,2-dimethyl-3-(3-methyl-1H-indol-1-
yl)propanoyl chloride 2ae using oxalyl chloride (50.8 μL, 0.600 mmol, 2.0 equiv) in 30 min. The 
crude acid chloride 2ae was dissolved in HFIP (0.75 mL) and the resultant reaction mixture was 
stirred at rt for 5 h. Purification on a Combiflash purification system using a silica flash column 
(90:10 hexanes/EtOAc) afforded an inseparable mixture of 3ae2 and 3ae7 (50.0 mg, 78%, 
3ae2:3ae7 = 85:15) as a pale yellow oil. TLC (10% EtOAc/hexanes) Rf = 0.80 (overlapping spots 
of 3ae2 and 3ae7). 3ae2: 1H NMR (400 MHz, CDCl3) 7.74–7.70 (m, 1H), 7.37–7.33 (m, 2H), 7.17 
(ddd, J = 8.1, 5.7, 2.2 Hz, 1H), 4.15 (s, 2H), 2.58 (s, 3H), 1.39 (s, 6H). 13C NMR (101 MHz, 
CDCl3) δ 199.3, 135.2, 132.6, 131.3, 125.3 (2C), 122.2, 120.5, 110.6, 54.6, 50.2, 24.9 (2C), 9.0. 
3ae7: Characteristic peaks only: 1H NMR (400 MHz, CDCl3) 7.77 (dd, J = 7.8, 0.9 Hz, 1H), 6.94 
(d, J = 1.2 Hz, 1H), 4.07 (s, 2H), 2.36 (d, J = 1.1 Hz, 3H), 1.30 (s, 6H). 13C NMR (101 MHz, 
CDCl3) δ 128.7, 125.6, 119.8, 119.5, 116.4, 113.2, 55.8, 43.6, 23.7, 9.9. For the mixture of 3ae2 
and 3ae7: IR (neat) 1698, 1568 cm–1; HRMS (ESI) m/z calcd for C14H16NO [M + H]
+: 214.1232, 






11-Methyl-10H-indolo[1,2-a]indol-10-one (3af):  
Following the general procedure C, 2-(3-methyl-1H-indol-1-yl)benzoic acid 1af (75.3 mg, 0.300 
mmol, 1.0 equiv) was converted to 2-(3-methyl-1H-indol-1-yl)benzoyl chloride 2af using oxalyl 
chloride (33.0 μL, 0.390 mmol, 1.3 equiv) in 50 min (oxalyl chloride was added over 10 min). The 
crude acid chloride 2af was dissolved in HFIP (0.75 mL) and the resultant reaction mixture was 
stirred at rt for 2.5 h. Purification on a Combiflash purification system using a 12 g silica flash 
column (0–15% EtOAc/hexanes over 30 min) afforded 3af (60.6 mg, 87%) as an orange-brown 
solid. Mp 153–156 °C; TLC (2% MeOH/DCM) Rf = 0.62; 
1H NMR (400 MHz, CDCl3) δ 7.62 
(ddd, J = 7.5, 1.2, 0.58 Hz, 1H), 7.56 (dt, J = 8.0, 0.90 Hz, 1H), 7.46 (td, J = 7.8, 1.3 Hz, 1H), 
7.43–7.36 (m, 2H), 7.27 (m, 1H), 7.10 (ddd, J = 8.1, 6.6, 1.5 Hz, 1H), 7.03 (td, J = 7.5, 0.78 Hz, 
1H), 2.54 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 182.1, 145.2, 135.2, 134.4, 133.8, 133.0, 130.1, 
128.4, 125.0, 123.4, 123.0, 122.5, 121.5, 111.4, 111.2, 9.5; IR (neat) 1678, 1619 cm–1; HRMS 
(ESI) m/z calcd for C16H12NO [M + H]







2,3-Dimethoxy-9H-fluoren-9-one (3agp) and 1,2-Dimethoxy-9H-fluoren-9-one (3ago):209 
Following the general procedure C, 3',4'-dimethoxy-[1,1'-biphenyl]-2-carboxylic acid 1ag (77.5 
mg, 0.300 mmol, 1.0 equiv) was converted to 3',4'-dimethoxy-[1,1'-biphenyl]-2-carbonyl chloride 
2ag using oxalyl chloride (50.8 μL, 0.600 mmol, 2.0 equiv) in 45 min. The crude acid chloride 
2ag was dissolved in HFIP (0.75 mL) and the resultant reaction mixture was stirred at rt for 2.5 h. 
Purification on a Combiflash purification system using a 12 g silica flash column (0–30% 
EtOAc/hexanes over 30 min) afforded a complete separation of 3agp (65.5 mg, 91%) as an orange 
solid and 3ago (1.50 mg, 2%) as a yellowish orange solid (combined yield = 67.0 mg, 93%; 
3agp:3ago = 98:2). The spectral data matched literature values. 
 
1-Fluoro-6-isopropoxy-9H-fluoren-9-one (3ahp) and 1-Fluoro-8-isopropoxy-9H-fluoren-9-
one (3aho):  
Following the general procedure C, 3-fluoro-3'-isopropoxy-[1,1'-biphenyl]-2-carboxylic acid 1ah 
(82.3 mg, 0.300 mmol, 1.0 equiv) was converted to 3-fluoro-3'-isopropoxy-[1,1'-biphenyl]-2-
carbonyl chloride 2ah using oxalyl chloride (50.8 μL, 0.600 mmol, 2.0 equiv) in 45 min. The crude 
acid chloride 2ah was dissolved in HFIP (0.75 mL) and the resultant reaction mixture was stirred 
at rt for 3.5 h. Purification on a Combiflash purification system using a 12 g silica flash column 
(0–10% EtOAc/hexanes over 40 min) afforded a mixture of 3ahp and 3aho (combined yield = 76.3 





by 1H NMR): TLC (15% EtOAc/hexanes) Rf = 0.39; 
1H NMR (400 MHz, CDCl3) δ 7.54 (3ahp; 
d, J = 8.3 Hz, 1H), 7.41–7.34 (3ahp and 3aho; m, 3H), 7.22 (3aho; d, J = 7.4 Hz, 1H), 7.20 (3ahp; 
d, J = 7.3 Hz, 1H), 7.05 (3aho; dd, J = 7.3, 0.60 Hz, 1H), 6.94 (3ahp; d, J = 2.1 Hz, 1H), 6.89–6.84 
(3ahp and 3aho; m, 2H), 6.80 (3aho; d, J = 8.4 Hz, 1H), 6.69 (3ahp; dd, J = 8.3, 2.2 Hz, 1H), 4.72–
4.59 (3ahp and 3aho; m, 2H), 1.40 (3aho; d, J = 6.1 Hz, 6H), 1.36 (3ahp; d, J = 6.1 Hz, 6H); 
13C 
NMR (For 3ahp; 101 MHz, CDCl3) δ 188.9 (d, J = 0.97 Hz, 1C), 164.0, 159.1 (d, J = 262.4 Hz, 
1C), 146.1 (d, J = 3.4 Hz, 1C), 145.6 (d, J = 3.9 Hz, 1C), 136.4 (d, J = 8.4 Hz, 1C), 136.3, 126.46, 
121.1 (d, J = 12.8 Hz, 1C), 117.8 (d, J = 20.9 Hz, 1C), 116.3 (d, J = 3.1 Hz, 1C, completely 
overlapped with 3aho peak), 115.2, 108.7, 70.8, 22.1 (2C); (For 3aho; 101 MHz, CDCl3) δ 188.0 
(d, J = 1.2 Hz, 1C), 159.2 (d, J = 262.8 Hz, 1C), 157.5, 145.6 (1C, overlapped with 3ahp peak), 
145.5 (d, J = 3.7 Hz, 1C), 136.1 (d, J = 8.3 Hz, 1C), 126.54, 121.2, 120.4 (d, J = 12.4 Hz, 1C), 
117.5 (d, J = 20.7 Hz, 1C), 117.3, 116.3 (d, J = 3.1 Hz, 1C, completely overlapped with 3ahp 
peak), 113.3, 72.2, 22.2 (2C); IR (neat; for a mixture of 3ahp and 3aho) 1703, 1619 cm
–1; HRMS 
(ESI) m/z calcd for C16H14FO2 [M + H]




Following the general procedure C, 3',5'-dimethoxy-[1,1'-biphenyl]-2-carboxylic acid 1ai (77.5 
mg, 0.300 mmol, 1.0 equiv) was converted to 3',5'-dimethoxy-[1,1'-biphenyl]-2-carbonyl chloride 





was dissolved in HFIP (0.75 mL) and the resultant reaction mixture was stirred at rt for 2.5 h. 
Purification on a Combiflash purification system using a 12 g silica flash column (0–50% 
EtOAc/hexanes over 25 min) afforded 3ai (71.5 mg, 99%) as a light yellow solid. The spectral 
data matched literature values.  
 
6-Chloro-1,3-dimethyl-9H-fluoren-9-one (3aj):  
Following the general procedure C, 5-chloro-3',5'-dimethyl-[1,1'-biphenyl]-2-carboxylic acid 1aj 
(78.2 mg, 0.300 mmol, 1.0 equiv) was converted to 5-chloro-3',5'-dimethyl-[1,1'-biphenyl]-2-
carbonyl chloride 2aj using oxalyl chloride (50.8 μL, 0.600 mmol, 2.0 equiv) in 45 min. The crude 
acid chloride 2aj was dissolved in HFIP (0.75 mL) and the resultant reaction mixture was stirred 
at rt for 3 h. Purification on a Combiflash purification system using a 12 g silica flash column (0–
5% EtOAc/hexanes over 50 min) afforded 3aj (70.5 mg, 97%) as a light yellow solid. Mp 159.5–
161 °C; TLC (15% EtOAc/hexanes) Rf =  0.67; 
1H NMR (400 MHz, CDCl3) δ 7.45 (d, J = 7.8 Hz, 
1H), 7.31 (d, J = 1.7 Hz, 1H), 7.17 (dd, J = 7.8, 1.8 Hz, 1H), 7.00 (s, 1H), 6.80 (s, 1H), 2.51 (s, 
3H), 2.31 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 193.1, 145.5, 145.2, 143.9, 140.3, 139.7, 133.3, 
133.1, 129.0, 128.8, 124.8, 120.5, 119.2, 22.1, 17.8; IR (neat) 1701, 1599 cm–1; HRMS (ESI) m/z 
calcd for C15H12ClO [M + H]






5,7-Dimethoxy-8H-indeno[2,1-b]thiophen-8-one (3ak):  
Following the general procedure C, 3-(3,5-dimethoxyphenyl)thiophene-2-carboxylic acid 1ak 
(79.3 mg, 0.300 mmol, 1.0 equiv) was converted to 3-(3,5-dimethoxyphenyl)thiophene-2-carbonyl 
chloride 2ak using oxalyl chloride (50.8 μL, 0.600 mmol, 2.0 equiv) in 60 min. The crude acid 
chloride 2ak was dissolved in HFIP (0.75 mL) and the resultant reaction mixture was stirred at rt 
for 4 h. Purification on a Combiflash purification system using a 12 g silica flash column (0–40% 
EtOAc/hexanes over 40 min) afforded 3ak (53.0 mg, 72%) as a yellowish-orange solid. Mp 169.5–
172 °C; TLC (30% EtOAc/hexanes) Rf = 0.28; 
1H NMR (400 MHz, CDCl3) δ 7.57 (d, J = 4.7 Hz, 
1H), 7.00 (d, J = 4.7 Hz, 1H), 6.35 (d, J = 1.9 Hz, 1H), 6.10 (d, J = 1.9 Hz, 1H), 3.89 (s, 3H), 3.82 
(s, 3H); 13C NMR (101 MHz, CDCl3) δ 183.3, 166.8, 159.5, 155.0, 143.6, 139.3, 136.8, 119.9, 
115.5, 101.5, 96.5, 56.0, 55.9; IR (neat) 1711, 1688, 1616, 1591, 1215, 1130, 1048 cm–1; HRMS 
(ESI) m/z calcd for C13H11O3S [M + H]
+: 247.0429, found: 247.0399.   
 
9H-Fluoren-9-one (3al):248,249 
Following the general procedure C, 1,1'-biphenyl]-2-carboxylic acid 1al (59.5 mg, 0.300 mmol, 





0.600 mmol, 2.0 equiv) in 45 min. The crude acid chloride 2al was dissolved in HFIP (0.75 mL) 
and the resultant reaction mixture was stirred at rt for 4 h. Purification on a Combiflash purification 
system using a 12 g silica flash column (0–5% EtOAc/hexanes over 50 min) afforded 3al (6.50 
mg, 12%) as a yellow oily solid. The spectral data matched literature values. 
 
6,8-Dimethoxyphenanthren-9-ol (3am):  
Following the general procedure C, 2-(3',5'-dimethoxy-[1,1'-biphenyl]-2-yl)acetic acid 1am (82.0 
mg, 0.300 mmol, 1.0 equiv) was converted to 2-(3',5'-dimethoxy-[1,1'-biphenyl]-2-yl)acetyl 
chloride 2am using oxalyl chloride (50.8 μL, 0.600 mmol, 2.0 equiv) in 30 min. The crude acid 
chloride 2am was dissolved in HFIP (0.75 mL) and the resultant reaction mixture was stirred at rt 
for 5 h. Purification on a Combiflash purification system using a silica flash column (50:50 
hexanes/EtOAc) afforded 3am (50.0 mg, 66%) as a yellow solid. Mp 143–144 °C; TLC (50% 
EtOAc/hexanes) Rf = 0.70; 
1H NMR (400 MHz, CDCl3) δ 9.33 (s, 1H), 8.47–8.39 (m, 1H), 7.73–
7.65 (m, 2H), 7.50 (ddd, J = 8.0, 6.9, 1.2 Hz, 1H), 7.41 (ddd, J = 8.3, 6.9, 1.4 Hz, 1H), 6.97 (s, 
1H), 6.71 (d, J = 2.2 Hz, 1H), 4.09 (s, 3H), 4.02 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 158.8, 
157.7, 152.2, 135.0, 134.5, 127.5, 126.9, 124.9, 123.4, 123.1, 110.8, 105.7, 98.8, 97.6, 56.7, 55.7; 
IR (neat) 3327, 1638, 1615 cm–1; HRMS (ESI) m/z calcd for C16H15O3 [M + H]









Intermolecular Friedel–Crafts acylation reaction promoted by hexafluoro-2-propanol 
3.1 Introduction 
Friedel–Crafts (FC) acylation is one of the most important reactions in both academia and 
industry for the synthesis of aromatic ketones.57,75,250,251 As discussed in the previous chapter, the 
reaction is promoted by Lewis acids (such as AlCl3, FeCl3, SnCl4, ZnCl2, and TiCl4) or protic acids 
(such as H2SO4).
211,252 FC acylation requires at least a stoichiometric amount of catalyst due to 
complex formation between product and catalyst.59 In addition, water workup required in these 
reactions generates acidic waste. Most existing methods that use catalysts in substoichiometric 
amounts typically require high temperatures.  
The FC acylation products have been utilized for the synthesis of natural products and 
pharmaceutically useful compounds (Figure 15). For example aryl ketones have been used to 
prepare the natural products (±)-lacinilene C and aspidospermidine.253,254 In addition, aryl ketones 






Figure 15. FC acylation in natural products and pharmaceutical compound synthesis. 
Considering the ease with which the intramolecular FC acylation worked in our methodology, 
we thought to extend it to a more difficult, intermolecular version of the same reaction. 
3.2 Results and discussion 
We began by studying the FC acylation reaction between 1,3-dimethoxybenzene (1a) and 
benzoyl chloride (2a). To the solution of 1,3-dimethoxybenzene (0.75 mmol, 1.0 equiv) in HFIP, 
benzoyl chloride (0.75 mmol, 1.0 equiv) was added and the resulting mixture stirred for 5 h at 
room temperature. Solvent was evaporated and the crude was purified by column chromatography 
to give 3a/3aʹ in 66% yield (Table 8, entry 1). The ratio of 3a/3aʹ was ca. 92:8, which is similar to 
literature report.256 When DCM was used as cosolvent, 80:20 HFIP/DCM (corresponding to 10 





in intramolecular version,173 THF and acetonitrile (H-bond accepting solvents) gave poor results. 
In the case of THF, in addition to FC products the known THF cleavage 4-chlorobutyl benzoate 
was obtained (Scheme 22).257,258 
Table 8. Effect of solvents on yielda 
 
entry solvent Yield (%)b 
1 HFIP 66 
2 8:92 HFIP/DCMc 0 
3 40:60 HFIP/DCM 39 
4 80:20 HFIP/DCM 63 
5 80:20 HFIP/THF 16d 





aTo 1,3-dimethoxybenzene (0.75 mmol, 1.0 equiv) in solvent (1 mL), was added benzoyl chloride 
(0.75 mmol, 1.0 equiv). The reaction mixture was stirred at rt for 5 h. bIsolated yields (3a/3aʹ ratios 
ca. 92:8 in each case). cReaction did not progress. dIn addition to FC products, 4-chlorobutyl 





Scheme 22. FC acylation using THF as cosolvent 
 
We screened other fluorinated alcohols, trifluoroethanol (TFE) and perfuoro-tert-butanol 
(PFTB), in FC acylation reaction to compare their results with HFIP. However, none of them gave 
FC products (Table 8, entries 7–8). In TFE, we only observed solvolysis products of benzoyl 
chloride. On the contrary, in PFTB, both starting materials were observed (Scheme 23).  
Scheme 23. FC acylation in TFE and PFTB 
 
A similar phenomenon was observed by Qu and coworkers when studying the epoxide-
initiated olefin polycyclizations where in HFIP was effective but TFE and PFTB were not (Scheme 
24).259 These data suggest that HFIP has unique properties that promote these reactions and also 
support the minor role of solvent acidity in promoting these reactions (pKa values: TFE 12.8; HFIP 
9.3; and PFTB 5.4260) (this finding supported the results obtained in Table 6 of chapter 2, where 





similar results to HFIP in the intramolecular version of FC acylation (Chapter 2, Table 6), which 
suggests the possibility of activating the acyl halide by coordination with PFTB, but the relative 
large bulk of solvent might prevent attack by the external nucleophile. 
Scheme 24. Fluorinated alcohols in epoxide initiated polycyclizations 
 
An examination of reaction stoichiometry revealed that best results were obtained when the 
nucleophilic arene was used in excess, with the optimal ratio being about 3:1 arene/acyl chloride 
(Table 9, entries 2–4; yields based on acyl chloride). In addition, when benzoyl chloride was added 











Table 9. Further exploration of reaction conditionsa 
entry 1a (equiv) Yield (%)b (3a/3a’) 
1 1 66 
2 2 80 
3 3 84 
4 4 80 
5c 1 66 
aTo 1,3-dimethoxybenzene in HFIP (1 mL), was added benzoyl chloride (0.75 mmol, 1 equiv). 
The reaction mixture was stirred at rt for 5 h. bIsolated yields (3a/3aʹ ratios ca. 92:8 in each case). 
cBenzoyl chloride was added in portionwise over a period of 2 h. 
The scope of the reaction was explored using the optimized conditions of 3:1 ketone/acyl 
chloride stoichiometry (Table 9, entry 3). Electron-rich arenes worked well giving product ketones 
in moderate to good yields (3a–3i, Figure 16). Reaction of anisole (singly-activated benzene) with 
benzoyl chloride resulted 3j in 34% yield. However, benzene was failed to give FC product 3k 
under our conditions. Pyrrole, indoles, and benzothiphenes reacted with acyl chlorides under these 
conditions to give heteroaryl ketones (3l–3s). Ferrocene gave benzoylferrocene 3t in 62% yield 
















Benzoyl chloride with different substituents at the para-position were explored. In FC 
acylation with 1,3,5-trimethoxybenzene, both containing electron-donating and some electron-
withdrawing substituents gave product ketones in good yields (3u–3y). Though, reaction of arene 
and strongly deactivated p-NO2-benzoyl chloride was failed to give product ketone (3z). 
A common concern of HFIP is that it is expensive, however it can be procured at relatively 
low prices from specialty vendors ($0.16/g for 1 kg, Oakwood Products, Inc.). In addition, HFIP 
can be recycled at decagram scale with ease (Figure 17). Using HFIP (12 equiv, 57 mL) as solvent, 
1,3,5-trimethoxybenzene 4 (22.7 g, 135 mmol) reacted with benzoyl chloride 2a (6.33 g, 45 mmol) 
at rt to yield product ketone 3f (10.5 g, 86%). HFIP (46 mL) was distilled out directly from the 
reaction pot and 19 mL of which was further used in reaction between 4 and 2a to yield 3.80 g of 
3f (93%). HFIP (18 mL) was again distilled out from this reaction and 9.5 mL of which used in 
third cycle to give 1.85 g of 3f (91%), allowing recovery of solvent (9 mL). As a result, starting 
with 57 mL of HFIP, 16.16 g of 3f was obtained with 45 mL HFIP recovered.  In other words, we 
lost a total of 12 mL of HFIP in this whole process, which was worth ca. $3.17. Moreover, the 






Figure 17. Gram scale reaction. 
3.3 Conclusions 
In conclusion, we have successfully developed a mild and efficient HFIP promoted 
intermolecular FC acylation. Electron-rich arenes and heteroarenes gave good results under our 
conditions. This method is mild and do not require water work up, which is essential in traditional 
methods. Thus, toxic water waste generation is not a concern with this method. 
3.4 Experimental Section 
General information. Reactions were performed under an inert atmosphere (argon or nitrogen) 
in oven-dried glassware. All chemicals were used as received from commercial source without 
further purification. TLC was performed using commercial glass-backed silica plates (250 
microns) with an organic binder. Visualization was accomplished using UV light. Purification was 





IR spectra were acquired as thin films or solids. All NMR spectra (1H, 13C) were acquired on either 
a 400 MHz. Chemical shifts are reported in parts per million (ppm) and are referenced to the center 
line of the solvent ( 7.26 and 2.50 ppm with respect to CDCl3 and DMSO-d6 for 
1H NMR and  
77.16 and 39.52 ppm with respect to CDCl3 and DMSO-d6 for 
13C NMR, respectively). Coupling 
constants are given in Hertz (Hz). HRMS data were collected with an electrospray ion source 
(ESI). Allyl bromide intermediates were failed to give HRMS. Melting points were determined on 
an automated melting point apparatus and are uncorrected.  
List of known compounds 
(2,4-Dimethoxyphenyl)(phenyl)methanone (3a),261 (2,6-dimethoxyphenyl)(phenyl)methanone 
(3a'),262 1-(2,4-dimethoxyphenyl)ethan-1-one (3b),263 1-(2,6-dimethoxyphenyl)ethan-1-one 
(3b'),264 phenyl(2,4,5-trimethoxyphenyl)methanone (3c),261 1-(2,4,5-trimethoxyphenyl)ethan-1-
one (3d),264 1-(2,4-dimethoxyphenyl)-2-methylpropan-1-one (3e),265 phenyl(2,4,6-
trimethoxyphenyl)methanone (3f),266 1-(2,4,6-trimethoxyphenyl)ethan-1-one (3g),267 (3,4-
dimethoxyphenyl)(phenyl)methanone (3i),261 (4-methoxyphenyl)(phenyl)methanone (3j),261 
phenyl(1H-pyrrol-2-yl)methanone (3l2),268 phenyl(1H-pyrrol-3-yl)methanone (3l3),269 (1H-indol-
3-yl)(phenyl)methanone (3m),270 (2-methyl-1H-indol-3-yl)(phenyl)methanone (3n),271 (1-methyl-
1H-indol-3-yl)(phenyl)methanone (3o),272 (1H-indol-3-yl)(4-methoxyphenyl)methanone (3p),273 
1-(1H-indol-3-yl)-2,2-dimethylpropan-1-one (3q),273 (2-methylbenzo[b]thiophen-3-
yl)(phenyl)methanone (3r),274 benzoylferrocene (3t),275 (4-methoxyphenyl)(2,4,6-
trimethoxyphenyl)methanone (3v),276 (4-chlorophenyl)(2,4,6-trimethoxyphenyl)methanone 







General Procedure for Solvent Screening (Table 8) 
To a solution of 1,3-dimethoxybenzene (104 mg, 0.75 mmol, 1.0 equiv) in HFIP and/or specified 
solvent (1.0 mL) in an oven-dried N2-flushed 2-dram vial, benzoyl chloride (87 μL, 0.750 mmol, 
1.0 equiv) was added. The resultant mixture was stirred at room temperature for 5 h. The reaction 
mixture was concentrated and crude was purified on a Combiflash purification system using a 
silica flash column (90:10 hexanes/EtOAc) to afforded 3a/3a' as a mixture. 
General Procedure for Concentration and Stoichiometry Screening (Table 9) 
To a solution of 1,3-dimethoxybenzene (1.0–4.0 equiv as indicated in Table 2) in HFIP (1.0 mL, 
0.5 mL or 0.25 mL as indicated in Table 2) in an oven-dried N2-flushed 2 dram vial, benzoyl 
chloride (87 μL, 0.750 mmol, 1.0 equiv) was added (for entry 7, total amount of benzoyl chloride 
was divided into five portions, and each portion was added at 30 min interval over a period of 2 
h). The resultant mixture was stirred at room temperature for 5 h. The reaction mixture was 
concentrated and crude was purified on a Combiflash purification system using a silica flash 
column (90:10 hexanes/EtOAc) to afforded 3a/3a' as a mixture. 
General Procedure for the Friedel-Crafts reaction in HFIP 
To a solution of arenes or heterocyclic arenes (2.25 mmol, 3.0 equiv) in HFIP (1.0 mL) in an oven-
dried N2-flushed 2-dram vial, acid chloride (0.750 mmol, 1.0 equiv) was added. The resultant 
mixture was stirred at room temperature for 5 h, unless otherwise noted. Reaction mixture was 
concentrated and crude was purified on a Combiflash purification system using a normal phase 






Compound Preparation and Characterization 
 
(2,4-Dimethoxyphenyl)(phenyl)methanone (3a)261 and (2,6-
dimethoxyphenyl)(phenyl)methanone (3a')262 
Following the general procedure, 1,3-dimethoxybenzene (311 mg, 2.25 mmol, 3.0 equiv) was 
reacted with benzoyl chloride (87 μL, 0.750 mmol, 1.0 equiv) to give the known ketones 3a/3a' 
(152 mg, 84%, 3a/3a' = 91/9) as a mixture. 
 
1-(2,4-Dimethoxyphenyl)ethan-1-one (3b)263 and 1-(2,6-dimethoxyphenyl)ethan-1-one 
(3b')264 
Following the general procedure, 1,3-dimethoxybenzene (311 mg, 2.25 mmol, 3.0 equiv) was 
reacted with acetyl chloride (53 μL, 0.750 mmol, 1.0 equiv) to give the known ketones 3b/3b' 







Following the general procedure, 1,2,4-trimethoxybenzene (378 mg, 2.25 mmol, 3.0 equiv) was 
reacted with benzoyl chloride (87 μL, 0.750 mmol, 1.0 equiv) to give the known ketone 3c (111 
mg, 54%) as a yellow solid. 
 
1-(2,4,5-Trimethoxyphenyl)ethan-1-one (3d)264 
Following the general procedure, 1,2,4-trimethoxybenzene (378 mg, 2.25 mmol, 3.0 equiv) was 
reacted with acetyl chloride (53 μL, 0.750 mmol, 1.0 equiv) to give the known ketone 3d (95 mg, 






1-(2,4-Dimethoxyphenyl)-2-methylpropan-1-one (3e)265 and 1-(2,6-dimethoxyphenyl)-2-
methylpropan-1-one (3e') 
Following the general procedure, 1,3-dimethoxybenzene (311 mg, 2.25 mmol, 3.0 equiv) was 
reacted with isobutyryl chloride (79 μL, 0.750 mmol, 1.0 equiv) to give the known ketones 3e/3e' 
(95 mg, 61%, 3e/3e' = 99/1, ratio was determined by GCMS) as a colorless oil. 
 
Phenyl(2,4,6-trimethoxyphenyl)methanone (3f)266 
Following the general procedure, 1,3,5-trimethoxybenzene (378 mg, 2.25 mmol, 3.0 equiv) was 
reacted with benzoyl chloride (87 μL, 0.750 mmol, 1.0 equiv) to give the known ketone 3f (176 
mg, 86%) as a white solid. 
 
1-(2,4,6-Trimethoxyphenyl)ethan-1-one (3g)267 
Following the general procedure, 1,3,5-trimethoxybenzene (378 mg, 2.25 mmol, 3.0 equiv) was 
reacted with acetyl chloride (53 μL, 0.750 mmol, 1.0 equiv) to give the known ketone 3g (145 mg, 







Following the general procedure, 1,3,5-trimethoxybenzene (378 mg, 2.25 mmol, 3.0 equiv) was 
reacted with phenylacetyl chloride (99 μL, 0.750 mmol, 1.0 equiv) to give the title ketone (171 
mg, 84%) as a yellow solid. Mp 66–68 °C; TLC (20% EtOAc/hexanes) Rf = 0.50; 
1H NMR (400 
MHz, CDCl3) δ 7.37.24 (m, 2H), 7.20 (dt, J = 5.8, 1.5 Hz, 3H), 6.06 (s, 2H), 4.03 (s, 2H), 3.80 (s, 
3H), 3.73 (s, 6H); 13C NMR (101 MHz, CDCl3) δ 201.6, 162.5, 158.3, 135.0, 130.0, 128.3, 126.6, 
113.3, 90.7, 55.9, 55.5, 51.7. IR (neat) 1698 cm–1; HRMS (ESI) m/z calcd for C17H19O4 [M + H]
+: 
287.1283, found: 287.1280.  
 
(3,4-Dimethoxyphenyl)(phenyl)methanone (3i)261 
Following the general procedure, 1,2-dimethoxybenzene (311 mg, 2.25 mmol, 3.0 equiv) was 
reacted with benzoyl chloride (87 μL, 0.750 mmol, 1.0 equiv) to give the known ketone 3i (73 mg, 







Following the general procedure, anisole (243 mg, 2.25 mmol, 3.0 equiv) was reacted with benzoyl 
chloride (87 μL, 0.750 mmol, 1.0 equiv) to give the known ketone 3j (69 mg, 34%) as a colorless 
oil. 
 
Phenyl(1H-pyrrol-2-yl)methanone (3l2)268 and phenyl(1H-pyrrol-3-yl)methanone (3l3)269  
Following the general procedure, pyrrole (151 mg, 2.25 mmol, 3.0 equiv) was reacted with benzoyl 
chloride (87 μL, 0.750 mmol, 1.0 equiv) to give the known ketones  3l2 (86 mg, 42%) and 3l3 (21 








Following the general procedure, indole (264 mg, 2.25 mmol, 3.0 equiv) was reacted with benzoyl 




Following the general procedure, 2-methyl-1H-indole (295 mg, 2.25 mmol, 3.0 equiv) was reacted 
with benzoyl chloride (87 μL, 0.750 mmol, 1.0 equiv) to give the known ketone 3n (144 mg, 82%) 
as a yellow solid. 
 
(1-Methyl-1H-indol-3-yl)(phenyl)methanone (3o)272 
Following the general procedure, 1-methyl-1H-indole (295 mg, 2.25 mmol, 3.0 equiv) was reacted 
with benzoyl chloride (87 μL, 0.750 mmol, 1.0 equiv) to give the known ketone 3o (152 mg, 86%) 







Following the general procedure, indole (264 mg, 2.25 mmol, 3.0 equiv) was reacted with 4-
methoxybenzoyl chloride (103 μL, 0.750 mmol, 1.0 equiv) to give the known ketone 3p (99 mg, 
53%) as a brown solid. 
 
1-(1H-Indol-3-yl)-2,2-dimethylpropan-1-one (3q)273 
Following the general procedure, indole (264 mg, 2.25 mmol, 3.0 equiv) was reacted with pivaloyl 









Following the general procedure, 2-methylbenzo[b]thiophene (334 mg, 2.25 mmol, 3.0 equiv) was 
reacted with benzoyl chloride (87 μL, 0.750 mmol, 1.0 equiv) to give the known ketone 3r (121 
mg, 64%) as a white solid. 
 
1-(2-Methylbenzo[b]thiophen-3-yl)ethan-1-one (3s) 
Following the general procedure, 2-methylbenzo[b]thiophene (334 mg, 2.25 mmol, 3.0 equiv) was 
reacted with acetyl chloride (53 μL, 0.750 mmol, 1.0 equiv) to give title ketone (67 mg, 47%) as a 
white solid. Mp 66–68 °C; TLC (20% EtOAc/hexanes) Rf = 0.40; 
1H NMR (400 MHz, CDCl3) δ 
8.18 (dt, J = 8.3, 0.9 Hz, 1H), 7.75 (ddd, J = 8.0, 1.3, 0.7 Hz, 1H), 7.41 (ddd, J = 8.3, 7.1, 1.3 Hz, 
1H), 7.33 (ddd, J = 8.2, 7.1, 1.2 Hz, 1H), 2.79 (s, 3H), 2.66 (s, 3H); 13C NMR (101 MHz, CDCl3) 
196.0, 149.1, 138.5, 137.4, 133.1, 125.3, 124.5, 123.9, 121.8, 32.0, 17.2; IR (neat) 1637 cm–1; 
HRMS (ESI) m/z calcd for C11H11OS [M + H]









Following the general procedure, ferrocene (419 mg, 2.25 mmol, 3.0 equiv) was reacted with 




Following the general procedure, 1,3,5-trimethoxybenzene (378 mg, 2.25 mmol, 3.0 equiv) was 
reacted with 4-methylbenzoyl chloride (99 μL, 0.750 mmol, 1.0 equiv) to give title ketone (190 
mg, 93%) as a white solid. Mp 142–144 °C; TLC (20% EtOAc/hexanes) Rf = 0.50; 
1H NMR (400 
MHz, CDCl3) 7.74 (d, J = 8.2 Hz, 2H), 7.21 (d, J = 8.0 Hz, 2H), 6.17 (s, 2H), 3.86 (s, 3H), 3.68 
(s, 6H), 2.39 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 194.8, 162.4, 158.7, 143.9, 135.9, 129.7, 
129.2, 111.3, 90.8, 55.9, 55.6, 21.8; IR (neat) 1655 cm–1; HRMS (ESI) m/z calcd for C17H19O4 [M 









Following the general procedure, 1,3,5-trimethoxybenzene (378 mg, 2.25 mmol, 3.0 equiv) was 
reacted with 4-methoxybenzoyl chloride (103 μL, 0.750 mmol, 1.0 equiv) to give the known 
ketone 3v (189 mg, 83%) as a white solid. 
 
(4-Fluorophenyl)(2,4,6-trimethoxyphenyl)methanone (3w) 
Following the general procedure, 1,3,5-trimethoxybenzene (378 mg, 2.25 mmol, 3.0 equiv) was 
reacted with 4-fluorobenzoyl chloride (90 μL, 0.750 mmol, 1.0 equiv) to give title ketone (161 mg, 
79%) as a white solid. Mp 152–154 °C; TLC (20% EtOAc/hexanes) Rf = 0.40; 
1H NMR (400 
MHz, CDCl3) δ 7.90–7.81 (m, 2H), 7.11–7.02 (m, 2H), 6.17 (s, 2H), 3.86 (s, 3H), 3.69 (s, 6H); 
13C NMR (101 MHz, CDCl3) δ 193.5, 165.9 (d, JC–F = 255 Hz, 1C), 162.7, 158.8, 134.9 (d, JC– C– 
C–C–F = 3 Hz, 1C), 132.2 (d, JC– C–C–F = 9 Hz, 2C), 115.5 (d, JC–C–F = 22 Hz, 2C), 110.7, 90.8, 55.9, 
55.6; IR (neat) 1657 cm–1; HRMS (ESI) m/z calcd for C16H16FO4 [M + H]









Following the general procedure, 1,3,5-trimethoxybenzene (378 mg, 2.25 mmol, 3.0 equiv) was 
reacted with 4-chlorobenzoyl chloride (96 μL, 0.750 mmol, 1.0 equiv) to give the known ketone 
3x (140 mg, 69%) as a white solid. 
 
(4-Bromophenyl)(2,4,6-trimethoxyphenyl)methanone (3y) 
Following the general procedure, 1,3,5-trimethoxybenzene (378 mg, 2.25 mmol, 3.0 equiv) was 
reacted with 4-bromobenzoyl chloride (165 mg, 0.750 mmol, 1.0 equiv) to give the title ketone 
(151 mg, 74%) as a white solid. Mp 188–190 °C; TLC (20% EtOAc/hexanes) Rf = 0.60; 
1H NMR 
(400 MHz, CDCl3) δ 7.69 (d, J = 8.6 Hz, 2H), 7.54 (d, J = 8.5 Hz, 2H), 6.16 (s, 2H), 3.86 (s, 3H), 
3.68 (s, 6H); 13C NMR (101 MHz, CDCl3) δ 194.0, 162.8, 158.9, 137.2, 131.7, 131.1, 128.1, 110.4, 
90.8, 55.9, 55.6; IR (neat) 1657 cm–1; HRMS (ESI) m/z calcd for C16H16BrO4 [M + H]
+: 351.0232, 
found: 351.0229. 








To a solution of 1,3,5-trimethoxybenzene (22.7 g, 135 mmol, 3.0 equiv) in HFIP (57 mL, 12 
equiv) in an oven-dried flask benzoyl chloride (6.33 g, 5.22 mL, 45 mmol, 1.0 equiv) was added. 
The resultant mixture was stirred at room temperature for 7 h. HFIP solvent was recovered by 
distillation directly from the reaction pot (40–50 ˚C, under vacuum (5 millibar)) (46 mL, 81%). 
The remaining product was purified on a Combiflash purification system using solid loading on a 
silica flash column (80:20 hexanes/EtOAc) to afforded 3f (10.51 g, 86%) as a white solid. 
Second reaction, using recovered HFIP 
 
To a solution of 1,3,5-trimethoxybenzene (7.57 g, 45 mmol, 3.0 equiv) in HFIP (19 mL, 12 
equiv), obtained by distillation from previous reaction, in an oven-dried flask, benzoyl chloride 
(2.11 g, 1.74 mL, 15 mmol, 1.0 equiv) was added. The resultant mixture was stirred at room 
temperature for 7 h. HFIP solvent was recovered by distillation as described above (18 mL, 
95%). The crude was purified on a Combiflash purification system using a silica flash column 








Third reaction, using doubly recovered HFIP 
 
To a solution of 1,3,5-trimethoxybenzene (3.78 g, 22.5 mmol, 3.0 equiv) in HFIP (9.5 mL, 12 
equiv), obtained by distillation from previous reaction, in an oven-dried flask, benzoyl chloride 
(1.05 g, 0.87 mL, 7.5 mmol, 1.0 equiv) was added. The resultant mixture was stirred at room 
temperature for 7 h. HFIP solvent was recovered by distillation (9 mL, 95%). The crude was 
purified on a Combiflash purification system using a silica flash column (80:20 hexanes/EtOAc) 
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